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INDIRECT ANALYSIS OF OLIGONUCLEOTIDES USING CLEAVABLE SMALL 
MOLECULE MASS TAGS WITH DETECTION BY MASS SPECTROMETRY 
Jo-Anne Sarah Riley 
In the 1990s, siRNAs and microRNAs were discovered to be naturally 
occurring genetic regulators. This provided a new potential mechanism of 
action for drugs with applicability to a wide range of therapeutic areas. 
Consequently, a substantial increase into oligonucleotide research has 
occurred, leading to the need for improved and novel techniques for their 
analysis. Standard methods of oligonucleotide analysis are based on 
hybridisation assays with analysis via detection probes labelled with 
fluorescent tags. However, multiplexing potential is limited due to the broad, 
and thus often overlapping, signals emitted. 
An alternative to labelling detection probes with fluorescent tags is to use 
cleavable small molecule mass tags with detection by mass spectrometry. 
Herein, a self-reporting detection probe was designed for use in a hybridisation 
assay for indirect oligonucleotide detection via cleavable small molecule mass 
tags. The self-reporting detection probe contains an analyte complementary 
region and a reporter region. The reporter region is a custom designed 
DNA/RNA chimeric nucleotide sequence. The ribose-phosphate backbone is 
used as a built-in enzyme cleavable linker, generating small nucleotide 
products upon cleavage by RNase A. These nucleotides can then serve as mass 
tags for indirect detection of oligonucleotides. This system avoids the need to 
design or synthesise a cleavable linker by exploiting the properties of the RNA 
molecule. This approach was used for the successful detection of a synthetic 
microRNA and the multiplexing potential was demonstrated by the 
simultaneous detection of two RNAs.  
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1. INTRODUCTION 
1.1  Nucleic Acids 
Nucleotides are the monomers from which natural nucleic acid polymers, 
such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), are formed. 
Nucleotides are composed of a phosphate group, a pentose sugar and a 
nitrogenous base whereas nucleosides contain only a sugar and base. The 
phosphate group can be attached to the 3ʹ or the 5ʹ carbon of the sugar. The 
base is joined via a C-N bond between the 1ʹ carbon of the sugar and a ring 
nitrogen of one of five nitrogenous bases; adenine, guanine, cytosine, thymine 
or uracil (Figure 1-1). Adenine and guanine are purine derivatives found in both 
DNA and RNA. Cytosine, thymine and uracil are pyrimidine derivatives, with 
cytosine and thymine found in DNA and cytosine and uracil found in RNA. DNA 
nucleotides contain the sugar 2-deoxyribose (Figure 1-2) and RNA nucleotides 
contain ribose (Figure 1-3). 
 
Figure 1-1   Structures of the naturally occurring bases found in nucleic acids  
 
Figure 1-2   DNA nucleotide (blue) and nucleoside (purple) structures showing 
numbering convention of the sugar carbon atoms 
Deoxyadenosine 
5ʹ-monophosphate 
Deoxyguanosine 
5ʹ-monophosphate 
Deoxycytidine 
5ʹ-monophosphate 
Thymidine 
5ʹ-monophosphate 
Deoxyadenosine   Deoxyguanosine  Deoxycytidine  Thymidine  1.  Introduction 
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Figure 1-3   RNA nucleotide (blue) and nucleoside (purple) structures showing 
numbering convention of the sugar carbon atoms 
Nucleotides are joined together via phosphodiester linkages to form 
oligonucleotides. The 5′ phosphate group of one nucleotide is covalently 
attached to the 3′ hydroxyl group of another nucleotide (Figure 1-4). Each 
oligonucleotide strand therefore has a 3′ OH terminus and a 5′ phosphate 
terminus.  
 
Figure 1-4   Phosphodiester linkage of the nucleic acid backbone  
Double stranded oligonucleotides are formed when complementary bases 
form hydrogen bonds between each other to form base pairs. Three hydrogen 
bonds form between cytidine and guanosine and two between adenosine and 
thymidine in DNA or adenosine and uridine in RNA (Figure 1-5). This is known 
as Watson-Crick base pairing, named after James Watson and Francis Crick who 
first solved the secondary structure of DNA in 1953.
[1] The two strands are 
antiparallel, meaning one strand runs in the 3′ to 5′ direction and the second 
strand runs in the 5′ to 3′ direction relative to the first strand. Complementary 
Adenosine 
5ʹ-monophosphate 
Guanosine 
5ʹ-monophosphate 
Cytidine 
5ʹ-monophosphate 
Uridine 
5ʹ-monophosphate 
Deoxyadenosine   Deoxyguanosine  Deoxycytidine  Uridine  1.  Introduction 
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base pairing is the basis for transmission of genetic information as well as 
being a property upon which many methods for oligonucleotide analysis are 
based (as discussed in section 1.4). 
 
 Figure 1-5   Watson-Crick hydrogen bonding (red dashed lines) between 
naturally occurring bases 
1.1.1  Phosphoramidite Chemistry 
Oligonucleotides can be chemically synthesised and the most common 
procedure is the phosphoramidite method.
[2] Protected nucleosides modified at 
the 3ʹ position are used as monomers and are coupled together using solid 
phase synthesis to form oligonucleotides.  
1.1.1.1  Development of the Phosphoramidite Method 
The phosphoramidite method used today is based on the phosphite triester 
method originally introduced by Lestinger et al.
[3] These authors used 
phosphoromonochloridite modified nucleosides (Figure 1-6 (a)), which were 
unstable and required an undesirable reaction temperature of -78 °C. 
Developments made by Caruthers et al.
[4] solved these problems. The most 
significant development was the use of 3′ N, N-dimethylamino phosphine 
modified nucleosides (Figure 1-6 (b)). These monomers could be easily 
prepared and were more stable under standard laboratory conditions. The 
monomers can be coupled together to form a natural 5′–3′ internucleotide 
phosphate linkage (section 1.1.1.2). 1.  Introduction 
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Figure 1-6   Structures of (a) phosphoromonochloridite and (b) 
3ʹ-O-methyl-N,  N-dimethylamino phosphine nucleoside monomers 
The N, N-dimethylamino modified nucleoside (Figure 1-6 (b)) was further 
developed.
[2] The methyl group was replaced with a cyanoethyl group which 
gave significant improvements in deprotection after oligonucleotide synthesis. 
Removal of the cyanoethyl group, the base protecting groups and cleavage 
from solid support could all be achieved in one step using concentrated 
ammonia at 50 °C in under 16 hours rather than the several days previously 
required. The N, N-dimethylamino group was replaced with an 
N,  N-diisopropylamino group which meant less stringent reaction conditions 
were required in terms of anhydrous and inert conditions. These developments 
are used in the modified phosphoramidite nucleosides commonly used today 
(Figure 1-7). 
 
Figure 1-7   Structure of 3ʹ-O-β-cyanoethyl-N, N-diisopropylamino phosphine 
nucleoside 
  (b)  (a) 1.  Introduction 
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1.1.1.2  The Phosphoramidite Cycle 
The process of oligonucleotide synthesis involves the sequential addition of 
nucleosides, with each addition involving a cycle of four steps (Figure 1-8). The 
process is performed using solid phase synthesis, with the first protected 
nucleoside attached to a solid support via a linker at the 3ʹ position. Step one 
of the cycle is removal of the dimethoxytrityl (DMTr) group from the first solid 
support bound nucleoside using trichloroacetic acid. Step two is the activation 
and coupling of the next phosphoramidite. A weak acid such as tetrazole is 
used as a catalyst to protonate, and thus activate, the phosphoramidite 
allowing it to couple to the previous nucleoside. Step three is to cap the 5ʹ OH 
group of any unreacted nucleosides with an acetyl group to prevent further 
reaction with subsequent nucleosides. Step four is oxidation of the phosphite 
triester bond to form a stable, natural pentavalent phosphate linkage. This is 
achieved using iodine and water in pyridine. The cycle is then repeated 
numerous times until the desired oligonucleotide has been synthesised. 
Following completion, the oligonucleotide is cleaved from the solid support 
using ammonia. The ammonia also deprotects the bases and removes the 
cyanoethyl groups.  
Synthesis of RNA requires additional protection of the 2ʹ hydroxyl group, for 
example using a t-butyldimethylsilyl group. This group remains attached 
throughout synthesis and is removed after deprotection of the phosphate. 1.  Introduction 
6 
 
Figure 1-8   The phosphoramidite cycle for oligonucleotide synthesis 1.  Introduction 
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1.2  Genetic Information, Transcription and 
Translation 
In nature, the sequence of DNA bases in a gene is a code which is converted 
by transcription into a sequence of RNA, which is then translated into a 
sequence of amino acids to form a protein. This transfer of sequence 
information from DNA to RNA to protein is known as the central dogma.
[5, 6]  
Transcription (Figure 1-9) takes place in the cell nucleus and is catalysed by 
the enzyme RNA polymerase. A promoter sequence of DNA is located at the 3ʹ 
end of a gene, to which transcription factor proteins can bind and recruit RNA 
polymerase, which catalyses transcription. A section of DNA is uncoiled and a 
single strand of RNA is synthesised by base pairing to form a messenger RNA 
(mRNA) primary transcript. The base sequence of the mRNA is complementary 
to the antisense strand of the DNA template and the mRNA is said to be sense 
mRNA. The strand of DNA which is not transcribed into mRNA is called the 
sense strand. Genes consist of exons which are coding regions and introns 
which are noncoding regions. After synthesis, introns of the mRNA primary 
transcript are removed by the process of splicing. This involves the enzyme 
spliceosome and the exons join together to form a mature mRNA.  
 
Figure 1-9   Schematic of the transcription process 
Translation takes place at ribosomes in the cytoplasm and is the process of 
synthesising a protein from a sequence of mRNA. The base sequence of the 
mRNA determines the amino acid sequence of the protein. Triplets of bases 
form a codon, each of which codes for a specific amino acid and this is known 
as the genetic code. Each codon corresponds to a complementary anticodon 
sequence of a transfer RNA (tRNA) molecule. Each tRNA with a certain 
anticodon is attached to a specific amino acid and thus the sequence of bases 
can be translated into an amino acid chain. 
DNA 
Sense strand  
Antisense strand 
+ NTPs 
RNA polymerase 
Sense mRNA 
Spliceosome 
Mature mRNA 1.  Introduction 
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Prevention of transcription or translation of a gene results in a lower level of 
the protein for which the gene encodes. Relatively recent discoveries of in vivo 
genetic regulation mechanisms, described below, have become the basis for 
oligonucleotides as a new class of therapeutics. 
1.2.1  Antisense RNA 
In 1984 it was recognised by two research groups that a gene could be 
silenced in vivo in mouse cells and in E. coli by RNA with a complementary 
sequence to an mRNA.
[7, 8] Izant et al.
[7] constructed plasmids specially designed 
so upon microinjection into cells, transcription of RNA with a sequence 
complementary to their chosen mRNA would occur in vivo. Mizuno et al.
[8] 
observed that E. coli was able to transcribe antisense mRNA naturally for the 
inhibition of a specific membrane protein.
[8] Upon duplex formation of the 
complementary strands, translation proteins cannot access the bases of the 
mRNA and translation of sequence information into a protein is prevented.  
1.2.2  microRNA 
MicroRNAs (miRNAs) are a class of non-coding regulatory RNAs which are 
transcribed from genes and act to post-transcriptionally down-regulate gene 
expression. Primary-microRNA (pri-miRNA) is transcribed from a gene and is 
cleaved in the cell nucleus by Drosha, an endonuclease ribonuclease (RNase) 
enzyme, to produce precursor microRNA (pre-miRNA). This is exported from 
the nucleus to the cytoplasm where it is cleaved by the Dicer enzyme to form 
duplexes of approximately 22 base pairs, one strand of which is the mature 
miRNA (Figure 1-10). miRNAs act on mRNA by forming imperfect duplexes to 
induce mRNA degradation or translational repression resulting in 
down-regulation of proteins. 1.  Introduction 
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Figure 1-10   Schematic of the microRNA mechanism 
Initial observations leading to the discovery of miRNAs were made form 
experiments involving the lin-14 gene of Caenorhabditis elegans, which 
controls the sequence of developmental events of postembryonic cells over 
time. Wightman et al.
[9] reported that genetic mutations leading to 
overproduction of Lin-14 protein in later stages of development were located in 
the 3′ untranslated region (UTR) of the lin-14 gene. These mutations resulted in 
deletions from the 3′ UTR of the lin-14 mRNA. The authors suggested that the 
binding of a regulatory factor to the 3′ UTR of lin-14 mRNA down regulated its 
translation into a protein. lin-4 mutants showed similar defects to lin-14 
mutants, so it was proposed that the lin-4 gene product was a candidate for 
being the regulatory factor. In 1993 Lee et al.
[10] reported that the lin-4 gene 
did not code for a protein, but produced two RNA transcripts which contained 
sequences complementary to a repeated element of the 3′ UTR of lin-14 mRNA. 
They suggested that lin-4 regulates lin-14 translation via an antisense RNA-
RNA interaction.  
It was seven years later that Reinhart et al.
[11] reported further examples of 
this type of regulatory RNA in C. elegans. The transcription product of the let-7 
gene was found to be a 21 base RNA molecule which regulates later stages of 
development, just as lin-4 regulated early stages. The let-7 mRNA was found to 
have a complementary sequence to the 3′ UTR of the mRNA transcripts from 
five genes, all of which controlled the timing of developmental sequences. 
Later that year,
[12] let-7 RNA was reported to be found in other species including 
Drosophila flies and humans and in 2001 over 100 microRNA genes had been 
identified,
[13-15] leading to the appreciation that the regulatory role of miRNAs 
was not limited to temporal control of developmental events. There are now 
over 30,000 mature miRNA sequences from 206 species entered on the miRNA 1.  Introduction 
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database miRBASE,
[16] however the targets and functions of many of these have 
yet to be elucidated. 
1.2.3  RNA Interference 
In 1998 Fire et al.
[17] published a paper for which Professors Andrew Fire and 
Craig Mellow received the Nobel Prize in Physiology or Medicine in 2006. The 
mechanism of RNA interference (RNAi) was investigated and it was found that 
double stranded RNA (dsRNA) was more effective than either antisense or 
sense single stranded RNA at inhibiting protein synthesis. This led to the 
conclusion that a simple antisense mechanism was unlikely. It is now known 
that lengths of dsRNA are first cleaved into fragments of approximately 21-23 
nucleotides in length called small interfering RNA (siRNA)
[18] by the enzyme 
Dicer.
[19] An RNA-induced silencing complex (RISC) enzyme then combines with 
the siRNA and the mRNA to cleave and degrade the target mRNA (Figure 1-11).  
 
Figure 1-11   Schematic of the RNAi mechanism 
1.3  Oligonucleotides as Drugs 
Currently there are three oligonucleotides approved by the US Food and 
Drug Administration (FDA); fomivirsen (Vitravene; Isis), pegaptanib (Macugen; 
Eyetech/Pfizer) and mipomersen (Kynamro; Isis), approved in 1998, 2004 and 
2013 respectively.  
Fomivirsen targets human cytomegalovirus (HCMV) retinitis which is a 
common herpes virus.
[20] In immunocompetent adults HCMV causes only mild 
disease however it causes chorioretinitis, which is inflammation of the choroid 
layer in the eye, in immunocompromised individuals. HCMV can lead to 
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blindness by destroying retinal cells. Fomivirsen is an antisense 
oligonucleotide 21 bases in length with a phosphothioate backbone.
[21] The 
nucleotide sequence is complementary to a section of viral mRNA encoding 
immediate-early region 2 (IE2) proteins of the HCMV which are essential for 
viral replication. Fomivirsen reduces expression of IE2 proteins and is a specific 
and potent inhibitor of viral replication.
[22] Fomivirsen also inhibits the 
expression of IE1 proteins encoded by mRNA which is not complementary to 
the fomivirsen sequence.
[22] This sequence-independent antiviral action occurs 
due to inhibition of adsorption of HCMV to host cells resulting in inhibition of 
all viral proteins, including IE proteins. 
Pegaptanib is an aptamer and its mechanism of action is not based on the 
transcription or translation processes. It is used for the treatment of age-
related macular degeneration (AMD) which causes neovascularisation of the 
choroid in the eye leading to severe vision loss in people over the age of 55.
[23] 
The neovascularisation is linked to a rise in the levels of the vascular 
endothelial growth factor (VEGF) protein. Pegaptanib is an oligonucleotide 28 
bases in length with a modified backbone to prevent degradation in vivo and is 
conjugated to two 20 kDa polyethylene glycol (PEG) molecules to increase its 
half-life in vivo. The drug is an aptamer with a three-dimensional structure 
designed to bind to and inhibit the activity of VEGF.
[24]  
Mipomersen was approved in 2013 for the treatment of familial 
hypercholesterolemia, an inherited disease causing high levels of circulating 
low-density lipoprotein-cholesterol (LDL-C) particles, which leads to 
atherosclerosis, causing cardiovascular disease. LDL-C particles are formed in 
and secreted by the liver. Apolipoprotein B-100 (ApoB-100) is the primary 
protein constituent of LDL-C and inhibition of its synthesis in the liver by 
mipomersen reduces production, and therefore blood levels, of LDL-C. 
Mipomersen is a phosphorothioate oligonucleotide 20 bases in length with five 
2ʹ-O-methyl modified bases at each end. It acts via an antisense mechanism, 
with a sequence complementary to part of the ApoB-100 mRNA.  
In addition to these three approved oligonucleotide drugs, there are 
currently many more in clinical trials which show promise for treating a variety 
of diseases,
[25] including cancer,
[26, 27] Duchene muscular dystrophy
[28] and 
asthma.
[29]  1.  Introduction 
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Development of fomivirsen, pegaptanib and mipomersen, as well as many 
other oligonucleotide drug candidates, began before the mechanisms of 
microRNA or siRNA were known and they are therefore based on other 
mechanisms of action. Discovery of the new mechanisms has provided new 
targets for drug discovery applicable to a wide range of therapeutic areas. The 
increased research in this area coupled with the significant differences between 
oligonucleotides and traditional small molecule drug candidates means novel 
analytical methods are required for use throughout the drug discovery and 
development process. 
1.4  Approaches towards Oligonucleotide 
Analysis 
Approaches towards oligonucleotide analysis using techniques other than 
mass spectrometry are described below, along with their advantages and 
limitations. 
1.4.1  Hybridisation Assays 
Most common methods of oligonucleotide detection use hybridisation 
assays which exploit the complementary base pairing property of 
oligonucleotides. Hybridisation assays use oligonucleotide probes, which are 
designed based on the target oligonucleotide sequence and synthesised using 
phosphoramidite chemistry. The assays typically use an oligonucleotide 
capture probe immobilised onto a solid support. The capture probe is a single 
stranded oligonucleotide with a base sequence complementary to that of the 
analyte. It can therefore immobilise the analyte onto the solid support by 
complementary base pairing. The detection probe will also have a sequence 
complementary to part of either the oligonucleotide analyte or the capture 
probe. There are a number of different hybridization methods based on this 
principle. 
The assay can be used to capture labelled target analytes, or can use an 
additional detection probe with a labelled reporter region to detect label free 1.  Introduction 
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analytes. The label used can be a reporter enzyme, for example alkaline 
phosphatase or horseradish peroxidase, which has a substrate which produces 
a coloured or fluorescent signal upon reaction that can be detected to indicate 
the presence of the target oligonucleotide. Alternatively, a fluorescent label can 
be used and the light emitted can be detected. A drawback to these types of 
labels is that their signals cover a broad range of wavelengths, typically over 
100 nm, and therefore signals from different labels overlap (Figure 1-12). This 
limits the number of fluorescent or coloured labels that can be used 
simultaneously, i.e. their multiplexing potential.  
 
Figure 1-12   Emission spectra of commonly used fluorescent labels. Image 
generated using Invitrogen’s Fluorescence SpectraViewer
[30] 
The sandwich hybridisation assay
[31] (Figure 1-13) uses an immobilised 
capture probe with a base sequence complementary to one end of the 
oligonucleotide analyte to immobilise it onto the solid support. A labelled 
detection probe is designed to be complementary to the other end of the 
oligonucleotide analyte. It will therefore hybridise to the immobilised 
oligonucleotide analyte via complementary base pairing. Stringent wash 
procedures are then employed to wash away unhybridised detection probes 
and analyte and the amount of remaining detection probe is measured using 
the colorimetric or fluorescent signal produced by the label. The signal 
intensity can be used to determine the concentration of oligonucleotide in the 
sample. Advantages of hybridisation based assays include good sensitivity, 
high throughput and little or no sample clean-up.
[32]  
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Figure 1-13   Schematic of the sandwich hybridisation assay 
1.4.2  Microarrays 
Microarray technology was first introduced in 1995 as a method of 
performing multiple simultaneous hybridisation assays for the analysis of gene 
expression levels in cells.
[33] The initial study analysed the expression of 45 
genes and the technology has now been developed and analysis of tens of 
thousands of genes in parallel is now possible.  
Microarrays use a glass or silicon slide with thousands of individual DNA 
sequences immobilised in fixed locations in a regular pattern using robotic 
printing. Each spot is typically less than 200 µm in diameter and contains 
picomoles of DNA, with each spot containing a different sequence 
complementary to a different analyte. Microarrays are analysed using 
fluorescence detection.  
mRNA levels can be analysed via the production of fluorescently labelled 
complementary DNA (cDNA). This is achieved by isolating the total mRNA from 
a biological sample and performing reverse transcription in the presence of 
fluorescently labelled nucleotides. The fluorescent cDNA is then incubated on a 
microarray slide allowing each cDNA to hybridise with its complementary 
sequence. Following washing steps, the microarray slide is scanned for 
fluorescence emission (Figure 1-14). Two fluorescent labels can be used to 
label two different biological samples, e.g. two different cell types or diseased 
and non-diseased tissue, which can then be mixed and hybridised onto a single 
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microarray slide for differential analysis.
[33] Microarrays have also been used to 
analyse microRNA.
[34, 35] 
 
Figure 1-14   Schematic of the microarray process for gene expression analysis 
A microarray experiment has also been demonstrated using the sandwich 
hybridisation principle, allowing detection of unlabelled oligonucleotide 
analytes.
[36]  
Whilst microarrays allow the analysis of thousands of oligonucleotides at 
once, fluorescent detection limits the number of different cell states which can 
be directly compared in one experiment.  
1.4.3  Sequencing Analysis 
The base sequence of an oligonucleotide is key in determining its biological 
function and therefore the ability to establish the sequence is an important 
part of analysis. A number of sequencing methods exist, the ‘gold standard’ of 
which is considered to be Sanger sequencing. 
1.4.3.1  Sanger Sequencing 
Sanger sequencing, named after Fredrick Sanger who first published the 
method in 1977,
[37] is an enzymatic method of DNA sequencing. RNA can also 
be sequenced but first requires reverse transcribing to produce cDNA. Sanger 
sequencing is based on the use of chain-terminating dideoxynucleotide 
triphosphates, which lack the 3ʹ OH group required to form a phosphodiester 
bond. A single stranded DNA template to be sequenced is incubated in a 
reaction mixture containing a primer, designed to anneal adjacent to the 
region to be sequenced, four deoxynucleotide triphosphates (dNTPs), four 
dideoxynucleoside triphosphates (ddNTPs) each with a different fluorescent 
label and DNA polymerase. DNA polymerase adds dNTPs to form new DNA 
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strands with a complementary sequence to the template DNA. When a ddNTP is 
added, chain extension stops and the length of DNA will terminate in a labelled 
base, complementary to the base at that position in the template. At the end of 
the reaction, numerous strands of DNA will be present, each varying in length 
by one base. Separation by capillary electrophoresis and identification of the 
fluorescently labelled bases which terminate each strand allows identification 
of the base in each position in the template DNA.  
Whilst Sanger sequencing is considered the gold standard for DNA 
sequencing, it is unable to identify modifications within an oligonucleotide, 
such as base or backbone modifications. 
1.4.3.2  Nanopore Sequencing 
A novel method of oligonucleotide sequencing uses biological nanopores. 
The method was first described in 1996 for determining the length of 
oligonucleotides and its potential for sequencing was suggested.
[38] A single 
biological nanopore is located in a lipid bilayer membrane which separates two 
buffer filled compartments. A voltage is applied across the membrane and the 
current is measured. The transmembrane protein α-hemolysin is traditionally 
used, which has a pore diameter of 2.6 nm which can accommodate a single 
strand of DNA. The applied voltage drives a single stranded polyanionic DNA 
or RNA strand through the pore and as it traverses through the pore, the 
current is blocked. The amount of time the current is blocked for is 
proportional to oligonucleotide length,
[38] the number of blocking events per 
unit of time is proportional to oligonucleotide concentration and the amount 
the current is reduced by has been shown to relate to the identity of the 
base.
[39] 
Nanopore sequencing shows promise in providing low cost sequencing, 
however developments are required to provide a greater discrimination 
between different bases and sequencing of modified oligonucleotides would 
provide further challenges.  1.  Introduction 
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1.5  High Performance Liquid 
Chromatography 
High performance liquid chromatography (HPLC) is a technique used for the 
separation of components in a mixture based on their affinities for a stationary 
phase and a mobile phase. In a HPLC system, the liquid mobile phase is 
pumped through a column which contains the stationary phase. The column is 
packed with small particles commonly comprised of silica with diameters 
typically between 2 – 10 µm. The particles are often porous, with pore sizes 
typically between 100 – 300 Å. Bare silica particles can act themselves as the 
stationary phase or the surface of the particles can be modified with one of a 
variety of different functional groups. Analytes are injected into the system and 
are carried by the mobile phase through the column to a detector (Figure 
1-15). 
 
Figure 1-15   Schematic of an analytical HPLC system. Arrows show flow 
direction 
As solutions containing analytes are pumped through the column, the 
analytes can interact with the stationary phase and these interactions delay the 
analytes’ migration through the system. The interactions which occur depend 
on the identity of the stationary phase and the analyte, and can be 
hydrophobic, dipole-dipole and ionic. Analytes which have a higher affinity for 
the stationary phase than for the mobile phase will elute later than those with a 
lower affinity for the stationary phase. 
Normal phase HPLC uses a stationary phase which is more polar than the 
mobile phase. Examples of stationary phases used in normal phase 
chromatography include silica and cyanopropyl and mobile phases used 
include hexane and acetonitrile. Reversed phase HPLC is more commonly used 
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and has a stationary phase which is less polar than the mobile phase. C
18 is the 
most common reversed phase stationary phase and the mobile phase is 
typically a mixture of water and an organic solvent, such as methanol or 
acetonitrile. In reversed phase HPLC a more polar molecule has a higher 
affinity for the polar mobile phase than for the stationary phase and is 
therefore carried through the system faster and elutes with a shorter retention 
time. Conversely, a less polar molecule interacts more strongly with the 
stationary phase so is retained in the column for longer and elutes later. HPLC 
therefore separates analytes based on their varying affinities for the stationary 
phase. Isocratic elution maintains a constant mobile phase composition 
throughout the analysis, whereas for gradient elution, the composition of the 
mobile phase is varied over time. For reversed phase HPLC, the percentage of 
organic solvent is increased over time. 
1.5.1  Ion Pair Chromatography 
Ion Pair Chromatography (IPC) is a method for separating ionic analytes 
using a reversed phase chromatography system with a stationary phase such 
as C
18. Ionic analytes are too polar to be retained by a reversed phase column 
and adjusting the pH of the mobile phase to suppress ionisation would require 
a pH outside the working range of most stationary phases. IPC uses an ion pair 
reagent added to the mobile phase. An ion pair reagent has a charged 
functional group with opposite charge to the analyte and also contains 
hydrophobic groups. The charged functional group associates with the analyte 
and the hydrophobic groups interact with the stationary phase, allowing 
retention of the neutral analyte-reagent pair on a reversed phase column. As 
the concentration of ion pair reagent increases, retention of the neutral 
analyte-reagent pair increases. However, at higher concentrations the ion pair 
reagent begins to saturate the stationary phase, effectively forming an ion 
exchange column and therefore the retention times of analytes plateaus.
[40] In 
this way, ion exchange separation is possible without the use of involatile 
salts, which are incompatible with electrospray ionisation. Examples of ion pair 
reagents are alkyl sulfonates and alkyl-amine ions. 
IPC is suited to the separation of oligonucleotides using a positive ion pair 
reagent which associates to the anionic phosphate groups of the backbone. 1.  Introduction 
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Triethylammonium acetate (TEAA, Figure 1-16) is a common ion pair reagent 
used for the separation of oligonucleotides (Figure 1-17) and was added to the 
mobile phase for HPLC-ESI MS analyses undertaken for this study. 
 
Figure 1-16   Structure of triethylammonium acetate 
 
Figure 1-17   Schematic of ion pairing chromatography with a C
18 stationary 
phase, triethylammonium acetate ion pairing reagent and nucleic acid analyte 
In addition to TEAA, hexafluoroisopropanol (HFIP, Figure 1-18) was added to 
the mobile phase used for chromatographic separations undertaken in this 
study. Apffel et al.
[41] first demonstrated the effectiveness of adding HFIP to the 
mobile phase for oligonucleotide separation, along with triethylamine (TEA) for 
pH adjustment. Increasing the concentration of HFIP in the mobile phase was 
shown to improve peak shapes and resolution, with the optimum HFIP 
concentration found to be 400 mM. The mechanism by which HFIP improves 
chromatography and appears to act as an ion pairing reagent remains unclear. 
Apffel et al.
[41] also showed that using HFIP/TEA as the solvent for flow injection 
increased the total ion current observed in ESI experiments. Due to the 
volatility of HFIP and thus its facile evaporation during the desolvation process, 
it was proposed that evaporation of HFIP led to an increase in pH of the 1.  Introduction 
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charged droplets. This was then proposed to cause dissociation of the 
oligonucleotide and its ion pair allowing desorption of the oligonucleotide into 
the gas phase.  
 
Figure 1-18   Structure of hexafluoroisopropanol 
1.6  Mass Spectrometry 
Mass spectrometry is the measurement of the mass-to-charge ratio (m/z) of 
gas phase ions. A mass spectrometer is an analytical instrument comprised of 
an inlet system, ion source, mass analyser, detector and data processing 
system, with the mass analyser and detector and some ion sources being 
enclosed in a vacuum (Figure 1-19).  
 
Figure 1-19   Schematic of a mass spectrometer 
An inlet introduces the sample to the ion source and can be, for example, a 
chromatography system (liquid chromatography or gas chromatography), a 
syringe for direct infusion or a sample plate. There have been many ion 
sources developed and the choice of ion source depends on the chemical 
properties of the sample to be analysed and whether it is in the solid, liquid or 
gas phase. Matrix-assisted laser desorption/ionisation (MALDI) and 
electrospray ionisation (ESI) are ion sources which have been used for 
oligonucleotide analysis in this study and are described below. Once gas phase 
ions are produced, they enter the mass analyser, often via a series of ion 
guides which focus the ion beam. The ions can then be separated in time or 
space by a mass analyser based on their m/z using magnetic or electric fields, 
Ion 
source 
Mass 
analyser   Detector  
Data 
processing 
system 
Vacuum 
Inlet 1.  Introduction 
21 
or combinations thereof. Once separated, ions are detected by a device such as 
an electron multiplier and an electronic signal is produced. This signal is then 
processed by the data analysis system to produce a mass spectrum, which 
plots m/z against ion signal intensity.  
1.6.1  Matrix-Assisted Laser Desorption/Ionisation 
Lasers can transfer a large amount of energy to a small area in a short 
amount of time. If a laser beam is directed towards a molecular system, it will 
transfer energy to that system. If enough energy is transferred in a short 
amount of time it cannot be dissipated to the surroundings. This can cause 
melting, desorption and ionisation.
[42] For a substance to absorb the energy 
from the laser it must have a strong electromagnetic absorption at the 
wavelength of the laser. This would mean different wavelengths would be 
needed to suit different analytes using laser desorption ionisation.  
MALDI was introduced in 1988
[43, 44] and uses a matrix to overcome the need 
for different lasers for different analytes. Matrices are chosen which have 
strong absorption coefficients at the wavelength of the laser to be used. For 
example 2,5,-dihydroxybenzoic acid (DHB) and α-cyano-4-hydroxycinnamic acid 
(α-CHCA) have high absorption coefficients at around the wavelength of the 
nitrogen laser (337 nm). On irradiation by the laser, the matrix, which is 
present in excess, will absorb a large amount of energy, via electronic 
excitation in UV-MALDI or vibrational excitation in IR-MALDI.
[45] If an analyte is 
mixed with a matrix, some of the energy absorbed by the matrix will be 
transferred to the analyte which can cause it to desorb and ionise (Figure 
1-20). MALDI allows the production of singly charged gas phase ions from 
large, non-volatile and thermally labile compounds such as proteins, 
oligonucleotides and synthetic polymers.  1.  Introduction 
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Figure 1-20   Schematic of the MALDI process of positive gas phase ion 
production 
1.6.2  Electrospray Ionisation 
ESI is an atmospheric pressure ionisation technique which was developed by 
John Fenn,
[46] from initial work undertaken by Dole et al.
[47] in 1968. ESI 
produces gas phase ions from molecules in solution via the creation of 
charged droplets. The following section describes the formation of the charged 
droplets, the subsequent solvent evaporation and Coulombic explosions and 
finally the production of gas phase ions.  
A sample flows into an electrospray ion source via a capillary towards the 
mass spectrometry inlet. A potential difference of approximately 3-5 kV is 
applied between the capillary and a metal MS inlet. For positive ion ESI the 
capillary is held at a positive potential with respect to the MS inlet to produce 
positive ions, and vice versa for negative ion ESI. The following discussion will 
focus on positive ion ESI. The potential difference applied creates an electric 
field which causes positive ions in the solution to migrate towards the liquid 
surface at the capillary tip (Figure 1-21). This polarisation of the solution 
causes the emerging liquid to form a cone shape, known as a Taylor cone, 
which has the highest charge density at its apex. When a certain voltage, 
known as the onset voltage, is reached, the excess of positive charge at the 
capillary tip can no longer be stabilised by the cohesive effect of the surface 
tension of the liquid. The flow of liquid is therefore destabilised and a fine 
spray of positively charged droplets is produced from the tip of the Taylor 
cone. Each droplet contains an excess of positive charge relative to the 
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analytes present, and this charge is distributed evenly over the surface of the 
droplet to obtain the minimum electrostatic potential energy.
[48]  
 
Figure 1-21   Schematic of the ESI process of gas phase ion production 
In order to balance the positive charge removed from the capillary by the 
droplets, oxidation to remove electrons and create positive ions must occur at 
the liquid/metal interface.
[49] Therefore the electrospray process is said to be a 
special type of electrolysis cell in which some transfer of charge occurs 
through the gas phase.  
Once formed, the charged droplets travel towards the orifice of the MS inlet 
leading to the mass analyser, which acts as a counterelectrode. As they travel, 
solvent evaporation causes the droplets to shrink in size whilst the charge on 
the droplet remains the same. This forces the charges closer together, 
increasing charge density and repulsion. At a certain point, known as the 
Rayleigh limit, electrostatic repulsion causes the droplet to become unstable 
and the electrostatic forces overcome the surface tension resulting in 
Coulombic fission. This produces a number of smaller charged progeny 
droplets and the original drop becomes stable again. Solvent continues to 
evaporate from the progeny droplets as well as the original droplet and 
successive fission events occur. 
There are two theories regarding the final process of producing the gas 
phase ions (Figure 1-22). The original theory proposed by Dole et al.
[47] is 
known as the charged residue model (CRM). In the CRM, after a number of 
solvent evaporation and Coulombic explosion steps, solvent droplets 
containing one analyte molecule and one or more charges are formed. The 
solvent of these droplets continues to evaporate to ultimately leave behind one 
analyte molecule and the charges, which transfer to the analyte to form a gas 
phase ion. It is thought that the CRM is the most likely mechanism to be 
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responsible for the ionisation of large molecules, such as proteins. The second 
proposed theory of gas phase ion formation is that of Iribarne and Thomson
[50] 
and is known as the ion evaporation model (IEM). In this model, the initial 
stages of solvent evaporation and Coulombic explosion produce small highly 
charged droplets which contain a number of analyte ions. When the droplets 
are sufficiently small with a high enough charge density, but before the 
Rayleigh limit is reached, analyte ions are emitted into the gas phase. This 
mechanism is thought to be that by which small molecules ionise.  
 
Figure 1-22   Schematic of the ion evaporation model and the charge residue 
model of gas-phase ion generation by ESI 
1.6.3  Time-of-Flight Mass Analysers 
The first description of a time-of-flight (TOF) mass analyser was by Stephens 
in 1946,
[51] which highlighted that ions of different m/z values would have 
different velocities when travelling down an evacuated field free drift tube. 
Theoretically, TOF mass analysers have no upper mass limit and are therefore 
particularly suitable for the analysis of high molecular weight analytes such as 
biomolecules including oligonucleotides. TOF mass analysers were used in this 
study coupled to MALDI and ESI ion sources. The requirement for pulses of 
ions makes TOF mass analysers ideal to couple to MALDI, however they can be 
coupled to ionisation sources which produce a continuous flow. For this, a 
pusher applies a pulsed potential difference orthogonal to a flow of ions 
accelerating them into the drift tube. After the ions are accelerated by a 
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potential difference into a field free drift region they then separate according 
to their m/z. The following equations show how ions velocities are related to 
m/z.
[52]  
 
    
   
 
 
Equation 1-1 
where E
k is kinetic energy, m is the mass of the ion and v is its velocity. E
k 
can also be expressed in terms of the potential energy applied; V
s, and the 
total charge on the ion; ze, where z is the charge state and e is the absolute 
charge of a proton or electron; 
              Equation 1-2 
These equations can be combined and rearranged to give; 
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and therefore, an ion’s velocity is inversely proportional to the square root of 
its mass. The time taken, t, for an ion to leave the accelerating region and 
travel through the drift tube to the detector can be expressed in terms of its 
velocity and the length, L, of the drift tube; 
  t = 
v
L   Equation 1-4 
Rearranging this and replacing v with its value from Equation 1-3 gives; 
 
t = 
s zeV
m
L
2
  Equation 1-5 
2eV
s and L will be constant values and therefore m/z can be calculated from 
t, with ions of a smaller mass having shorter drift times than those with higher 
masses.  
Ions of the same m/z value can begin their acceleration with different kinetic 
energies if their distance from the accelerating potential varies. This spread of 
kinetic energies leads to a loss of mass resolution and therefore methods have 
been developed to address the problem. Delayed extraction, also called 
time-lag focusing, was developed by Wiley et al.
[53] and uses electric fields to 1.  Introduction 
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create a time delay before accelerating ions from the ion source (Figure 1-23). 
During the time delay, which is in the nanosecond to microsecond range, a 
potential is applied to an extraction grid equal to that applied to the source 
creating a field free region. In this time, ions with higher kinetic energy move 
further from the source than those of the same m/z with lower kinetic energy. 
After the time delay an extraction pulse potential accelerates the ions. Ions 
with higher kinetic energy move further from the source of the extraction pulse 
during the time delay than ions with lower kinetic energy. Higher kinetic 
energy ions therefore receive less kinetic energy from the pulsed extraction 
than ions with the same m/z but lower kinetic energy, which will be closer to 
the extraction pulse.  
 
Figure 1-23   Schematic of ion focussing by delayed extraction, where the blue 
and red circles represent ions of the same m/z but with lower (blue) and higher 
(red) relative kinetic energies. Arrows indicate direction of ion travel 
A second ion focussing method was developed by Mamyrin et al.
[54] so that 
the time-of-flight of an ion is practically independent of its initial kinetic 
energy. A reflectron consists of a series of ring electrodes to which a potential 
is applied to decelerate and then reflect the ions (Figure 1-24). Ions of the 
same m/z but different kinetic energies, i.e. velocities, will penetrate the 
reflectron by different amounts. Ions with higher kinetic energy will penetrate 
the reflectron more, and will thus have a longer flight path, than those with the 
same m/z but lower kinetic energy. The reflectron thereby improves mass 
resolution compared to a linear TOF. 
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Figure 1-24   Schematic of ion focussing by a reflectron TOF, where the blue 
and red circles represent ions of the same m/z but with lower (blue) and higher 
(red) relative kinetic energies. Dotted lines indicate flight paths and arrows 
indicate direction of ion travel 
1.6.4  Micromass TofSpec 2E Mass Spectrometer 
MALDI-TOF MS analyses undertaken during this study were performed using 
a Micromass TofSpec 2E mass spectrometer (Figure 1-25). Samples were 
prepared on a stainless steel MALDI plate which was placed in the sample 
holder before the chamber was sealed and evacuated and the plate moved into 
position. A nitrogen laser operating at 337 nm was then used for the 
desorption/ionisation process. Ions formed are accelerated by a pulsed voltage 
of 20 kV and travel through a series of ion lenses where the delayed extraction 
process occurs. Matrix suppression then occurs as the ions travel through a 
quadrupole which filters ions below a user defined m/z.  The ions then enter 
the field free drift tube, travelling towards the reflectron. When operating in 
reflectron mode, the reflectron reverses the direction of travel of the ions, 
sending them towards the reflectron multichannel plate detector.  
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Figure 1-25   Schematic of the Micromass TofSpec 2E mass spectrometer 
1.6.5  Bruker micrOTOF Mass Spectrometer 
For analyses undertaken by HPLC-ESI MS during this study a Bruker 
micrOTOF was used as the mass spectrometer (Figure 1-26). Values given in 
the following description, e.g. voltages, temperatures and pressures, were 
those used in this study unless otherwise stated. The sample was introduced 
into the spray chamber (Figure 1-27) via the sample inlet from the HPLC 
system along with a flow of nitrogen gas at 2.0 bar, which was used as the 
nebulising gas. As the eluent exits the spray needle, the ESI process occurs. 
For the micrOTOF instrument to produce negative ions, the potential difference 
is created by applying a potential of +4 kV to the cap of the capillary which 
leads to the mass analyser, whilst the spray needle is at zero volts. Located 
between the spray needle and the capillary cap is a spray shield to which a 
voltage of 500 V less than that of the capillary cap is applied, to aid guidance 
of ions into the mass analyser. Nitrogen gas heated to 230 °C is used as the 
drying gas and flows at 6.0 L/min in the opposite direction to the spray to aid 
desolvation of the charged droplets. The spray needle is angled off-axis 
relative to the spray shield and the capillary to minimise entry of neutral 
molecules into the mass analyser. The capillary transfers the ions through the 
desolvation assembly into the first vacuum stage of the mass spectrometer, 
which forms part of the ion transfer optics and is maintained at 4 mbar. The 
capillary exit has a potential of -100 V and the skimmer located opposite is 
maintained at 0 V. This potential difference along with the reduced pressure of 
the second vacuum stage accelerates the ions through the aperture of the 
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skimmer. The second vacuum stage is at a pressure of 0.5 mbar and contains a 
hexapole to which a radiofrequency (RF) potential is applied to guide the ions 
through the second skimmer to the third vacuum stage. The third vacuum 
stage is at a pressure of 5 × 10
–4 mbar and contains a second RF only hexapole 
to guide and focus the ion beam prior to mass analysis. The flight tube is 
located in the fourth vacuum stage which is at a pressure of 5 × 10
–7 mbar. 
Pulsed orthogonal acceleration is then used to begin the mass analysis process 
(described in section 1.6.3). 
 
Figure 1-26   Schematic of the Bruker micrOTOF mass spectrometer. 
Reproduced with permission from Bruker 1.  Introduction 
30 
 
Figure 1-27   Schematic of the ESI ion source of the Bruker micrOTOF mass 
spectrometer. Parameters shown were those used in this study. Reproduced with 
permission from Bruker 
1.7  Mass Spectrometry for Oligonucleotide 
Analysis 
Over the past four decades mass spectrometry has become an invaluable 
tool for the analysis of large biological molecules such as proteins and 
oligonucleotides. This is largely due to the advent of ionisation techniques 
capable of forming intact gas phase ions from biomolecules in solution; 
namely MALDI and ESI. In addition to molecular weight information, mass 
spectrometry can be used to determine an oligonucleotide’s sequence, purity 
and to analyse modifications to the base or the sugar-phosphate backbone. 
1.7.1  Direct Analysis of Oligonucleotides 
Prior to the introduction of soft ionisation techniques, analysis of nucleic 
acids by mass spectrometry was limited to single bases or dinucleotides, using 
ionisation techniques such as electron ionisation (EI) and chemical ionisation 
(CI).
[55] These ionisation techniques require volatile samples and can result in 
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extensive fragmentation, meaning molecular ions of oligonucleotides were not 
readily observed and analysis of oligonucleotides was not possible. Fast atom 
bombardment (FAB)
[56] was used to analyse short nucleotides
[57] and the first 
mass spectrometry based oligonucleotide sequencing method was developed 
using this ionisation technique, successfully sequencing a DNA 10mer.
[58] 
However, the lower sensitivity of FAB, especially for analytes of increasing 
molecular weight, meant that MALDI and ESI became the ionisation techniques 
of choice for analysis of large biomolecules and allowed mass spectrometry to 
become a routine tool for oligonucleotide analysis. Both MALDI and ESI can 
form intact gas phase ions of large molecules from the solution phase (see 
Chapter 2), however each has advantages and disadvantages for 
oligonucleotide analysis. 
1.7.1.1  Direct Analysis Using MALDI 
Wu et al.
[59] investigated different matrices for oligonucleotide analysis using 
MALDI and out of 48 matrices tested, 3-hydroxypicolinic acid (3-HPA, Figure 
1-28) was found to give the best results. 3-HPA had the best ability to ionise 
oligonucleotides of mixed-base composition without fragmentation and 
produce mass spectra with a high signal to noise ratio across a wide mass 
range. 3-HPA is now the most commonly used matrix for oligonucleotide 
analysis and is used in combination with a nitrogen laser (337 nm). A mixture 
of 3-HPA/picolinic acid (PA) (10:1, w/w) was used as the matrix for MALDI 
analyses undertaken in this study. TOF mass analysers are most commonly 
coupled to MALDI ion sources due to the pulsed nature of ions produced and 
MALDI-TOF instruments are often used for oligonucleotide analysis.  
 
Figure 1-28   Structure of 3-hydroxypicolinic acid 
Mass spectra of oligonucleotides obtained using MALDI show a clear 
dependence of ion signal intensity and mass resolution on oligonucleotide 
length. Longer oligonucleotides give lower intensity signals with poorer 
resolution than shorter oligonucleotides analysed using the same conditions.
[60] 1.  Introduction 
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Possible reasons for the lower signal intensities for longer oligonucleotides 
were suggested to be lower ionisation efficiency, lower detection efficiency or a 
greater degree of fragmentation, such as base losses, of longer 
oligonucleotides. Fragmentation was also suggested to be responsible for the 
poorer mass resolution of signals for larger oligonucleotides.
[60] Work by Chen 
et al.
[61] investigated ion signal fall-off with increasing mass and the effects of 
instrument factors relating to ion detection. Their work concluded that the 
detector efficiency, detector saturation and the divergence of the ion beam 
alone could account for the decrease in ion signal with increasing mass. 
Another significant factor affecting both mass resolution and sensitivity is 
adduct formation with ubiquitous alkali metal ions such as sodium and 
potassium, which replace hydrogen atoms of the phosphate group of the 
nucleotide backbone. Adduction is more significant for longer oligonucleotides 
due to their additional phosphate groups. The extent of alkali metal adducts 
observed can be reduced by substitution with ammonium ions. This can be 
achieved by adding cation exchange beads loaded with ammonium ions during 
sample preparation.
[62, 63] Replacement of sodium with ammonium ions can 
result in proton transfer to the phosphate group and subsequent loss of 
ammonia. For positive ionisation, this then results in generation of [M + H]
+ 
ions rather than a series of [M + nNa – n-1H]
+ ions, thus improving sensitivity. 
In addition to oligonucleotide length, base composition was also found to 
affect ion signals produced by MALDI. Polydeoxythymidines were found to give 
mass spectra with significantly higher signal intensity and mass resolution 
than homopolymers of other bases.
[64] It was hypothesised by Schneider et al.
[65] 
that fragmentation of homopolymers of other bases caused their lower mass 
spectrometric response, rather than poorer ionisation efficiency or 
co-crystallisation with the matrix.  
A disadvantage of the MALDI technique is the poor repeatability which 
results from the sample preparation process. Samples are spotted onto a 
MALDI plate, mixed with matrix solution and dried. During drying, the analyte 
and the matrix co-crystallise, however the analyte does not end up evenly 
distributed throughout the sample spot. This results in so called ‘sweet spots’ 
of high analyte concentration and therefore laser shots sampling different 1.  Introduction 
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areas of the spot result in ion signals of varying strength. Sample spot 
inhomogeneity can also result in poor spot-to-spot repeatability. 
The dependence of ion signal intensity on oligonucleotide length and base 
composition along with sample spot inhomogeneity means that ion signal is 
not determined by controllable instrument parameters and can therefore not 
be used for accurate quantitation. The use of an internal standard can 
compensate for variations in sample inhomogeneity.
[66] The use of an 
oligonucleotide with similar chemical properties to the analyte, such as a 
nucleotide with the base sequence of the analyte, but with one base added or 
removed, was demonstrated to allow for quantitation of oligonucleotides 
between 0.2-5 µM with construction of a linear calibration curve with R
2 values 
of >0.998 using analyte to internal standard ion intensity ratio.
[67] 
MALDI produces primarily singly charged ions, meaning spectra are simple 
which provides a good degree of multiplexing potential for oligonucleotide 
analysis. Each oligonucleotide in a mixture is detected as a single peak with a 
relatively narrow mass range compared to fluorescent signals, thus allowing 
simultaneous detection of numerous oligonucleotide analytes. 
1.7.1.2  Direct Analysis Using ESI 
Ionisation of high molecular weight molecules using ESI forms a distribution 
of multiply charged species, bringing their m/z values into the range analysed 
by quadrupole and ion trap mass analysers.  
Similar to analysis using MALDI, oligonucleotide analysis using ESI can be 
hindered by alkali metal adduction. Once again however, substitution with 
ammonium ions can greatly reduce the extent of sodium adducts observed, 
with ammonium ions being more easily dissociated during the ESI process than 
Na
+ or K
+. This was first demonstrated for oligonucleotide analysis using ESI by 
Stults and Marsters,
[68] where an ammonium acetate precipitation step was 
performed prior to infusion ESI to significantly improve the quality of data 
acquired. Addition of organic bases, such as triethylamine or piperidine, to the 
buffer used for infusion ESI also significantly reduced sodium adduction 
without requiring pre-desalting of the sample.
[69] In addition to the clear 
advantage of sample separation, coupling of ESI to HPLC can serve to desalt 1.  Introduction 
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oligonucleotides resulting in improved signal to noise ratios and higher mass 
resolution of mass spectra.
[70]  
In contrast to MALDI, ESI produces a distribution of multiply charged species 
resulting in observation of a ‘charge state envelope’. This spreads the total ion 
current of an analyte across numerous m/z values which reduces sensitivity 
and increases spectral complexity. Charge state distribution can be 
manipulated by altering the buffer conditions. Lowering the pH of the buffer 
solution by addition of acids causes charge state reduction and observation of 
ions at lower charge states (higher m/z) as well as showing a narrower 
distribution of charge states which can simplify spectra and increase 
sensitivity.
[71] As well as achieving adduct ion suppression, addition of 
ammonium species can also lead to charge state reduction.
[71] Association of 
ammonium ions with the anionic phosphate groups followed by proton 
transfer and loss of neutral ammonia means fewer phosphate groups remain 
charged (Figure 1-29). However, additives such as acids or bases often result in 
lower ion abundance and reduced sensitivity due to ion suppression.  
 
Figure 1-29   Proposed mechanism of oligonucleotide charge state reduction 
and adduct ion suppression by ammonium species
[71] 
For quantitation using ESI, use of peak areas of ion current chromatogram 
signals from data acquired in full-scan, selected ion monitoring (SIM), MS/MS, 
selected reaction monitoring (SRM) or multiple reaction monitoring (MRM) 
modes are possible options. Full-scan is used to refer to acquisition of data 
across a wide range of m/z values, whereas for SIM, only selected m/z values 
of relevant ions are recorded. For SRM an ion is selected for MS/MS 
Gas phase 
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fragmentation and then a selected m/z value of a relevant product ion is 
recorded, or for MRM, selected m/z values of more than one product ion are 
recorded. Multiple charging of large molecules in ESI can complicate 
quantitative analysis. If ion current chromatograms extracted from a full-scan 
experiment are to be used, a decision regarding which charge state(s) to use 
must be made. A similar decision must be made for SIM, MS/MS, SRM and MRM 
experiments as to which charge state(s) to monitor and/or fragment. 
Calibration curves have been constructed using peak areas of MS/MS data with 
one charge state selected for fragmentation,
[72] using a single transition upon 
fragmentation of a chosen charge state in SRM mode
[73] or using the sum of 
peak areas of transitions in MRM mode.
[74, 75] 
1.7.2  Mass Spectrometry for Analysis of 
Oligonucleotide Digest Products 
The disadvantages of direct analysis of oligonucleotides by mass 
spectrometry arise due to their high molecular weight and the accompanying 
high number of anionic phosphate groups. To circumvent these disadvantages, 
enzymatic digestion of large biomolecules can be performed prior to MS 
analysis, allowing subsequent measurement of the smaller digestion products. 
Originally, the method was developed for protein analysis and was termed 
peptide mass fingerprinting.
[76-78] Proteins can be analysed via measurement of 
characteristic smaller peptides following an enzyme digest. Observed peptide 
masses create a fingerprint and are searched against a list of theoretical 
digestion products of proteins in a database to identify the original protein. 
RNA can be analysed in a similar fashion, i.e. RNA mass mapping. Large RNA 
molecules, such as transfer RNAs or ribosomal RNAs, are digested with RNase 
enzymes and the products subsequently analysed by mass spectrometry. The 
masses of the digestion products are used to identify the original 
oligonucleotide. Kowalak et al.
[79] first demonstrated this approach for analysis 
of ribosomal RNA with off-line chromatographic separation of digest products 
followed by ESI MS analysis. The method was able to locate and characterise 
post-translational modifications. Research in the Limbach group
[80]  has 
developed a similar approach where digestion of large RNAs results in a 
collection of products which are unique to the original RNA. Analysis by 1.  Introduction 
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MALDI-TOF MS produces a mass spectrum with the ions observed being termed 
the signature digestion pattern. 
Digestion of oligonucleotides by RNase enzymes has been combined with 
mass spectral analysis for sequencing. The approach is based on analysis of 
mass ladders formed from the sequential loss of nucleotides from the 3ʹ and 5ʹ 
ends. A mass ladder is the masses of a series of oligonucleotides which are 
produced by the degradation of a full length oligonucleotide. The difference in 
mass between each oligonucleotide in a mass ladder corresponds to the mass 
of the base which has been lost (Figure 1-30). 
 
Figure 1-30   Schematic representation of the 5ʹ (green) and 3ʹ (purple) 
oligonucleotides which form a mass ladder for oligonucleotide sequencing using 
mass spectrometry 
Pieles et al.
[81] first demonstrated RNA sequencing using this approach. 
Exonuclease enzymes, which cleave bases from the 3ʹ or 5ʹ end of an 
oligonucleotide, were used to digest RNA and analysis by MALDI-TOF MS 
generated two mass ladders (Figure 1-31). This approach can also be used to 
sequence modified RNAs, as demonstrated by Gao et al.,
[82] who sequenced 
RNAs containing a variety of 2ʹ modifications.  
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Figure 1-31   Schematic of oligonucleotide sequencing by exonuclease 
digestion followed by MALDI-TOF MS analysis of the products.
[81] Reproduced from 
reference 81 by permission of Oxford University Press 
1.7.2.1  Ribonuclease Enzymes 
RNase enzymes catalyse the hydrolysis of the phosphodiester backbone of 
RNA. There are numerous RNase enzymes with different specificities. RNases 
can be endonucleases which cleave internal phosphate groups or exonucleases 
which cleave terminal nucleotides. They can be specific for single stranded 
RNA or for RNA in a duplex with DNA or another RNA strand. For example, the 
enzymes Dicer and Drosha which are involved in microRNA and siRNA 
formation are RNases specific for double stranded RNA. RNases may also be 
base specific. For example, RNase A is an endonuclease which specifically 
cleaves at the 3ʹ side of single stranded cytidine and uridine bases. RNase T
1 is 
also an endonuclease and cleaves specifically at the 3ʹ side of guanosine 
phosphate bonds.  
RNase A has been used in previous studies for digestion of RNA and 
subsequent mass spectral analysis of digest products. RNase A was chosen for 
use in this study due to its specificity for the pyrimidine bases and its 
inexpensive commercial availability. The X-ray crystal structure of RNase A has 
been reported
[83] (Figure 1-33) and cleavage takes place via a 2ʹ, 3ʹ-cyclic 
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phosphate intermediate to form 3ʹ-phosphate and 5ʹ-OH nucleotide products 
(Figure 1-32).
[84, 85]  
 
Figure 1-32   Cleavage mechanism of RNase A, where B = Histidine12 and A = 
Histidine119 
 
Figure 1-33   X-ray crystal structure of RNase A
[83] 
1.7.3  SNP Analysis 
Single nucleotide polymorphisms (SNPs) are locations in the genome at 
which a base in the DNA sequence can be altered in different individuals. SNPs 
are the most common type of mutation and occur approximately once every 
1,000 base pairs. Mass spectrometry has been used to genotype SNPs to 
identify which of the four bases is present at a particular point.  1.  Introduction 
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Haff and Smirnov developed an assay termed the PinPoint assay
[86] (Figure 
1-34). A primer (a short oligonucleotide with a base sequence complementary 
to that of the region flanking the SNP) is hybridised to the region one base 
away from an SNP of interest. The primer is then extended by a single 
dideoxynucleotide triphosphate (ddNTP) which lacks the 3ʹ hydroxyl group 
required for further extension. The ddNTP which anneals will be 
complementary to the polymorphic base. MALDI-TOF MS is then used to 
determine the mass difference between unextended primers and primer single 
base extension products, following duplex dissociation under MALDI 
conditions. The mass difference corresponds to the mass of the base 
complementary to the SNP and can thus be used for genotyping.  
 
Figure 1-34   The PinPoint assay
[86] 
Li et al.
[87] chemically cleaved the products of single base extension reactions 
to reduce the molecular mass of the oligonucleotide analytes. This improved 
sensitivity and mass resolution of peaks when analysed using a TOF mass 
analyser. As with the PinPoint assay, the mass difference between unextended 
primer and primer extension products was used to identify the added 
nucleotide.  
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1.7.4  Mass Tags 
The smallest mass difference between naturally occurring bases in DNA is 
just 9 Da, between adenine and thymidine, and in RNA is 1 Da, between 
cytidine and uridine. Mass resolving power of TOF mass analysers can be 
insufficient to resolve peaks for oligonucleotides of similar mass. Genotyping 
SNPs by mass spectrometry relies on the difference in mass between base 
pairs, as shown in the PinPoint described assay above. However, analysis of 
two extension products formed for heterozygous A/T alleles may result in the 
observation of one unresolved peak. This is especially true in the high mass 
range reached by extension products of SNP genotyping assays which can be 
over 100 base pairs in length (Figure 1-35).
[88] 
 
Figure 1-35   MALDI-TOF MS analysis of SNP primer extension products of an 
A/T heterozygote. M
av is the average mass of the two extension products.
[88] 
Reproduced from reference 88 by permission of Oxford University Press 
To overcome the problem of small mass differences, Fei et al.
[88, 89] described 
the process of mass tagging ddNTPs with fluorescent dye molecules. Tagged 
ddNTPs were used in a primer extension assay similar to the PinPoint assay 
described above. For analysis of biallelic SNPs, one complementary ddNTP was 
unmodified and the other was tagged with a dye molecule. The fluorescent dye 
increases the difference in mass between signals for alleles in heterozygous 
samples to assist identification. 
Mass tags have also been joined to primers to improve multiplexing 
capabilities. Primers used for SNP analyses are typically similar in length and 
therefore similar in mass. The PinPoint assay was modified
[90] by using different 
lengths of 5ʹ oligo(T) as mass tags for different primers. The different primers 1.  Introduction 
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would therefore be additionally separated in the mass spectrum by the mass of 
the added oligo(T). 
For protein analysis, a method was developed for relative quantitation of 
proteins from two samples, which combined enzyme digestion with the use of 
two isotopically labelled mass tags. Isotope-coded affinity tags (ICATs)
[91] 
(Figure 1-36) consist of biotin for avidin affinity isolation, a linker which 
contains either zero or eight deuterium atoms to give heavy or light tags, 
respectively, and a thiol-specific reactive group. ICAT reagents are added to 
two protein mixtures from two different cell states, with the heavy isotope 
labelled tag being added to one cell state and the light isotope labelled tag 
being added to the other. The thiol-specific reactive group reacts with and tags 
cysteine residues in the protein. The two samples are then combined and 
subjected to enzymatic digestion to form peptide fragments, with those 
containing cysteine residues being tagged. Avidin affinity chromatography then 
isolates tagged peptide fragments which are then analysed by μLC-MS/MS. 
Relative quantitation is performed from data acquired in the MS mode from the 
relative intensities of a pair of peaks, eight mass units apart, representing a 
pair of light and heavy tagged peptides. MS/MS is then used to fragment the 
peptides to obtain sequence information which is then used to identify the 
protein from which the peptide fragment originated.  
 
Figure 1-36   Structure of the ICAT reagents. Light reagent X = H, heavy reagent 
X = D 
1.7.4.1  Isobaric Mass Tags with Tandem Mass Spectrometry 
An improvement to the ICAT mass tags described above was synthesis of a 
series of isobaric mass tags, where tandem mass spectrometry could be 
utilised to generate reporter fragment ions of differing masses. The isobaric 
nature of the mass tags results in tagged peptides from different samples 
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being chemically identical and therefore having the same behaviour in regards 
to chromatographic separation ionisation efficiency.  
This idea has led to the commercialisation of a isobaric mass tagging 
reagents, namely tandem mass tags (TMTs, Proteome Sciences)
[92] and isobaric 
tags for relative and absolute quantification (iTRAQ, Applied Biosystems).
[93] 
Each system uses tags with three components; an amine reactive N-
hydroxysuccinimide (NHS) ester group which reacts with terminal amine 
groups and lysine residues of peptides, reporter groups with varying numbers 
of 
13C and 
15N atoms and mass balance groups, also with varying numbers of 
13C and 
15N atoms. TMTs are sold as 2-plex or 6-plex (Figure 1-37) systems and 
iTRAQ reagents as 4-plex (Figure 1-38) or 8-plex systems. Samples of proteins 
are first individually enzymatically digested and then each sample labelled with 
one of the isobaric mass tagging reagents. Samples can then be combined and 
analysed. Peptides from each sample labelled with different tags will have the 
same m/z and will be indistinguishable. However, upon CID the four isobaric 
tags fragment to produce four different reporter ions. Peak intensities can be 
used for relative quantitation and can be used for absolute quantitation when 
compared to tagged synthetic peptides. Using isobaric mass tags, sequencing 
information is generated simultaneously with mass tag fragmentation.  
 
Figure 1-37   Structure of 6-plex TMT reagents 
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Figure 1-38   Structure of 4-plex iTRAQ reagents 
1.7.4.2  Cleavable Small Molecule Mass Tags 
In the above examples of using mass tags for oligonucleotide or peptide 
analysis, the biomolecule was analysed along with the mass tag which fails to 
circumvent the inherent problems of analysing large molecules. An alternative 
to enzymatic digestion methods such as peptide mass fingerprinting or RNA 
mapping (section 1.7.2) for the generation of smaller molecule products is the 
use of cleavable small molecule mass tags. Following cleavage, the small 
molecule can be analysed using mass spectrometry as a surrogate for a large 
biomolecule. This avoids the problems of oligonucleotide analysis described in 
section 1.7.1, such as charge state distribution, alkali metal adduction and 
difficulty in resolving larger oligonucleotides with similar masses. Mass tags 
can be cleaved chemically, enzymatically, be photocleavable or be cleaved 
during the ESI process or using tandem mass spectrometry, as discussed 
below. Cleavable mass tags have been used for SNP analysis as well as for 
detection of target oligonucleotide analytes.  
One method using peptide mass tags for SNP genotyping was demonstrated 
by Hammond et al.
[94] A quaternised and brominated peptidic mass tag was 
attached to a primer via a photocleavable linker. The primer was designed to 
hybridise one base upstream of the SNP of interest. A biotinylated ddNTP 
complementary to the polymorphic base then extended the primer and 
extension products were isolated using streptavidin-coated beads. The mass 
tag was photocleaved from the DNA probe by the laser pulse used in the 
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MALDI process and analysed by TOF MS. Using peptides allows synthesis of 
numerous mass tags with unique masses, making the method suitable for 
multiplexing. Inclusion of a bromine atom facilitates data analysis with its 
isotope pattern being easily distinguished from background signals both by 
eye and by isotope cluster pattern recognition software. A similar approach 
was reported by Ball et al.,
[95] where halogenated, quaternised mass markers 
were conjugated to PNA probes via a photocleavable linker. Again, the linker 
was cleaved by the MALDI laser. 
QIAGEN Genomics Inc. have developed the Masscode System, also for SNP 
genotyping.
[96] Here an allele specific polymerase chain reaction (PCR) product 
containing a photocleavable mass tagged oligonucleotide primer (Figure 1-39) 
was passed through transparent tubing. The tubing was illuminated by 
ultraviolet light to induce photocleavage. The sample was then ionised by 
positive ion atmospheric pressure chemical ionisation (APCI) and the cleaved 
protonated mass tags analysed using a quadrupole mass spectrometer. The 
mass tags used were a set of carboxylic acids with molecular masses ranging 
from 90 – 298 Da, all at least 4 Da apart. 
 
Figure 1-39   Structure of the cleavable mass tag used in the Masscode 
system
[96] 
Olejnik et al.
[97] used octapeptides as mass tags attached to DNA, RNA or 
peptide nucleic acid (PNA) probes via a photocleavable linker to detect target 
DNA sequences immobilised on a solid support (Figure 1-40). The MALDI laser 
was used to photocleave the peptide from the DNA probe and the mass tag 
was then analysed by TOF MS. The potential for multiplexing was 
demonstrated by the simultaneous analysis of three target DNA sequences via 
three different probes each attached to a different mass tag.  
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Figure 1-40   Schematic of the use of photocleavable mass tags for detection of 
target oligonucleotides.
[97] Adapted from reference 96 by permission of Oxford 
University Press 
Thompson et al.
[98] designed and synthesised a linker which could be cleaved 
by in-source collision-induced dissociation (is-CID) during ESI (Figure 1-41). The 
linker was used to conjugate a mass tag to a PNA probe for analysis of target 
DNA or RNA sequences. Following cleavage by is-CID, the tag was designed to 
then fragment further under CID conditions to form a positively charged 
fragment ion which served as the mass tag. The use of a CID step allows 
isobaric mass tags to be used as they can be distinguished from each other if 
the two fragments have different masses. Isobaric mass tags would allow 
different tagged PNA probes to be chemically identical and show the same 
behaviour in analytical separations and hybridisations. 
+ 
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linker  
Probe  
Target oligonucleotides 
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Figure 1-41   Structure of an ESI cleavable mass tagged PNA probe (ESI 
cleavable linker cleaved by is-CID drawn in blue) and the products formed upon 
is-CID and subsequent CID 
1.8  Cleavable Linkers 
For cleavage of a small molecule from a large biomolecule, the two parts of 
the molecule are joined together by a functional group which can be cleaved 
under certain conditions. Linkers can be designed to be cleaved using 
chemicals, light or enzymes.  
1.8.1  Photocleavable Linkers 
Photolysis was first described in 1962 and the potential was recognised to 
use photocleavable protecting groups during organic synthesis. Removal of the 
protecting groups could be achieved by exposure to light, avoiding the need 
Tag portion   Mass normaliser 
CID 
is-CID during ESI 
+ 
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for reagents such as strong acids or bases. Photocleavable linkers were next 
applied to solid phase synthesis, where a resin modified with a UV-cleavable 
linker was first used as the solid support for peptide synthesis. The most 
commonly used photolabile groups are based on o-nitrobenzyl derivatives, first 
demonstrated in 1970.
[99] Other photolabile groups have been developed with 
different cleavage mechanisms
[100] and novel o-nitrobenzyl analogues have been 
synthesised and tested
[101] with the aim of improving photocleavage rates and 
product yields. 
Holmes
[101] investigated the rate of photocleavage of a number of both 
existing and novel photolabile groups. A butyric acid tether anchoring the 
linker to a solid support and an α-methyl group were found to improve 
photocleavage in solutions of four different solvents. Based on these findings 
two novel photocleavable linkers were designed and synthesised (Figure 1-42) 
containing the α-methyl-6-nitroveratryl group suitable for attachment to solid 
supports.
[101] The synthetic routes to achieve photocleavable linkers such as 
these are often lengthy with low overall yields. For example, six steps were 
required to obtain the linker in Figure 1-42 (a) taking over seven days with an 
overall yield of 56%.  
 
Figure 1-42   Structure of a photocleavable linker designed by Holmes.
[101] (a) R 
= NHFmoc, (b) R = OH 
The work of Olejnik et al.
[97] described above (section 1.7.4.2), using MALDI-
cleavable mass tags for analysis of target oligonucleotides, required 
development of phosphoramidite monomers modified with photolabile groups 
for incorporation into synthetic oligonucleotide probes. Work leading up to the 
design of these complex phosphoramidite monomers was undertaken over 
many years
[102-104] and the resulting products (Figure 1-43) required numerous 
reaction steps to produce.  1.  Introduction 
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Figure 1-43   Structures of (a) and (b) two phosphoramidite monomers 
containing an o-nitrobenzyl photolabile group and an Fmoc protected amine
[104] 
Hammond et al.
[94] also used an o-nitrobenzyl photolabile group in the work 
described above (1.7.4.2). The phosphoramidite monomer designed and 
synthesised (Figure 1-44) required 9 synthetic steps with an overall yield of 
14%. The monomer was then incorporated into an oligonucleotide by 
automated phosphoramidite chemistry followed by conjugation to a peptidic 
mass tag.  
 
Figure 1-44   Structure of the phosphoramidite monomer containing an o-
nitrobenzyl photolabile group synthesised by Hammond et al.
[94] 
1.8.2  Enzyme Cleavable Linkers 
Another class of linkers which has been used in solid phase synthesis is 
enzyme cleavable linkers. Enzyme catalysed reactions can occur under mild 
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conditions of pH ca 5–8 and at ambient temperatures of ca 25–37 °C. Enzymes 
also offer the advantage of being highly chemo, regio and stereo selective.  
As well as photocleavable linkers, enzyme cleavable linkers have also found 
use in solid phase synthesis. A phenylalanyl ester bond acts as a substrate for 
α-chymotripsyn and has been used to link a molecule being synthesised to a 
solid support (Figure 1-45). 
 
Figure 1-45   Structures of a phenylalanyl ester bond linking a silica solid 
support to a molecule being synthesised (R) 
Brown
[105] demonstrated the synthesis and application of an enzyme 
cleavable linker which was synthesised as a phosphoramidite monomer. The 
linker contained a Gly-Lys-Gly tripeptide which could be cleaved by trypsin. An 
eleven step synthetic reaction with an overall yield of 8% was followed to 
produce the phosphoramidite monomer. The linker was attached to a solid 
support via a polyethylene glycol spacer and a single thymidine nucleotide was 
added to the 5ʹ end (Figure 1-46). Cleavage efficiency was measured and after 
48 hours only a 40% loss of the nucleoside was observed.  
 
Figure 1-46   Structure of a lysine containing enzyme cleavable linker joining a 
thymidine nucleotide to a solid support
[105] 
Solid 
support  +  α-chymotrypsin, H
2O 
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1.9  Self-reporting Probes for Indirect 
Analysis of Oligonucleotides 
Work undertaken for this project aimed to combine elements of existing 
techniques for oligonucleotide analysis to develop an alternative, improved 
method. A hybridisation assay has been designed which uses cleavable small 
molecule mass tags in place of traditional fluorescent tags for the indirect 
analysis of oligonucleotides with detection by mass spectrometry. The ribose-
phosphate group of the RNA backbone has been exploited as a built-in enzyme 
cleavable linker and the subsequent small nucleic acid products have been 
used as small molecule mass tags.  
A signal produced by a small molecule in a mass spectrum is relatively 
narrow compared to a signal produced by a fluorescent tag. An ion signal from 
a small organic molecule typically covers in the region of 3 Da, taking into 
account carbon isotopes, in a mass window of approximately 1,000 Da. A 
fluorescent signal in contrast covers in the region of 100 nm in a wavelength 
window of approximately 600 nm. Consequently a theoretical number of over 
300 small molecule mass tags could fit within the analysis window without any 
overlap of isotope peaks, compared to approximately six fluorescent tags. This 
gives mass spectrometry a far greater degree of multiplexing potential. 
Design and synthesis of a new or improved cleavable linker is a challenging, 
time consuming and expensive process. Cleavage of the resulting linker may 
require a long reaction time and have cleavage efficiency below 100% (section 
1.8). The natural ribose-phosphate group of the RNA molecule is rapidly 
cleaved by highly efficient RNase enzymes. Quick and easy synthesis of RNA 
using automated phosphoramidite chemistry means using the ribose-
phosphate group as a built-in enzyme cleavable linker avoids the need for 
custom design, synthesis and conjugation of a cleavable linker. The ribose-
phosphate group can be easily incorporated into the reporting region of a 
detection probe, greatly simplifying its design. 
Cleavage of RNA by RNase enzymes results in generation of small nucleotide 
digestion products, the size of which depends on the enzyme specificity and 
the RNA base sequence. These two factors can be controlled to allow design of 
the digestion products, both in terms of their length and base identity. Using 1.  Introduction 
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this approach, a custom designed base sequence can be incorporated into the 
reporter region of a detection probe and the digestion products can become 
cleavable small molecule mass tags for indirect detection of target 
oligonucleotide sequences.  
Indirect analysis of oligonucleotides via mass tags will give the benefits of 
small molecule analysis. For ESI MS this means simplification of mass spectra 
with observation of singly charged ions having less salt adduction, meaning 
improvements in sensitivity, limits of detection and multiplexing potential 
compared to direct analysis of oligonucleotides. For MALDI-TOF MS improved 
ionisation efficiency of small molecules and less salt adduction should also 
give improved sensitivity and an improved ability to analyse oligonucleotides 
with small mass differences.  
In the following chapters, direct analysis of oligonucleotides using MALDI-
TOF MS and HPLC-ESI MS will be presented for comparison with the indirect 
analysis approach. Development of the reporting region of the detection probe 
from RNA to DNA/RNA chimeric sequences is reported. Finally, use of the 
resulting detection probe in a hybridisation assay for indirect analysis of a 
synthetic microRNA is demonstrated. 
1.9.1  Aims and Objectives 
The objective of the project is to design a hybridisation assay which uses 
cleavable small molecule mass tags for the indirect analysis of short RNAs 
(~20-23 nucleotides, i.e. siRNA and microRNA length) with detection by mass 
spectrometry. The developed approach aims to provide additional multiplexing 
capabilities compared to hybridisation assays with fluorescence detection.  
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2. DIRECT ANALYSIS OF 
OLIGONUCLEOTIDES USING MASS 
SPECTROMETRY 
Direct analysis of oligonucleotides using MALDI-TOF MS and HPLC-ESI MS 
was undertaken to enable a comparison with the indirect approach using mass 
tags. For these initial experiments, two DNA oligonucleotides of lengths typical 
of siRNAs and microRNAs were used as well as a 12mer and 40mer (Table 2-1). 
DNA analytes were chosen for these experiments due to their higher stability 
and ease of handling compared to RNA. 
Length 
(nucleotides)  MW
(av) 
12  3646 
21  6471 
24  7335 
40  12781 
Table 2-1   Details of DNA analytes used for direct analysis experiments 
using MALDI-TOF MS and HPLC-ESI MS 
2.1  Direct Analysis of Oligonucleotides 
using MALDI-TOF MS 
Experiments were undertaken using MALDI-TOF MS to determine limits of 
detection as well as investigate and demonstrate spot-to-spot and intra-spot 
variability and dependence of ion signal on oligonucleotide length. Linearity of 
the ion signal over a range of moles on-plate was also investigated for the 
21mer and 24mer. Each oligonucleotide was analysed at a range of 
moles-on-plate with replicate analyses performed. Solutions of each 2.  Direct Analysis of Oligonucleotides Using Mass Spectrometry 
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oligonucleotide were prepared at concentrations of 0.1, 0.5, 1, 5 and 
10 pmol/µL. 1 µL of solution was used to prepare each sample, giving 0.1, 0.5, 
1, 5 and 10 pmol on-plate, respectively.  
Analyses of the 21mer and 24mer showed poor linearity of the analyte 
signal to noise ratio (S/N) as a function of the amount of oligonucleotide 
spotted on the plate (Figure 2-1). Four samples of each on-plate amount were 
spotted onto the MALDI plate in an identical manner for replicate analyses. 
However upon analysis of identically prepared sample spots, the analyte ion 
signal intensity was observed to vary considerably. This poor precision was 
especially problematic when the amount of oligonucleotide neared the limit of 
detection (LOD). For a given amount of oligonucleotide on the MALDI plate, a 
signal for the analyte was observed upon analysis of some spots but not for 
others (Figure 2-2 and Table 2-2). For example, using a S/N of >3:1, the lowest 
amount of 12mer observed was 0.1 pmol on-plate, however this was only 
observed in 3 out of the 4 replicate analyses. The amount on-plate which was 
consistently observed for all replicates was 1.0 pmol; a tenfold difference 
compared to the lowest amount detected. This poor spot-to-spot repeatability 
led to high standard deviations of between ±30 – 200%. 
 
Figure 2-1   Signal Intensity vs. pmol on-plate of (a) 21mer and (b) 24mer 
analysed using MALDI-TOF MS (solid lines). Error bars show ± 1 SD from four 
replicate analyses. Linear trendlines (dashed lines) and R
2 values are shown. 
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Lowest amount detected 
(pmol on-plate) 
Repeatable LOD 
(pmol on-plate) 
12mer  21mer  24mer  40mer  12mer  21mer  24mer  40mer 
0.1 
±99% 
0.5 
±127% 
1.0 
±82% 
10.0 
±96% 
1.0 
±38% 
1.0 
±34% 
5.0 
±32% 
50.0 
±29% 
Table 2-2   Lowest on-plate amounts detected and repeatable LOD of each 
test oligonucleotide using MALDI-TOF MS ± 1 SD based on a minimum of three 
repeat measurements 
Poor spot-to-spot repeatability can be illustrated by visual comparison of 
mass spectra acquired from replicate analyses. S/N and absolute ion signal 
intensity varied considerably between samples, as represented by data for the 
24mer at 1.0 pmol on-plate (Figure 2-2). Spot-to-spot variability is attributed to 
the sample preparation step and inhomogeneous analyte distribution 
throughout the spot, as discussed above (section 1.7.1.1). 
 
Figure 2-2   Spectra acquired using MALDI-TOF MS of 24mer at 1 pmol 
on-plate at four different spots. Vertical axes are linked to highlight inter-spot 
signal intensity variability. Inserts show expansion of m/z regions of analyte ions 
A final observation was that the LOD increased as the length of 
oligonucleotide increased, as was expected (Table 2-2). Longer 
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oligonucleotides with more anionic phosphate groups are likely to form more 
adducts with cations such as sodium and potassium. The formation of 
numerous ionic species reduces sensitivity and therefore the limit of detection 
is higher. Therapeutic oligonucleotides are on average between 20-25 
nucleotides in length and therefore the LOD which is likely to be achieved by 
analysis using MALDI-TOF for their direct analysis is approximately 1-5 pmol 
on-plate. 
2.2  Direct Analysis of Oligonucleotides 
Using HPLC-ESI MS 
In addition to MALDI-TOF MS, HPLC-ESI MS was used to analyse the four test 
DNA analytes (Table 2-1). Solutions of the 21mer and 24mer were each 
prepared at concentrations of 0.10, 0.25, 0.50, 1, 5, 10, 50 and 100 pmol/µL. 
An injection volume of 2 µL was used, giving on-column loadings of 0.20, 
0.50, 1, 2, 10, 20, 100 and 200 pmol, respectively. 
Typical chromatograms showed a single peak using UV detection and single 
peaks in the total ion current chromatograms (TICCs) and extracted ion current 
chromatograms (EICCs) of relevant ions (Figure 2-3 (a)). ESI data showed 
multiply charged species, typically with two or three charge states observed for 
the 12mer, 21mer and 24mer (Figure 2-3 (b)). At the LOD only one charge state 
was observed, as demonstrated for the 21mer (Figure 2-4). Up to eleven charge 
states were observed for the 40mer at higher concentrations, whereas only one 
charge state was observed at 0.2 pmol on-column (Figure 2-5).  2.  Direct Analysis of Oligonucleotides Using Mass Spectrometry 
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Figure 2-3   Representative data acquired using HPLC-ESI MS of 24mer at 
2  pmol on-column, showing (a) UV chromatogram, TICC and EICC of all isotopic 
peaks of all prominent charge states, i.e. 3–, 4– and 5–, and (b) negative ESI mass 
spectrum at t
R 8.3-8.4 min. Insert shows expansion of the m/z region of the 
analyte ions 
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Figure 2-4   Mass spectra of the 21mer analysed at the detection limit of 
0.2  pmol on-column using HPLC-ESI MS. Insert shows an expansion of the m/z 
region of the analyte ions 
 
Figure 2-5   ESI spectra of the 40mer at (a) 20 pmol and (b) 0.2 pmol 
on-column 
Data acquired from analyses of the 21mer and 24mer were analysed using a 
number of available approaches, including integration of UV peak areas as well 
as integration of EICC peak areas.  
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Peak areas from data acquired using UV detection showed excellent 
linearity, with R
2 values >0.999 (Figure 2-6). Analysis using this method 
showed good repeatability, with standard deviations typically below 15%. 
Higher standard deviations were observed at lower on-column amounts of 
oligonucleotide. 
 
Figure 2-6   UV peak area vs oligonucleotide on-column for (a) 21mer and (b) 
24mer analysed using HPLC-ESI MS (solid lines). Error bars show ± 1 SD from three 
replicate analyses. Linear trendlines (dashed lines) and R
2 values are shown 
Peak areas in EICCs were also analysed to compare linearity and 
repeatability. Peak areas of three different EICCs were analysed (see Table 2-3 
for m/z values): EICCs of the most intense ion of the most intense charge state 
(Figure 2-7), EICCs of all isotopic peaks of the most intense charge state 
(Figure 2-8) and EICCs of all isotopic peaks of all prominent charge states, 
which was typically two or three charge states (Figure 2-9). Again, results 
showed good linearity with all R
2 values of >0.992. Above 2 pmol 
oligonucleotide on-column, standard deviations were between 3-17% and once 
again standard deviations at lower amounts of oligonucleotide were often 
higher.  
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m/z values used to construct EICCs 
(charge state) 
  21mer  24mer 
The most intense ion of 
the most intense charge 
state 
1616.5 or 1616.8 (4–)  1832.5 (4–) 
All isotopic peaks of the 
most intense charge 
state 
1615.6 – 1618.70 (4–)  1831.4 – 1834.5 (4–) 
All isotopic peaks of all 
prominent charge states 
 
1615.6 – 1618.7 (4–) 
and 
2154.5 – 2158.3
 (3–) 
 
1464.7 – 1467.6 (5–) 
and 
1831.4 – 1834.5 (4–) 
and 
2442.0 – 2445.5 (3–) 
Table 2-3   m/z values used to construct EICCs for calibration curves 
 
Figure 2-7   EICC peak area of the most intense ion of the most intense 
charge state vs. oligonucleotide on-column for (a) 21mer and (b) 24mer analysed 
using HPLC-ESI MS (solid lines). Error bars show ± 1 SD from three replicate 
analyses. Linear trendlines (dashed lines) and R
2 values are shown 
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Figure 2-8   EICC peak area of all isotopic peaks of the most intense charge 
state vs. oligonucleotide on-column for (a) 21mer and (b) 24mer analysed using 
HPLC-ESI MS (solid lines). Error bars show ± 1 SD from three replicate analyses. 
Linear trendlines (dashed lines) and R
2 values are shown 
 
Figure 2-9   EICC peak area of all isotopic peaks of all prominent charge 
states vs. oligonucleotide on-column for (a) 21mer and (b) 24mer analysed using 
HPLC-ESI MS (solid lines). Error bars show ± 1 SD from three replicate analyses. 
Linear trendlines (dashed lines) and R
2 values are shown 
It was thought that using EICCs of all isotope peaks of all prominent charge 
states would give better accuracy and precision because it would account for a 
larger proportion of the ion signal of the analyte than using one ion or charge 
state alone. It would also account for changes in the abundance of charge 
states which can occur with changing analyte concentration. However, results 
obtained showed all analysis methods gave similar results in terms of R
2 values 
and standard deviations. 
The LOD for the 12mer analysed using HPLC-ESI MS was 1.0 pmol on-column 
and for the 21mer, 24mer and 40mer was 0.2 pmol on-column (Table 2-4). 
Standard deviations shown are based on analysis by integration of the peak 
area in the EICC of all isotopic peaks of the most intense charge state. 
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Repeatable LOD 
(pmol on-column) 
12mer  21mer  24mer  40mer 
1.0 
±1% 
0.2 
±26% 
0.2 
±11% 
0.2 
±19% 
Table 2-4   LODs of each test oligonucleotide analysed using HPLC-ESI MS ± 
1SD based on triplicate results 
2.3  Comparison of MALDI-TOF MS and 
HPLC-ESI MS for Direct Analysis of 
Oligonucleotides 
For the 12mer, the LOD was the same using both MALDI-TOF MS and 
HPLC-ESI MS, whereas for the three longer oligonucleotides HPLC-ESI MS gave 
LODs of between one and two orders of magnitude lower than MALDI-TOF MS. 
These results also showed that when using MALDI-TOF MS, LOD was dependent 
on oligonucleotide length, with shorter chains giving lower LODs. LODs 
achieved using HPLC-ESI MS however, were less dependent on oligonucleotide 
length.  
Linearity of data acquired using HPLC-ESI MS was better than for data 
acquired using MALDI-TOF MS, as demonstrated by a comparison of R
2 values 
(Figure 2-10). 2.  Direct Analysis of Oligonucleotides Using Mass Spectrometry 
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Figure 2-10   R
2 values for analyses of each test oligonucleotide using the four 
methods data analysis of HPLC-ESI MS data and MALDI-TOF MS data 
MALDI-TOF MS produced results with higher standard deviations than 
HPLC-ESI MS. Better reproducibility may be possible using MALDI-TOF MS if a 
different spotting technique was used. For example the thin-layer technique 
was shown to improve both reproducibility and linearity by creating a more 
homogenous sample spot.
[106] 
As expected, MALDI primarily produced singly charged ions, although the 
doubly charged ion of the 40mer was observed (data not shown). ESI produced 
a number of multiply charged species; for the 12mer, 21mer and 24mer, 
typically up to four charge states were observed, and for the 40mer as many as 
12 charge states were observed at higher on-column amounts. Maximum 
entropy (MaxEnt) software can be used to deconvolute ESI spectra and 
determine the molecular mass of an analyte from its multiply charged species. 
For ESI analyses there were generally only one or two dominant charge states, 
with other charge states being represented by only small peaks (Figure 2-3 (b) 
and Figure 2-5 (a)). This leads to a less significant drop in sensitivity than may 
have been expected as a result of the various charge states produced by the 
ESI process. Typically only one or two charge states were observed at levels 
close to the limits of detection, for example only one charge state was 
observed for the 40mer at 0.2 pmol on-column (Figure 2-5 (b)). 
A comparison of the mass resolution of analyte ions showed isotopic 
information could be obtained from ESI data (Figure 2-3 (b) and Figure 2-4). 
Insufficient mass resolution in the higher m/z region where analytes were 
detected using MALDI-TOF MS meant isotopic information was not available 
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using this technique (Figure 2-2). This poor resolution has implications for 
multiplexing as it would not be possible to distinguish between two 
oligonucleotides of similar mass using MALDI. 
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3. RNASE A DIGESTION OF BROMINE 
LABELLED RNA 
Initial experiments were undertaken to determine if RNase digestion of RNA 
could produce digestion products of sufficiently low molecular weight to be 
used as small molecule mass tags, i.e.  mono-, di- or trinucleotides. Indirect 
mass spectral analysis of oligonucleotides via small molecule mass tags would 
avoid inherent problems of directly analysing large oligonucleotide molecules.   
A bromine atom, with its distinctive isotope pattern, was incorporated into 
the small molecule mass tags to facilitate data analysis. Isotope patterns of 
atoms such as chlorine or bromine can be readily recognised both by eye and 
by cluster pattern recognition software. This allows easy distinction between 
signals arising from mass tags and background arising from other digestion 
products. The protected phosphoramidite monomer of 5-bromouridine (u
Br, 
Figure 3-1) was commercially available, allowing facile incorporation of this 
labelled base into RNA molecules by automated phosphoramidite chemistry.  
 
Figure 3-1   Structure of the commercially available 5-bromouridine 
phosphoramidite monomer 
RNase A was chosen as the enzyme for use in this study due to its ability to 
cleave at the 3ʹ side of uridine bases and therefore also its likely ability to 
cleave at the modified u
Br base. 3.  RNase A Digestion of Bromine Labelled RNA 
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3.1  RNA Sequence Design 
RNA sequences were designed to investigate the ability of RNase A to digest 
bromine labelled RNA and to determine whether complete digestion, i.e. 
cleavage at all expected sites, would occur. To produce a single labelled base 
or labelled di- or trinucleotide the RNA must include an appropriate base 
sequence. Using RNase A, production of the single base u
Br
p (where the lower 
case signifies an RNA nucleotide and
 p = 3ʹ-monophopshate) would require the 
sequence Yu
BrN (5ʹ  3’), where Y is uridine or cytidine and N is any base. To 
produce a dinucleotide would require the sequence YRu
BrN (5ʹ  3’), where Y is 
uridine or cytidine, R is adenosine or guanosine and N is any base. In total, six 
small molecule mass tags up to a maximum of three nucleotides in length are 
possible using this approach (Table 3-1). 
Mass tag 
digestion product 
Required RNA sequence 
(5ʹ  3ʹ) 
u
Br
p  Yu
Br
pN 
au
Br
p  Yau
Br
pN 
gu
Br
p  Ygu
Br
pN 
aau
Br
p  Yaau
Br
pN 
agu
Br
p  Yagu
Br
pN 
ggu
Br
p  Yggu
Br
pN 
Table 3-1   RNA sequences required to produce the specified mass tag 
digestion products upon RNase A digestion, where u
Br = 5-bromouridine, Y = 
uridine or cytidine, N = any base and 
p = 3ʹ-monophosphate 
One consideration was that RNase A may not recognise 5-bromouridine and 
would therefore not cleave at the expected location. Therefore, the RNA 
sequence was designed to include an unmodified uridine at the 3ʹ side adjacent 
to the 5-bromouridine base (Figure 3-2). If the labelled base was recognised 
and cleaved by RNase A then the products would be as expected (those shown 
in Table 3-1). If 5-bromouridine was not a suitable substrate for RNase A and 
cleavage at its 3ʹ side did not occur, the adjacent uridine should still be 
cleaved. This would produce digestion products one uridine longer than if 3. RNase A Digestion of Bromine Labelled RNA 
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complete digestion occurred. This design was intended to both test and, if 
necessary, overcome the possibility that RNase A may have been unable to 
cleave 5-bromouridine.  
 
Figure 3-2   Example sequence of oligonucleotides and cleavage sites using 
RNase A. Dotted lines represent sites of cleavage only if 5-bromouridine was 
recognised by RNase A. Products would be (a) monomers or dimers, (b) dimers or 
trimers and (c) trimers or tetramers 
A series of RNA sequences 19 nucleotides long were designed which 
incorporated the sequences listed in Table 3-1 required to produce mono-, di- 
or trinucleotides upon RNase A digestion (Table 3-2).  
The first three RNA sequences (ONT-1-i, ONT-1-ii and ONT-1-iii) were 
analogues, where ONT-1-i contained no modifications and ONT-1-ii ONT-1-iii 
contained a number of 5-bromouridine bases in place of uridine bases and 
were designed to produce the mass tag u
Br
p (Figure 3-3) upon RNase A 
digestion . ONT-1-i was used for initial experiments to investigate whether 
complete digestion to the desired products, including single bases, was 
possible and to test digestion conditions. ONT-1-ii contained one 
5-bromouridine base at position 10 and was used for initial experiments to 
investigate whether RNase A would cleave at the 3ʹ side of 5-bromouridine to 
produce a bromine labelled single base. ONT-1-iii contained three 
5-bromouridine bases at positions 5, 10 and 15 and was designed to 
investigate the advantage of incorporating repeats of labelled sequences to 
allow production of a greater amount of labelled digestion product. 
c u
Br u N
 
c a u
Br u N
 
c a a u
Br u N
 
(b) 
(a) 
(c) 3.  RNase A Digestion of Bromine Labelled RNA 
68 
 
Figure 3-3   Structure of the mass tag u
Br
p, formed upon RNase A digestion of 
ONT-1-ii and ONT-1-iii 
RNA sequences ONT-2 – ONT-6 each incorporated three 5-bromouridine 
bases at positions 5, 10 and 15 and were each designed to generate a different 
bromine labelled product upon RNase A digestion.  3. RNase A Digestion of Bromine Labelled RNA 
  69     
Oligonucleotide 
(ONT) 
Sequence (5ʹ  3ʹ)  MW
(mono) 
Expected 
digestion 
products 
MW
(mono) 
1-i  ugacuugacuugacuugac  5996.8 
u
p 
gac 
gac
p 
324.04 
917.18 
997.15 
1-ii  ugacuugacu
Brugacuugac  6074.7 
u
p 
u
Br
p 
gac 
gac
p 
324.04 
401.95 
917.18 
997.15 
1-iii  ugacu
Brugacu
Brugacu
Brugac  6230.5 
u
p 
u
Br
p 
gac 
gac
p 
324.04 
401.95 
917.18 
997.15 
2  ugcau
Brugcau
Brugcau
Brugca  6230.5 
a 
u
p 
gc
p 
au
Br
p 
267.10 
324.04 
668.10 
731.00 
3  uacgu
Bruacgu
Bruacgu
Bruacg  6230.5 
g 
u
p 
ac
p 
gu
Br
p 
283.09 
324.04 
652.10 
746.99 
4  ucaau
Brucaau
Brucaau
Brucaa  6166.5 
c
p 
u
p 
aa 
aau
Br
p 
323.05 
324.04 
596.15 
1060.05 
5  ucgau
Brucgau
Brucgau
Brucga  6230.5 
c
p 
u
p 
ga 
gau
Br
p 
323.05 
324.04 
612.14 
1076.05 
6  ucggu
Brucggu
Brucggu
Brucgg  6294.5 
c
p 
u
p 
gg 
ggu
Br
p 
323.05 
324.04 
628.14 
1092.04 
Table 3-2   RNA sequences and expected digestion products with 
monoisotopic masses. u
Br
 = 5-bromouridine, 
p = 3ʹ-monophosphate 3.  RNase A Digestion of Bromine Labelled RNA 
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3.2  RNase A Digestion of ONT-1-i, ONT-1-ii 
and ONT-1-iii 
From literature examples that use RNase digestion followed by mass 
spectral analysis (section 1.7.2), a number of common reaction conditions were 
noted. Digestion typically took place at a temperature of 37 °C and pH around 
7-7.5, with reaction times commonly between 1-2 hours. Two buffers were 
commonly used: Tris-HCl ranging in concentration from 10-50 mM
[107-109] or 
220 mM ammonium acetate, which was the buffer of choice for work of the 
Limbach group.
[80, 110, 111] The ratio of RNase A to RNA however varied by several 
orders of magnitude between different reports. Digestion conditions chosen 
for this study were taken from Limbach et al.
[110] with use of 220 mM 
ammonium acetate buffer, a temperature of 37 °C, RNA concentration of 2 
µg/µL and 0.1 Kunitz units
[112] of RNase A per µg RNA. Samples of the assays 
were taken at 5 minutes, 2, 4 and 24 hours and analysed using HLPC-ESI MS 
and MALDI-TOF MS.  
Each oligonucleotide was analysed immediately prior to digestion and all 
were confirmed to be intact at the beginning of the experiments (Appendix 1). 
Control experiments were also conducted under identical conditions alongside 
the digestion assay, omitting addition of RNase A. RNA in each control assay 
was observed to remain intact for the duration of the experiment (data not 
shown).  
3.2.1  ONT-1-i 
In the sample taken after 5 minutes digestion time, neither HPLC-ESI MS nor 
MALDI-TOF MS analysis showed evidence of the intact RNA. Instead, HPLC-ESI 
MS analysis showed all the digestion products expected from complete 
digestion. Two peaks were observed in the UV chromatogram at t
R 1.1 and 1.5 
minutes (Figure 3-4 (a)). In the mass spectrum at t
R 1.1 min., ions at m/z 
916.10 and 457.54 were observed, corresponding to [gac − H]– and 
[gac − 2H]
2–, respectively, in addition to sodiated species. This digestion 
product originated from the 3ʹ terminus of ONT-1-i, i.e. with a 3ʹ-OH group. 
Also observed at t
R 1.1 minutes was a peak at m/z 647.01, which corresponded 3. RNase A Digestion of Bromine Labelled RNA 
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to the deprotonated gas phase dimer of uridine 3ʹ-monophosphate; [2u
p − H]– 
(Figure 3-4 (b)). Significantly, observation of this species demonstrated that 
RNase A digestion can generate single base products and in less than 5 
minutes. At t
R 1.5 minutes gac
p was observed as [gac
p − H]– and [gac
p − 2H]
2– at 
m/z 996.06 and 497.53, respectively, as well as the related sodium adducts 
(Figure 3-4 (c)). This digestion product originated from within the RNA 
sequence and thus possessed a 3ʹ-monophosphate group as a result of the 
RNase A cleavage mechanism. Detection of all expected digestion products and 
absence of any partially digested products or cyclic-phosphate intermediates in 
the sample taken at 5 minutes demonstrated that complete digestion occurred 
rapidly under the experimental conditions chosen.  
 
Figure 3-4   HPLC-ESI MS analysis of ONT-1-i sampled at 5 min. digestion time, 
showing (a) UV chromatogram, and negative ion ESI mass spectra at t
R (b) 1.1 min. 
and (c) 1.5 min. 
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Analysis by positive ion MALDI-TOF MS of the sample taken at 5 minutes 
showed peaks at m/z 917.6 and 997.9, which corresponded to the ions 
[gac + H]
+ and [gac
p + H]
+, respectively (Figure 3-5). The uridine 
mononucleotide however, was not observed using this technique.  
 
Figure 3-5   MALDI-TOF MS analysis of ONT-1-i sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
Analysis of samples taken at 2, 4 and 24 hours all showed very similar data 
to the samples taken at 5 minutes, which suggests digestion was complete 
within five minutes (data not shown).  
3.2.2  ONT-1-ii 
Upon digestion of ONT-1-ii, once again analysis showed complete digestion 
to the expected products for the sample taken at 5 minutes digestion time. 
HPLC-ESI MS analysis showed two peaks in the UV chromatogram at t
R 1.1 and 
t
R 1.5 minutes (Figure 3-6 (a)). As seen previously for ONT-1-i, in the mass 
spectrum at t
R 1.5 minutes the product gac
p was observed as the singly and 
doubly charged ions at m/z 916.06 and 497.53, respectively (Figure 3-6 (c)). In 
the mass spectrum at t
R 1.1 minutes numerous species were observed (Figure 
3-6 (b)). gac was observed as singly and doubly charged ions at m/z 916.10 
and 457.54, respectively. The gas phase dimer of the single uridine 
3ʹ-monophosphate was observed at m/z 647.01, as was seen for ONT-1-i. In 
addition to these products, three brominated species were also observed. At 
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m/z 400.90 and 402.90 were equal intensity ions corresponding to the 
bromine labelled u
Br
p mononucleotide. Also observed were the gas phase 
dimers of the single nucleotides; [u
p + u
Br
p − H]
– was observed as equal intensity 
ions at m/z 724.92 and 726.91 and [2u
Br
p − H]
– was observed at m/z 802.82, 
804.82 and 806.81, with these three ions showing the 1:2:1 intensity ratio 
expected from a species containing two bromine atoms. Importantly, 
observation of the single bromine labelled uridine nucleotide shows that RNase 
A is capable of cleaving the phosphodiester bond at the 3ʹ side of the 
5-bromouridine modified base.  3.  RNase A Digestion of Bromine Labelled RNA 
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Figure 3-6   HPLC-ESI MS analysis of ONT-1-ii sampled at 5 min. digestion 
time, showing (a) UV chromatogram, and negative ion ESI mass spectra at t
R (b) 1.1 
min. and (c) 1.5 min. 
Bruker DataAnalysis
© software can generate isotope cluster analysis 
chromatograms (ICACs) based on user defined data of the mass difference 
between two peaks and their relative intensity. These chromatograms show a 
peak wherever a pair of ions matches the specifications and an isotope cluster 
filtered mass spectrum (ICFMS) can then be generated which shows only those 
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pairs of ions, eliminating all other signals. The ICAC generated from the data 
acquired for ONT-1-ii showed one main peak at the time the bromine labelled 
product eluted (Figure 3-7 (a)). The ICFMS based on a mass difference of 2 ± 
0.1 Da and a relative intensity of 1:1 ± 10 % showed two species which 
corresponded to the bromine labelled product and its gas phase dimer with 
unlabelled uridine (Figure 3-7 (b)). Elimination of signals arising from other 
digestion products and background noise simplifies the mass spectrum 
allowing easy identification of bromine labelled products. 
 
Figure 3-7   HPLC-ESI MS analysis of ONT-1-ii sampled at 5 min. digestion 
time, showing (a) ICAC and (b) ICFMS at t
R 1.1 min. 
Positive ion MALDI-TOF MS data showed the gac and gac
p digestion products 
at m/z 917.9 and 998.3, respectively (Figure 3-8). Also observed were gas 
phase dimers and trimers of these trinucleotides. Once again, as for ONT-1-i, 
the single mononucleotide u
p was not observed using MALDI-TOF MS and 
neither was the single bromine labelled base. 
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Figure 3-8   Positive ion MALDI-TOF MS analysis of ONT-1-ii sampled at 5 min. 
digestion time. Insert shows an expansion of the m/z region of the digestion 
product ions  
3.2.3  ONT-1-iii 
The final RNA in this series was also observed to fully digest upon addition 
of RNase A. All expected digestion products were observed upon analysis of 
the sample taken after 5 minutes digestion time. Using HPLC-ESI MS, at t
R 1.1 
minutes gac was observed as [gac − H]– and [gac − 2H]
2– at m/z 916.15 and 
457.57, respectively. The uridine mononucleotide was observed as the gas 
phase dimer [2u
p − H]– at m/z 647.04 (Figure 3-9 (b)). The product gac
p was 
observed to elute at t
R 1.4 minutes as [gac
p − H]– and [gac
p − 2H]
2– at m/z 
996.11 and 497.55, respectively (Figure 3-9 (c)). Again, as for ONT-1-ii, the 
bromine labelled mononucleotide was observed as [u
Br
p − H]– with equal 
intensity ions at m/z 400.93 and 402.93. The gas phase heterodimer 
[u + u
Br
p − H]– was observed as equal intensity ions at m/z 724.95 and 726.95 
and the gas phase homodimer [2u
Br
p − H]– was observed at 802.86, 804.86 and 
806.86 (Figure 3-9 (b)). 
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Figure 3-9   HPLC-ESI MS analysis of ONT-1-iii sampled at 5 min. digestion 
time, showing (a) UV chromatogram, and negative ion ESI mass spectra at t
R (b) 1.1 
min. and (c) 1.4 min. 
ONT-1-iii was designed to include three 5-bromouridine bases with the aim 
of increasing the signal of the u
Br
p digestion product, compared to ONT-1-ii 
which contained one 5-bromouridine base. EICC peak areas were used to 
compare signals (Figure 3-10). ONT-1-ii and ONT-1-iii were both designed to 
generate the same amount of gac
p and a comparison of signals showed the 
expected 1:1 ratio of peak areas. Similarly, both oligonucleotides were 
designed to generate the same amount of gac and once again peak areas 
showed the expected 1:1 ratio. It is also worth noting that for both 
oligonucleotides the ratio of gac
p:gac was expected to be 3:1 and peak areas of 
these two products did show a ratio of approximately 3:1. Incorporation of 
three 5-bromouridine bases in ONT-1-iii rather than one in ONT-1-ii led to an 
increase in EICC peak area of the [u
Br
p − H]
– and [2u
Br
p − H]
– ions. A two-fold 
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increase in peak area (×2.33) was observed rather than the expected threefold 
increase. Nevertheless, incorporation of multiple labelled bases led to an 
increase in signal from the labelled digestion products and therefore further 
studies were conducted using oligonucleotides containing three 
5-bromouridine bases. 
 
Figure 3-10   Comparison of EICC peak areas of digestion-product ions 
between ONT-1-ii and ONT-1-iii. Expected ratios based on the number of digestion 
product molecules per molecule of RNA are shown 
Similar to analysis of ONT-1-ii, MALDI-TOF MS analysis showed signals from 
the gac and gac
p digestion products, observed as singly charged ions at m/z 
918.0 and 998.2, respectively (Figure 3-11). Gas phase dimers and trimers of 
these species were also observed. Signals arising from u
p or u
Br
p 
mononucleotides were not observed by positive ion MALDI-TOF MS. 
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Figure 3-11   MALDI-TOF MS analysis of ONT-1-iii sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
3.2.4  Summary 
Analysis of all three oligonucleotides in this study showed complete 
digestion of each RNA into the expected mononucleotides and trinucleotides in 
less than five minutes. No remaining intact RNA or partially digested products 
were observed. This demonstrated that the digestion conditions chosen were 
suitable for complete digestion of RNA to units as small as mononucleotides 
and therefore these conditions were used for future studies.  
The bromine labelled digestion product u
Br
p was observed by HPLC-ESI MS 
and software was shown to successfully distinguish brominated species. No 
mononucleotides were observed by MALDI-TOF MS, making this technique 
unsuitable for analysis of these smallest digestion products. MALDI-TOF MS is 
most commonly used for analysis of high molecular weight compounds as low 
molecular weight compounds are often obscured by matrix ion signals. Use of 
different conditions, such as a different matrix, may have allowed observation 
of these small digestion products. Observation of u
Br
p confirmed that RNase A 
is capable of cleaving adjacent to the 5-bromouridine base.  
Analysis times using MALDI-TOF MS were around 2 minutes compared to 18 
minutes (later reduced to 13 minutes, see section 4.1.1) using the HPLC-ESI MS 
method. However, sample preparation time was longer for MALDI-TOF MS than 
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for HPLC-ESI MS and the HPLC-ESI approach can be easily automated for high 
throughput analysis making it the more time efficient approach.  
A comparison of data acquired for ONT-1-ii and ONT-1-iii showed that the 
peak area of the EICC of peaks corresponding to u
Br
p species could be increased 
by incorporating additional modified bases. For use as a detection probe in a 
hybridisation assay, the incorporation of multiple labels into one probe would 
reduce the limit of detection of the analyte RNA.  
3.3  RNase A Digestion of ONT-2 and ONT-3 
ONT-2 and ONT-3 were designed to produce the bromine labelled 
dinucleotides au
Br
p and gu
Br
p, respectively (Figure 3-12), upon digestion by 
RNase A (Table 3-2).  
 
Figure 3-12   Structures of the mass tags (a) au
Br
p and (b) gu
Br
p, formed upon 
RNase A digestion of ONT-2 and ONT-3, respectively 
Using HPLC-ESI MS for analysis of ONT-2 and ONT-3 (5 minutes digestion 
time) all expected digestion products were observed with the exception of the 
terminal adenosine and guanosine mononucleosides (Table 3-3). It is likely that 
these products were formed, however they do not possess a phosphate group 
and may therefore not have been ionised using the negative ion ESI process 
and thus were not observed. For ONT-2, the bromine labelled dinucleotide was 
observed to elute at t
R 1.4 minutes as [au
Br
p − H]– at m/z 729.96 and 731.96 
(a)  (b) 3. RNase A Digestion of Bromine Labelled RNA 
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showing the distinctive isotope pattern (Figure 3-13 (a)). The ICAC showed just 
one peak corresponding to the retention time of au
Br
p, allowing the generation 
of an ICFMS (Figure 3-13 (b)).  
 
Figure 3-13   HPLC-ESI MS analysis of ONT-2 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectrum at t
R 1.4 min. 
and (b) ICAC and isotope cluster filtered mass spectrum at t
R 1.4 min. Inserts 
show expansion of m/z regions of digestion products 
Similarly for ONT-3, the bromine labelled dinucleotide eluted at t
R 1.2 
minutes as [gu
Br
p − H]– at m/z 745.97 (Figure 3-14 (a)). This species coeluted 
with ac
p which had a t
R of 1.3 minutes in the EICC, however the isotope cluster 
filtered mass spectrum was able to distinguish the brominated species from 
other digestion products (Figure 3-14 (b)).  
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Figure 3-14   HPLC-ESI MS analysis of ONT-3 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectrum at t
R 1.2 min. 
and (b) ICAC and isotope cluster filtered mass spectrum at t
R 1.2 min. Inserts 
show expansion of m/z regions of digestion products 
For ONT-2 and ONT-3, in addition to the expected digestion products, ions 
were observed in the mass spectra at m/z 400.92 and 402.93 at a ratio of 
approximately 1:1, which corresponded to [u
Br
p − H]
– (Figure 3-13 (a) and Figure 
3-14 (a)). The low relative intensity (ca 0.3%) of these ions prevented confident 
assignment, however the presence of u
Br
p upon analysis of digested ONT-2 and 
ONT-3 would be concerning due to the potential implications for multiplexed 
analyses. u
Br
p was the mass tag designed to be produced from ONT-1-ii  and 
ONT-1-iii. Production of u
Br
p from ONT-2 and ONT-3 would become problematic 
if these sequences were to be used in detection probes of a multiplexed 
system alongside detection probes containing the sequence of ONT-1. The low 
relative intensity of the ions meant they were not significantly concerning, 
(a) 
2  3  4  5  
Time 
[min]  1 
0 
20 
40 
Int. 
[mAU] 
1.2 
6   7  
Res2300_t=5min_3_BE2_01_6277.d: -MS, 1.2min #73, Background Subtracted, Background Subtracted
0
20
40
60
80
100
Intens.
[%]
743 744 745 746 747 748 749 750 751 752 m/z 745  747  749  751 
745.97  747.97 
746.97 748.97 
m/z 
1.2 
2  3  4  5  
Time 
[min]  1  6   7  
0 
2 
4 
Int. 
×10
4 
(b) 
Res2300_t=5min_3_BE2_01_6277.d: -MS, 1.1-1.3min #(68-76), Background Subtracted
0
20
40
60
80
100
Intens.
[%]
400 500 600 700 800 900 1000 1100 1200 1300 m/z 400  600  800  1000 
100 
%  
0 
651.08 
[ac
p – H]
– 
745.97 
[gu
Br
p – H]
– 
m/z 
745.9717
746.9739
747.9695
748.9734
Res2300_t=5min_3_BE2_01_6277.d:‎-MS,‎1.2min‎#72,‎IsotopeCluster‎filtered‎(Isotope‎Cluster‎Analysis:‎d‎m/z‎2±0.1,‎I/I‎1±10%,‎Smoothed‎(3.02,2,SG))
0
20
40
60
80
100
Intens.
[%]
743 744 745 746 747 748 749 750 751 752 m/z
400  600  800  1000 
100 
%  
0 
745.97 
[gu
Br
p – H]
– 
m/z 
745.9717
Res2300_t=5min_3_BE2_01_6277.d:‎-MS,‎1.2min‎#72,‎IsotopeCluster‎filtered‎(Isotope‎Cluster‎Analysis:‎d‎m/z‎2±0.1,‎I/I‎1±10%,‎Smoothed‎(3.02,2,SG))
0
20
40
60
80
100
Intens.
[%]
400 500 600 700 800 900 1000 1100 1200 1300 m/z
745  747  749  751 
745.97  747.97 
m/z 
748.97  746.97 
Res2300_t=5min_3_BE2_01_6277.d: -MS, 1.1-1.3min #(68-76), Background Subtracted
0.00
0.05
0.10
0.15
0.20
0.25
Intens.
[%]
397 398 399 400 401 402 403 404 405 406 m/z 400  402  404 
400.92 402.93 
m/z 
[gu
Br
p – H]
– 
[gu
Br
p – H]
–  [u
Br
p – H]
– 3. RNase A Digestion of Bromine Labelled RNA 
  83     
however the problem was observed more significantly upon digestion of 
ONTs-4-6 (section 3.5). 
Using MALDI-TOF MS, neither the terminal mononucleosides nor the internal 
u
p mononucleotide were observed for either ONT-2 or ONT-3. The expected 
dinucleotides were observed however, including the bromine labelled products 
[au
Br
p + H]
+ and [gu
Br
p + H]
+ at m/z 732.2 and 747.7, respectively (Figure 3-15, 
Figure 3-16 and Table 3-3).  
 
Figure 3-15   MALDI-TOF MS analysis of ONT-2 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
 
Figure 3-16   MALDI-TOF MS analysis of ONT-3 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
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ONT 
Expected 
Digestion 
Products 
MW
(mono) 
Observed 
HPLC-ESI MS  MALDI-TOF MS 
2 
a  267.10     
u
p  324.04     
au
p  653.09     
gc
p  668.10     
au
Br
p  730.10     
3 
g  283.09     
u
p  324.04     
ac
p  652.10     
gu
Br
p  746.99     
Table 3-3   Summary of results obtained upon analysis of ONT-2 and ONT-3 
after 5 minutes RNase digestion time 
3.3.1  Summary 
Bromine labelled dinucleotides were observed by both HPLC-ESI MS and 
MALDI-TOF MS. Observation of the two bromine labelled dinucleotides from 
ONT-2 and -3 along with the labelled mononucleotide produced by digestion of 
ONT-1-ii and -iii demonstrated that this approach could be applicable to 
multiplexed analyses. 
Observation of additional species corresponding to digestion products 
smaller than expected suggested that overdigestion of the RNA by RNase A 
could be occurring.  3. RNase A Digestion of Bromine Labelled RNA 
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3.4  RNase A Digestion of ONT-4, ONT-5 and 
ONT-6 
ONT-4, ONT-5 and ONT-6 were designed to produce the bromine labelled 
trinucleotides aau
Br
p gau
Br
p and ggu
Br
p, respectively (Figure 3-17), upon digestion 
by RNase A (Table 3-2). 
 
Figure 3-17   Structures of the mass tags (a) aau
Br
p, (b) gau
Br
p and (c) ggu
Br
p, 
formed upon RNase A digestion of ONT-4, ONT-5 and ONT-6, respectively 
After 5 minutes digestion time of the corresponding oligonucleotide, using 
HPLC-ESI MS each of these trinucleotides were observed using as both the 
singly and doubly charged ions (Figure 3-18 (c) Figure 3-19 (c) and Figure 3-20 
(c)). All other expected products were also observed by HPLC-ESI MS (Table 
3-4).  
In addition to the expected digestion products, data suggested that 
overdigestion of the RNA was occurring (Figure 3-18 (b) Figure 3-19 (b) Figure 
3-20 (b)) and this is discussed in detail below (section 3.5). 3.  RNase A Digestion of Bromine Labelled RNA 
86 
 
Figure 3-18   HPLC-ESI MS analysis of ONT-4 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 1.4 min. 
and (c) 1.8 min. Inserts show expansion of m/z regions of bromine labelled 
digestion products 
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Figure 3-19   HPLC-ESI MS analysis of ONT-5 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 1.9 min. 
and (c) 2.2 min. Inserts show expansion of m/z regions of bromine labelled 
digestion products 
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Figure 3-20   HPLC-ESI MS analysis of ONT-6 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 1.2 min. 
and (c) 1.5 min. Inserts show expansion of m/z regions of bromine labelled 
digestion products 
Using MALDI-TOF MS the three bromine labelled trinucleotides were each 
observed as singly charged protonated molecules with the characteristic 
isotope pattern (Figure 3-21, Figure 3-22, Figure 3-23). The dinucleotides from 
the 3ʹ terminal ends were also observed as expected. In contrast to previous 
results, mononucleotides were also observed. c
p was observed as [c
p + H]
+ upon 
analysis of digestion products of each of the three oligonucleotides. An ion at 
one m/z unit higher was also observed but it was not possible to determine 
whether this was detection of [u
p + H]
+ or the 
13C isotope of the [c
p + H]
+ ion. In 
addition to protonated molecules, sodium adducts were observed as well as 
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protonated gas phase dimers and trimers formed by association of two or 
more digestion products.
 
 
Figure 3-21   MALDI-TOF MS analysis of ONT-4 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
 
Figure 3-22   MALDI-TOF MS analysis of ONT-5 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
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Figure 3-23   MALDI-TOF MS analysis of ONT-6 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
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ONT 
Expected 
Digestion 
Products 
MW
(mono) 
Observed 
HPLC-ESI MS  MALDI-TOF MS 
4 
c
p  323.05     
u
p  324.04    ? 
aa
  596.15     
aau
Br
p  1060.05     
5 
c
p  323.05     
u
p  324.04    ? 
ga
p  612.14     
gau
Br
p  1076.05     
6 
c
p  323.05     
u
p  324.04    ? 
gg  628.14     
ggu
Br
p  1092.04     
Table 3-4   Summary of results obtained upon analysis of ONT-4, ONT-5 and 
ONT-6 after 5 minutes RNase digestion time 
3.5  Unwanted digestion products 
RNase A digestion of the custom designed RNA sequences successfully 
resulted in formation of bromine labelled small molecules which have the 
potential to be used as mass tags. However, for a given sequence, in addition 
to the mass tag designed to be produced, a different bromine labelled mass 
tag with a nucleotide missing from the 5ʹ end was also observed. This must be 
eliminated for the system to be compatible with multiplexed analyses. 
These smaller bromine labelled species may have originated in one of three 
ways. RNase A reportedly cleaves specifically at the 3ʹ side of the pyrimidine 
ribonucleotides cytidine and uridine. However, overdigestion would result from 
the enzyme cleaving after adenosine or guanosine nucleotides. Other  3.  RNase A Digestion of Bromine Labelled RNA 
92 
possibilities were that these products were a result of the normal digestion of 
failure sequences or the result of is-CID. 
ONT-2 and ONT-3 were designed to produce the mass tags au
Br
p and gu
Br
p, 
respectively. HPLC-ESI MS analysis of digestion products from both these 
oligonucleotides showed ions corresponding to [u
Br
p − H]
–. The following 
discussion is based on assignment of these ions as [u
Br
p − H]
–, however the low 
relative signal intensity of ca 0.3% makes this assignment uncertain. Analysis 
of the EICCs of ions at m/z 400.2 – 403.9 showed that peak areas did not 
increase over time which suggested overdigestion was not the cause of u
Br
p 
formation. Instead, u
Br
p could be formed upon the normal RNase A cleavage of 
the n-4 failure sequence, which would terminate with the 5-bromouridine 
nucleotide at the 5ʹ end. is-CID of the dinucleotide could also explain the 
observation of the mononucleotide as both species had the same retention 
time.  
ONT-4, ONT-5 and ONT-6 were designed to produce the mass tags aau
Br
p, 
gau
Br
p, and ggu
Br
p, respectively. However, for each of these oligonucleotides, 
RNase A digestion also resulted in the formation of bromine labelled 
dinucleotides. The dinucleotides eluted earlier than the trinucleotides, ruling 
out IS-CID as a cause in these cases. For ONT-4 after 5 minutes digestion time, 
[au
Br
p − H]
– was observed at m/z 729.98, with a relative intensity of 1.8%. The 
bromine isotope pattern and 
13C peaks observed allowed confident assignment 
of these peaks. Analysis of UV chromatograms (Figure 3-24) and EICCs of m/z 
729.5–735.0 from samples taken after 2, 4 and 24 hours digestion time 
(Figure 3-25, purple line) showed an increase in peak area over time. An 
increase in the amount of au
Br
p over time suggested that for ONT-4, RNase A 
overdigested the RNA by cleaving at the 3ʹ side of adenosine. It is worth noting 
that using MALDI-TOF MS au
Br
p was observed, but not until analysis of the 
sample taken after 4 hours digestion time when its concentration would have 
increased. The digestion product au
Br
p was also observed upon HPLC-ESI MS 
analysis of ONT-5 after 5 minutes digestion time, at m/z 729.96 with a relative 
intensity of 1.3%. Peak areas in the EICCs of this species did not increase 
significantly between the sample taken at 5 minutes digestion time and that 
taken after 2 hours. After 2 hours, the EICC peak areas were observed to 
increase, however at a lower rate than the increase observed for au
Br
p formation 
from ONT-4 (Figure 3-25, red line). For ONT-6 the dinucleotide gu
Br
p was 3. RNase A Digestion of Bromine Labelled RNA 
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observed by HPLC-ESI MS after 5 minutes digestion time at m/z 745.98 with a 
relative intensity of 2.7%. In contrast to ONT-4, peak areas in the EICCs of this 
species did not increase over time (Figure 3-25, blue line). This suggested that 
for ONT-6, overdigestion by RNase A was not the cause of au
Br
p formation and 
that the alternative theory of normal digestion of the n-3 failure was more 
likely.  
The absence of a steep increase in the formation of au
Br
P and gu
Br
p from gau
Br
P 
and ggu
Br
P, respectively, over time suggested that RNase A cleavage at the 3ʹ 
side of guanosine did not occur as readily as the cleavage at the 3ʹ side of 
adenosine observed for ONT-4.  
 
Figure 3-24   HPLC-ESI MS analysis of ONT-4 showing UV chromatograms of 
samples taken at digestion times of (a) 5 minutes and (b) 24 hours. Inserts show 
negative ion ESI mass spectra at t
R 1.4 min. showing the m/z region of the 
overdigestion product au
Br
p 
2  3  4 
Time 
[min]  1 
0 
20 
40 
Int. 
[mAU] 
1.0  
1.4 
(a) 
1.8 
1.0  
1.4 
1.8 
2  3  4 
Time 
[min]  1 
-10 
0 
Int. 
[mAU] 
10 
20 
728  730  732  734 
729.98 
731.99 
m/z  0 
1.5  
%  
Res2099_t=5min_2_RE3_01_5426.d: -MS, 1.4-1.5min #(81-87), Background Subtracted
0.0
0.5
1.0
1.5
Intens.
[%]
727 728 729 730 731 732 733 734 735 736 m/z
Res2099_t=24h_1_RD2_01_5468.d: -MS, 1.3-1.4min #(80-84)
0
20
40
60
80
100
Intens.
[%]
727 728 729 730 731 732 733 734 735 736 m/z 728  730  732  734 
m/z  0 
100 
% 
729.97  731.97 
(b)  [au
Br
p – H]
–  
[au
Br
p – H]
– 3.  RNase A Digestion of Bromine Labelled RNA 
94 
 
Figure 3-25   Graph showing EICC peak areas of ions corresponding to Nu
Br
p 
over time. N = a for ONT-4 and ONT-5 and N = g for ONT-6. Error bars show ± 1 
standard deviation from triplicate results 
3.5.1  Attempts to Eliminate Unwanted Digestion 
Products 
Experiments were undertaken to investigate if modifying the assay 
conditions could eliminate overdigestion by RNase A. ONT-4 was used for 
these studies as overdigestion was most significant for this RNA sequence. 
HPLC-ESI MS was used for analysis rather than MALDI-TOF MS due to its 
superior repeatability and its ability to detect mononucleotides. 
3.5.1.1  Reduction of RNase A Concentration 
Zweib et al.
[113] reported that a reduced concentration of RNase A was 
required for their work to avoid overdigestion of RNA, specifically cleavage at 
the 3ʹ side of adenosine. To investigate whether a reduced enzyme 
concentration could avoid non-specific cleavage in this study, ONT-4 was 
digested with an RNase A concentration of 0.01 Kunitz units per μg RNA; a 
tenfold reduction compared to previous experiments. 
Using HPLC-ESI MS for analysis of ONT-4 after 5 minutes digestion time, a 
variety of digestion products were observed. Partially digested products which 
had not been cleaved at every expected site were not observed, however a 
significant amount of 2ʹ,3ʹ-cyclic phosphates were observed. Cyclic phosphates 
are intermediates in the RNase A cleavage mechanism and their presence 
indicated that digestion was not complete after 5 minutes. Single cytidine and 
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uridine mononucleotides were observed primarily as cyclic phosphates (Figure 
3-26 (b)) along with smaller amounts of the fully digested 3ʹ-monophosphate 
(Figure 3-26 (c)). The bromine labelled trinucleotide mass tag was observed 
primarily as the 3ʹ-monophosphate, although the cyclic phosphate intermediate 
was also observed (Figure 3-26 (e)). Importantly, under assay conditions 
containing a tenfold reduction in RNase A concentration, after 5 minutes 
digestion time the unwanted bromine labelled dinucleotide au
Br
p was still 
observed alongside the discussed cyclic phosphate intermediates (Figure 
3-26 (d)). The peak area of the EICC of the [au
Br
p − H]
– ions at m/z 729.5-735.0 
was on average (from triplicate results) 30% of the equivalent species observed 
in the analysis of the equivalent sample taken from the assay using the original 
enzyme concentration.  
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Figure 3-26 continued overleaf 
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Figure 3-26   HPLC-ESI MS analysis of ONT-4 sampled at 5 min. digestion time 
using a tenfold reduction in RNase A concentration, showing (a) UV chromatogram 
and negative ion ESI mass spectra at t
R (b) 0.9 min., (c) 1.0 min., (d) 1.4 min. and (e) 
1.8 min. Inserts show expansion of m/z regions of digestion products 
After 2 hours, digestion had advanced and analysis showed a significant 
reduction in ions corresponding to cyclic phosphate intermediates. c
>p and u
>p 
were not detected as homodimers, but only as low intensity gas phase 
heterodimers with 3ʹ-monophosphate mononucleotides at m/z 627.07, 628.05 
and 629.05 (Figure 3-27 (b)). aau
Br
>p was also detected at a low intensity of 0.4% 
(Figure 3-27 (d)). Importantly, the overdigestion product au
Br
p was observed 
(Figure 3-27 (c)) with an increase in EICC peak area compared to the sample 
taken after 5 minutes digestion time. Over 24 hours, this EICC peak area 
increased further, but at a significantly lower rate than under previously used 
assay conditions (Figure 3-28) 
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Figure 3-27   HPLC-ESI MS analysis of ONT-4 sampled at 2 h. digestion time 
using a tenfold reduction in RNase A concentration, showing (a) UV chromatogram 
and negative ion ESI mass spectra at t
R (b) 1.0 min., (c) 1.4 min. and (d) 1.8 min. 
Inserts show expansion of m/z regions of digestion products 
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Figure 3-28   Graph showing EICC peak areas of [au
Br
p  –  H]
– over time under 
different assay conditions. Error bars show ± 1 SD from triplicate results 
From these results it was concluded that a reduction in enzyme 
concentration significantly reduced the extent of overdigestion, especially over 
time, but did not eliminate it. The concurrent presence of both cyclic 
phosphate intermediates and overdigestion products in the sample taken at 5 
minutes suggested that cleavage after the adenosine base happened alongside 
the expected cleavage after uridine and cytidine bases, rather than occurring 
after complete digestion at the expected sites. Therefore, reducing the enzyme 
concentration was not a successful way of stopping overdigestion. 
3.5.1.2  Addition of NaCl 
A second possible solution to the problem of overdigestion was the addition 
of NaCl to the assay, which was suggested to be necessary to reduce 
overdigestion.
[114] Therefore, experiments were undertaken which included the 
addition of 10 mM NaCl to the digestion assay.  
HPLC-ESI MS analysis after 5 minutes digestion time gave results similar to 
those obtained under the original assay conditions. Cyclic phosphate 
intermediates were not detected and complete digestion to the expected 
products was observed. However, the overdigestion product au
Br
p was still 
observed. For a comparison with previous experiments, the EICC peak area of 
[au
Br
p – H]
– as a percentage of the EICC peak area of the designed mass tag 
[aau
Br
p – H]
– was used (Figure 3-29). Results for the experiment with the 
addition of 10 mM NaCl showed no significant difference from previous results 
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without NaCl up to 4 hours digestion time. At 24 hours the extent of 
overdigestion was reduced by the addition of 10 mM NaCl.  
 
Figure 3-29   Graph showing EICC peak areas of [au
Br
p  –  H]
– as a percentage of 
the EICC peak area of [aau
Br
p  –  H]
– over time under different assay conditions. 
Error bars show ± 1 standard deviation from triplicate results 
It was possible that the addition of a higher concentration of NaCl may have 
reduced overdigestion further, however based on these results it was believed 
it would be unlikely to stop it completely. Therefore, redesign of the 
oligonucleotide sequences as DNA/RNA chimeras was explored as an 
alternative solution, inserting DNA bases at positions where no RNase A 
cleavage was desired and RNA bases only at positions where it was (see 
Chapter 4). 
3.6  Conclusions 
RNase A digestion of RNA was undertaken and mono- di- and trinucleotide 
were shown to be formed. Through a combination of customised RNA 
sequence design and choice of RNase enzyme, design of the desired digestion 
products was possible. Use of 5-bromouridine allowed selected digestion 
products to possess the distinctive bromine isotope pattern when analysed by 
mass spectrometry. Ion signal intensity of the bromine labelled products was 
increased by incorporating multiple labelled mass tag sequences in one RNA 
molecule. In this way, the ribose-phosphate backbone of RNA was shown to 
function as an enzyme cleavable linker for the production of bromine labelled 
nucleotides which have the potential to be used as small molecule mass tags. 
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The design and detection of six bromine labelled mass tags with different 
masses gives this approach the potential for multiplexed analyses. 
MALDI-TOF MS was found to provide a rapid method capable of 
simultaneously observing numerous digestion products. However, 
mononucleotides were not consistently observed under the conditions used 
and u
Br
p was not observed using this technique. All expected digestion products 
were detected using HPLC-ESI MS except for the 3ʹ terminal mononucleosides 
which lacked a phosphate group. HPLC-ESI MS had the advantage of 
chromatographic separation, which also acted to desalt the analytes and 
reduce the effect of ion suppression which may arise from simultaneous 
analysis of ions when using MALDI-TOF MS. HPLC-ESI MS was also found to 
detect dinucleotide overdigestion products in samples taken at 5 minutes, 
rather than MALDI-TOF MS which first detected these species at 4 hours once 
their concentration had increased.  
RNase A cleavage was found to proceed quickly, with complete digestion 
occurring in less than 5 minutes under the original assay conditions which 
were taken from previous literature reports. However, overdigestion by RNase 
A was found to occur, with non-specific cleavage at the 3ʹ side of adenosine 
and guanosine being observed. Due to the impact this could have on 
multiplexing potential of this approach, experiments were undertaken to 
prevent overdigestion. A tenfold reduction in RNase A concentration was found 
to slow down digestion and significantly reduce the extent of overdigestion 
over time. This experiment also showed that overdigestion happened 
concurrently with normal digestion, rather occurring after normal digestion 
had finished. Addition of 10 mM NaCl was shown to slightly reduce 
overdigestion, but both approaches failed to eliminate the problem. The next 
stage of development was therefore aimed at solving the problem of 
overdigestion by redesign of the oligonucleotide sequences as DNA/RNA 
chimeras. 
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4. RNASE A DIGESTION OF BROMINE 
LABELLED DNA/RNA CHIMERAS 
To prevent cleavage at undesired sites and circumvent the problem of 
overdigestion which was observed upon digestion of RNA, oligonucleotide 
sequences were redesigned as DNA/RNA chimeras. Pyrimidine RNA nucleotides 
were only located at the positions where RNase A cleavage was desired and all 
other nucleotides were DNA. The RNase A cleavage mechanism (Figure 1-32) 
requires the 2ʹ-OH group of the ribose sugar, therefore DNA bases which lack 
this group were incorporated to give greater control over cleavage sites rather 
than relying on the specificity of RNase A.
[115]  
An additional advantage of using DNA/RNA chimeras was the increased 
multiplexing potential it would provide. For RNA sequences, only adenosine 
and guanosine could be used as additional bases to form di- or trinucleotide 
mass tags. However, using DNA bases meant thymidine and deoxycytidine as 
well as deoxyadensoine and deoxyguanosine could be used to extend the 
range of mass tags of differing molecular weights. An alternative series of 
mass tags could be designed to contain deoxyuridine instead of deoxycytidine. 
However, due to the mass difference of 1 Da between deoxycytidine and 
deoxyuridine these two series could not be used simultaneously due to the 
resulting overlapping ions which would be observed in the mass spectrum. 
This approach gives a total of fourteen mass tags up to three nucleotides long: 
four dinucleotides and ten trinucleotides (Table 4-1). The difference in mass 
between each dinucleotide ranges from 9 to 16 Da. For the trinucleotides, 
there are two mass tags which differ in mass by only 1 Da, i.e. ATu
Br
p with a 
molecular weight of 1019.05 and GCu
Br
p with a molecular weight of 1020.05. 
These two mass tags would have overlapping signals in a mass spectrum and 
therefore could not be used simultaneously in a multiplexed analysis. For the 
remaining trinucleotides the difference in masses ranges from 6 to 16 Da.  4.  RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Mass tag 
digestion product  MW
(mono) 
Cu
Br
p  690.99 
Tu
Br
p  705.99 
Au
Br
p  715.00 
Gu
Br
p  731.00 
CCu
Br
p  980.04 
CTu
Br
p  995.04 
ACu
Br
p  1004.05 
TTu
Br
p  1010.04 
ATu
Br
p  1019.05 
GCu
Br
p  1020.05 
AAu
Br
p  1028.06 
GTu
Br
p  1035.05 
GAu
Br
p  1044.06 
GGu
Br
p  1060.05 
Table 4-1   Possible mass tags available using the DNA/RNA chimera 
approach with digestion by RNase A. Upper case = DNA, lower case = RNA, u
Br = 
5-bromouridine,  
p  =  3ʹ-monophosphate 
4.1  RNase A Digestion of ONT-7, ONT-8 and 
ONT-9 
To test the suitability of using DNA/RNA chimeras for production of mass 
tags by RNase A digestion, four sequences were designed (Table 4-2) which 
would produce four of the mass tags listed in Table 4-1. The sequences and 
mass tags of ONT-7, ONT-8, ONT-9 and ONT-10 were analogous to those of 
ONT-2, ONT-4, ONT-5 and ONT-6, respectively, replacing purine 
ribonucleotides with deoxyribonucleotides and unlabelled uridine bases with 
thymidine.  4. RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Oligonucleotide 
(ONT) 
Sequence (5ʹ  3ʹ)  MW
(mono) 
Expected 
digestion 
products 
MW
(mono) 
7  TGcAu
BrTGcAu
BrTGcAu
Br TGcA  6094.6 
A
 
Au
Br
p 
TGc
p 
251.10 
715.00 
956.15 
8  TcAAu
BrTcAAu
BrTcAAu
BrTcAA
  6030.7 
AA 
Tc
p 
AAU
Br
p 
564.16 
627.10 
1028.06 
9  TcGAu
BrTcGAu
BrTcGAu
BrTcGA  6094.6 
GA 
Tc
p 
GAu
Br
p 
580.15 
627.10 
1044.06 
10  TcGGu
BrTcGGu
BrTcGGu
BrTcGG  6158.6 
GG 
Tc
p 
GGu
Br
p 
596.15 
627.10 
1060.05 
Table 4-2   DNA/RNA chimeric sequences and expected digestion products 
with monoisotopic masses. Upper case = DNA, lower case = RNA, u
Br = 
5-bromouridine,  
p = 3ʹ-monophosphate 
4.1.1  Chromatography Optimisation 
Prior to undertaking the digestion experiments it was not known how fast 
digestion would occur or whether some samples might show incomplete 
digestion. Therefore the mobile phase gradient used for HPLC-ESI MS analysis 
was one optimised for longer oligonucleotides (ca 20 bases). Complete 
digestion was observed in samples taken at 5 minutes meaning the products 
eluted between approximately 0.9 and 1.8 minutes of an 18 minute run (see 
Table 4-3 for gradient conditions), with many products coeluting. Therefore, a 
chromatographic gradient was developed to improve separation of the 
digestion products. The initial percentage of organic mobile phase was 
reduced from 5% to 1% followed by a shallower, shorter gradient increasing the 
organic percentage to 20% over 7 minutes. The organic percentage was then 
increased quickly to 40% over 2 minutes before re-equilibration of the column 
to 1% organic mobile phase until the end of the run at 13 minutes (Table 4-3). 
The optimised gradient was used for all future analyses of digestion products.  4.  RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Gradient for longer oligonucleotides  Gradient optimised for digestion 
products 
Retention time 
(min.) 
Organic 
percentage 
Retention time 
(min.) 
Organic 
percentage 
0.0  5.0  0.0  1.0 
1.0  5.0  1.0  1.0 
15.0  40.0  8.0  20.0 
15.1  5.0  10.0  40.0 
18.0  5.0  10.1  1.0 
-  -  13.0  1.0 
Table 4-3   Mobile phase gradients for analysis of oligonucleotides around 
20 bases long and optimised gradient for separation of digestion products 
4.1.2  ONT-7 
ONT-7 was designed to produce the mass tag Au
Br
p (Figure 4-1) upon RNase 
A digestion. 
 
Figure 4-1   Structure of the mass tag Au
Br
p, formed upon RNase A digestion of 
ONT-7 
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  HPLC-ESI MS analysis of ONT-7 after 5 minutes digestion with RNase A 
showed two major peaks in the UV chromatogram at t
R 6.4 and 6.7 minutes 
(Figure 4-2 (a)). The negative ion ESI mass spectrum at t
R 6.4 minutes showed 
equal intensity ions at m/z 713.97 and 715.97, which corresponded to the 
deprotonated bromine labelled mass tag [Au
Br
p − H]
– (Figure 4-2 (b)). The mass 
spectrum at the second peak identified the trinucleotide digestion product 
TGc
p as the singly and doubly deprotonated molecule at m/z 955.11 and 
477.05, respectively (Figure 4-2 (c)). The final digestion product, 
deoxyadenosine, originating from the 3ʹ end of the sequence and thus lacking 
a phosphate group, was once again not observed. Disappointingly, the 
bromine labelled uridine nucleotide, which could be formed by cleavage of the 
phosphate group at the 3ʹ side of deoxyadenosine, was once again observed. 
The EICC at the m/z values of u
Br
p species (m/z 400.2 – 406.9) showed two 
peaks; at t
R 6.4 and 6.7 minutes, i.e. the retention times of the two major 
digestion products. Examination of the mass spectrum at t
R 6.7 minutes 
showed an ion at m/z 402.00 with no bromine isotope pattern, therefore this 
peak was not attributed to u
Br
p. At t
R 6.4 minutes however, ions at m/z 400.93 
and 402.93 at a 1:1 ratio were observed (Figure 4-2 (b)) at a relative intensity 
of 0.2%. The retention time was identical to the bromine labelled dinucleotide, 
however using the optimised chromatographic conditions, mononucleotides 
should be easily separated from dinucleotides and were typically found to elute 
at around t
R 1 – 2 minutes. Therefore, is-CID was hypothesised to account for 
observation of a mononucleotide with the same retention time as a 
dinucleotide. The peak area of the EICC for ions related to u
Br
p did not increase 
over time, further supporting the hypothesis that overdigestion was not 
responsible for the production of this species. The absence of an increase in 
EICC peak area over time suggests that redesign of the oligonucldeotide 
sequences as DNA/RNA chimeras successfully prevented overdigestion. 4.  RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Figure 4-2   HPLC-ESI MS analysis of ONT-7 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 6.3 min. 
and (c) 6.6 min. Inserts show expansion of m/z regions of digestion products 
Positive ion MALDI-TOF MS analysis of ONT-7 confirmed the results obtained 
by HPLC-ESI MS. The protonated molecules [Au
Br
p + H]+ and [TGc
p + H]
+ were 
observed at m/z 715.8 and 957.0, respectively, along with sodium adducts and 
gas phase dimers and trimers of these species (Figure 4-3). The single 3ʹ-OH 
deoxyadenosine nucleotide was once again not observed 
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Figure 4-3   MALDI-TOF MS analysis of ONT-7 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
4.1.3  ONT-8 
Digestion of ONT-8, which was designed to produce the mass tag AAu
Br
p 
(Figure 4-4) was particularly important for comparison with ONT-4 which 
showed significant overdigestion of aau
Br
p to au
Br
p. 
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Figure 4-4   Structure of the mass tag AAu
Br
p, formed upon RNase A digestion 
of ONT-8 
After 5 minutes digestion time the UV chromatogram showed two major 
peaks at t
R 6.0 and 7.1 minutes (Figure 4-5 (a)). The mass spectrum of the peak 
at t
R 6.0 minutes showed an ion at m/z 626.06, which corresponded to 
[Tc
p − H]
– and the gas phase dimer of this species was also observed (Figure 
4-5 (c)). At t
R 7.1 minutes the bromine labelled trinucleotide mass tag 
[AAu
Br
p − H]
– was observed at m/z 1027.01 and as the doubly charged species 
at m/z 513.00 (Figure 4-5 (e)). EICCs were required to identify the elution of 
other digestion products. The dinucleotide AA from the 3ʹ terminus of the 
oligonucleotide was found to elute at t
R 2.7 minutes at m/z 563.13 (Figure 
4-5 (b)). In addition, the EICC of ions corresponding to the bromine labelled 
dinucleotide [Au
Br
p  − H]
– (m/z 713.2 – 707.5) unfortunately showed a peak at t
R 
6.5 minutes. Analysis of the mass spectrum showed equal intensity ions at m/z 
713.96 and 715.96 which corresponded to this species. The retention time of 
Au
Br
p was different to AAu
Br
p, meaning is-CID could not account for observation 
of the dinucleotide in this case. 4. RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Figure 4-5   HPLC-ESI MS analysis of ONT-8 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 2.7 min., 
(c) 6.0 min., (d) 6.5 min. and (e) 7.1 min. Inserts show expansion of m/z regions of 
bromine labelled digestion products 
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Redesign of the oligonucleotide sequence as a DNA/RNA chimera was aimed 
at eliminating overdigestion which results in production of the wrong mass 
tag. The wrong mass tag could also be produced by normal digestion of failure 
sequences and the use of DNA/RNA chimeras would not prevent this occurring. 
An indication of the reason why the wrong mass tag was observed was whether 
its concentration increased over time, which could be determined by 
comparison of the EICC peak areas. Comparison of the EICC peak areas of Au
Br
p 
associated ions (m/z 713.2 – 707.5) showed no increase in the amount of Au
Br
p 
over 24 hours (Figure 4-6). This observation led to the conclusion that redesign 
of the RNA sequences as DNA/RNA chimeras successfully solved the problem 
of overdigestion. It was believed therefore, that in this case Au
Br
p  resulted from 
the normal digestion of the n-3 failure sequence (Figure 4-7).  
 
Figure 4-6   Graph showing EICC peak areas of ions corresponding to Nu
Br
p 
over time. N = adenosine for ONT-4 (RNA) and deoxyadenosine for ONT-8 
(DNA/RNA chimera). Error bars show ± 1 standard deviation from triplicate results 
 
Figure 4-7   Potential routes to the production of the wrong mass tag 
(highlighted in red) upon RNase A digestion of ONT-8, showing RNase A expected 
cleavage sites (green solid line) and unexpected non-specific cleavage sites (red 
dashed lines). Upper case = DNA, lower case = RNA, u
Br  =  5-bromouridine 
The expected digestion products Tc
p and AAu
Br
p were detected using 
MALDI-TOF MS as singly charged ions in addition to sodium adducts and gas 
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phase dimers (Figure 4-8). The 3ʹ-OH terminal dinucleotide AA was not 
observed on this occasion.  
 
Figure 4-8   MALDI-TOF MS analysis of ONT-8 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
4.1.4  ONT-9 
The mass tag GAu
Br
p was designed to be produced upon RNase A digestion 
of ONT-9 (Figure 4-9).  
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Figure 4-9   Structure of the mass tag GAu
Br
p, formed upon RNase A digestion 
of ONT-9 
After 5 minutes digestion time, HPLC-ESI MS analysis showed two major 
peaks in the UV chromatogram at t
R 5.4 and 6.7 minutes (Figure 4-10 (a)). The 
first of these peaks was identified as Tc
p by observation of an ion at m/z 
626.06 in the mass spectrum (Figure 4-10 (c)). GAu
Br
p eluted at t
R 6.7 minutes 
and was observed as the singly and doubly deptotonated molecule at m/z 
1043.00 and 521.00, respectively (Figure 4-10 (e)). Once again, an EICC was 
required to identify the retention time of the final expected digestion product 
GA, which eluted at t
R 1.4 minutes (Figure 4-10 (b)). An EICC of Au
Br
p associated 
ions showed a peak at t
R 6.3 minutes and the mass spectrum confirmed that 
this peak corresponded to the bromine labelled dinucleotide Au
Br
p (Figure 4-10 
(d)). Similarly to ONT-7 and ONT-8, the peak area of the EICC did not increase 
over time (Figure 4-11), suggesting that Au
Br
p was once again observed due to 
digestion of failure sequences. 4. RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Figure 4-10   HPLC-ESI MS analysis of ONT-9 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 1.4 min., 
(c) 5.6 min., (d) 6.3 min. and (e) 6.8 min. Inserts show expansion of m/z regions of 
digestion products 
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Figure 4-11   Graph showing EICC peak areas of ions corresponding to Nu
Br
p 
over time. N = adenosine for ONT-5 (RNA) and deoxyadenosine for ONT-9 
(DNA/RNA chimera). Error bars show ± 1 standard deviation from triplicate results 
MALDI-TOF was able to detect all three expected digestion products; GA, Tc
p 
and GAu
Br
p, as singly protonated molecules at m/z 580.5, 627.5 and 1044.4, 
respectively (Figure 4-12). Ions arising from sodium adducts were not 
significant in this mass spectrum, although gas phase dimers and trimers were 
still observed. 
 
Figure 4-12   MALDI-TOF MS analysis of ONT-9 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
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4.1.5  ONT-10 
ONT-10 was designed to produce the mass tag GGu
Br
p upon RNase A 
digestion (Figure 4-13).  
 
Figure 4-13   Structure of the mass tag GGu
Br
p, formed upon RNase A digestion 
of ONT-10 
HPLC-ESI MS analysis after 5 minutes digestion time showed two major 
peaks in the UV chromatogram at t
R 5.2 and 6.6 minutes (Figure 4-14 (a)). Mass 
spectral analysis identified these peaks as corresponding to Tc
p (Figure 4-14 
(c)) and GGu
Br
p (Figure 4-14 (d)), respectively. Tc
p was observed as the singly 
deprotonated molecule at m/z 626.06 as well as the sodium adduct of this 
species and as the singly deprotonated gas phase dimer at m/z 1253.13. 
GGu
Br
p was observed as the singly and doubly deprotonated molecule at m/z 
1059.00 and 530.00, respectively. A smaller peak was also observed in the UV 
chromatogram at t
R 1.2 minutes which was identified as the dinucleotide GG, 
arising from the 3ʹ-OH terminus. An EICC of ions corresponding to the 
unwanted Gu
Br
p was constructed which showed two small peaks at t
R 5.1 and 
6.6 minutes, i.e. coeluting with the two major peaks (data not shown). Analysis 
of the mass spectrum at t
R 6.6 minutes showed no evidence of the bromine 
labelled dinucleotide. The mass spectrum at t
R 5.1 minutes could not 4.  RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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conclusively identify [Gu
Br
p – H]
–  due to the poor signal-to-noise ratio of ions 
potentially arising from this species. The same was true for samples analysed 
up to 24 hours digestion time, with only one analysis, that of a 4 hour 
digestion time sample, showing peaks which could more confidently be 
assigned as [Gu
Br
p – H]
–. The results showed that if Gu
Br
p was present in the 
sample, there was no sign that it increased in amount over time and therefore 
its presence was not attributed to overdigestion. 4. RNase A Digestion of Bromine Labelled DNA/RNA Chimeras 
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Figure 4-14   HPLC-ESI MS analysis of ONT-10 sampled at 5 min. digestion time, 
showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 1.2 min., 
(c) 5.2 min. and (d) 6.6 min. Inserts show expansion of m/z regions of bromine 
labelled digestion products 
Data acquired using MALDI-TOF MS showed all expected digestion products 
as protonated molecules with some sodium adducts observed as well as 
protonated gas phase dimers (Figure 4-15). 
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Figure 4-15   MALDI-TOF MS analysis of ONT-10 sampled at 5 min. digestion 
time. Insert shows an expansion of the m/z region of the digestion product ions 
4.2  Conclusions 
Formation of bromine labelled digestion products which were one 
nucleotide shorter than the designed mass tag would compromise the results 
of multiplexed analyses. A major factor contributing to formation of these 
species was believed to be overdigestion, where RNase A was cleaving at the 3ʹ 
side of purine bases in addition to the pyrimidine bases for which it is said to 
be specific. Whilst these shorter bromine labelled species were still observed 
upon analysis of digested DNA/RNA chimeras, overdigestion was not believed 
to be the cause. This conclusion was reached because the EICCs of these 
species did not show an increase in peak area over time. Comparison of 
analysis of ONT-4 (RNA) and ONT-8 (DNA/RNA chimera) highlighted the 
improvement achieved by redesign of the oligonucleotide sequences (Figure 
4-6). Therefore, redesign of RNA sequences as DNA/RNA chimeras was shown 
to successfully address the problem of overdigestion.  
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Two alternative explanations were believed to account for the observation of 
shorter bromine labelled nucleotides. For ONT-7, the mass tag Au
Br
p as well as 
the single u
Br
p nucleotide were observed at the same retention time. 
Observation of the deptoronated u
Br
p molecule was attributed to fragmentation 
of Au
Br
p by IS-CID. For ONT-8, -9 and -10, bromine labelled dinucleotides were 
observed at an earlier retention time than the designed bromine labelled 
trinucleotides. Therefore, these dinucleotides were believed to arise from 
RNase A digestion of n-3 failure sequences (Figure 4-7). 
For the future studies (chapter 5), based on these conclusions, sequences 
were designed as DNA/RNA chimeras with six thymidine nucleotides at the 5ʹ 
end to be used as detection probes in hybridisation assays. This should avoid 
problems associated with overdigestion and would mean the mass tags would 
not be so close to the 5ʹ end. Therefore if failure sequences remained present 
after purification, their presence would be less likely to interfere with results. 5. Indirect Analysis of RNA Using Self-Reporting Probes 
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5. INDIRECT ANALYSIS OF RNA USING 
SELF-REPORTING PROBES 
RNase A digestion of custom designed DNA/RNA chimeras containing 
5-bromouridine was shown to allow production of custom designed bromine 
labelled nucleotides. These nucleotides have the potential to be used as 
cleavable mass tags for the indirect detection of RNA. This potential was 
explored by incorporation of the custom designed sequences into the reporter 
regions of detection probes, forming self-reporting probes for use in 
hybridisation assays for indirect RNA analysis.
[116]  
5.1  Hybridisation Assay Design and 
Development 
Figure 5-1 shows the basic steps of a sandwich hybridisation assay, however 
each step required consideration and optimisation. This included selection of a 
target analyte, design of the capture probe and detection probe and 
optimisation of assay conditions, such as hybridisation and immobilisation as 
well as washing steps.  
 
Figure 5-1   Steps of a sandwich hybridisation assay 
Capture probe   Target analyte  Labelled detection 
probe 
Hybridisation and 
immobilisation 
Wash 
Detection of label 
Streptavidin 
coated magnetic 
beads 5.  Indirect Analysis of RNA Using Self-Reporting Probes 
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5.1.1  miR-155 as the Target Analyte 
In recent years miRNAs have emerged as a class of regulatory RNAs with the 
ability to affect protein synthesis and the potential to be used as drugs. 
(section 1.2.2). Simultaneous analysis of multiple miRNAs is often required and 
therefore an miRNA was chosen as the target for the hybridisation assays. The 
miRNA chosen was human miR-155 (see Table 5-1 for sequence). miR-155 is a 
noncoding RNA processed from the primary miRNA bic, which is transcribed 
from the bic/miR-155 gene. Human miR-155 is 23 bases long and miR-155 is 
also found in numerous other species with a high degree of sequence 
conservation. Studies have found links between miR-155 and a number of 
physiological processes. Rodriguez et al.
[117] found that miR-155 regulates a 
wide spectrum of genes with diverse molecular roles in T cells and plays a key 
part in the function of the immune system. miR-155 has also been linked to a 
number of autoimmune diseases
[118] including rheumatoid arthritis,
[119] lupus,
[120] 
and multiple sclerosis.
[121] Due to the wide range of processes affected by 
miR-155 its sequence was chosen as the target analyte for a proof of concept 
hybridisation assay. 
For a hybridisation assay to be specific for the target analyte, only the target 
analyte and its associated detection probe should be remain captured and be 
present at the end of the assay, prior to signal detection. All other non-target 
RNAs must be removed. To test the specificity of the assay, miR-155 sequences 
with single base substitution mutations at position 19; RNA-c, RNA-a and 
RNA-u, (Table 5-1), were used in place of the target analyte. This type of 
mutation results in a sequence most similar to the target and therefore 
successful discrimination between these mutants and the target analyte will 
provide best proof of the specificity of the assay. A scrambled miR-155 
sequence was also used as a control (Table 5-1). 5. Indirect Analysis of RNA Using Self-Reporting Probes 
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ID  Sequence (5ʹ  3ʹ)  MW
(mono)  MW
(av) 
miR-155  uuaaugcuaaucgugauaggggu  7386.0  7389.4 
RNA-c  uuaaugcuaaucgugauacgggu  7346.0  7349.4 
RNA-a  uuaaugcuaaucgugauaagggu  7370.0  7373.4 
RNA-u  uuaaugcuaaucgugauaugggu  7347.0  7350.4 
Scrambled  aggugcaugucgaauuaguauug  7386.0  7389.4 
Table 5-1   Sequences of RNA analytes for use in hybridisation assay 
experiments. Lower case = RNA, red base = site of mutation 
5.1.2  Design of Capture and Detection Probes 
A capture probe and a detection probe were designed for indirect analysis of 
miR-155. In addition, a second detection probe was designed for the indirect 
analysis of one of the miR-155 mutants; RNA-c. Due to the location of the 
mutation being in the region which formed a duplex with the detection probe 
and not the capture probe, the same capture probe was used for analysis of 
both miR-155 and RNA-c.  
The capture probe was comprised of a 3ʹ biotin group for immobilisation 
onto streptavidin coated magnetic beads, followed by a spacer of three 
thymidine nucleotides. The 5ʹ end of the capture probe was designed to be 
complementary to the 13 bases at the 5ʹ end of miR-155 (Figure 5-2 (b)). 
The detection probes had a 3ʹ region designed to be complementary to the 
10 bases at the 3ʹ end of their respective analytes. This region was followed by 
a spacer of five thymidine nucleotides before the specially designed mass tag 
region (Figure 5-2 (c)). Detection probe 1 was designed for detection of 
miR-155 and was designed to produce the bromine labelled mass tag Au
Br
p 
upon RNase A digestion. Detection probe 2 was designed for detection of 
RNA-c and was designed to produce the mass tag Tu
Br
p. Finally, at the 5ʹ end 
was a further six thymidine nucleotides included to prevent the problem of the 
wrong mass tag being produced upon digestion of failure sequences if this 
system were to be further multiplexed. 5.  Indirect Analysis of RNA Using Self-Reporting Probes 
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Figure 5-2   Sequences of (a) miRNA, (b) capture probe and (c) detection probe 
1, highlighting regions of complementarity and the reporter region of the 
detection probe 
5.1.2.1  Use of Locked Nucleic Acids 
The sugar group of nucleic acids exists in equilibrium between two 
dominant conformations; C
2ʹ-endo and C
3ʹ-endo (Figure 5-3 (a) and (b), 
respectively). Upon formation of a duplex, conformation of the sugar group is 
restricted. In B-form DNA (Figure 5-4 (a)) the sugar has C
2ʹ-endo puckering 
whereas A-form RNA (Figure 5-4 (b)) has C
3ʹ-endo puckering. In the 1990s when 
modified nucleotide analogues were being designed and developed, it was 
believed
[122] that reducing the flexibility of the sugar and fixing it in the ideal 
conformation would be an effective way of achieving high binding affinities 
with complementary DNA or RNA strands. Locked nucleic acids (LNAs) were the 
first analogues designed and synthesised which possessed fixed C
3ʹ-endo sugar 
puckering to restrict conformational flexibility of the sugar group (Figure 
5-3 (c)).
[122, 123]  
 
Figure 5-3   Conformations of the sugar group of (a) B-form duplexes with 
C
2ʹ-endo puckering, (b) A-form duplexes with C
3ʹ-endo puckering and (c) a locked 
nucleic acid in the fixed C
3ʹ-endo conformation 
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Figure 5-4   Structures of (a) B-form DNA and (b) A-form RNA.
[124] Adapted from 
reference 123 by permission of Oxford University Press 
Duplexes containing LNAs are more stable than native DNA or RNA duplexes 
of the same base sequence, as confirmed by T
m analysis.
[123] Decrease in 
thermal stability of a singly mismatched sequence compared to the fully 
complementary sequence has been shown to be more pronounced for 
duplexes containing LNAs than native DNA or RNA.
[123] This selectivity towards 
the fully complementary sequence compared to a sequence with a single 
mismatch has been further investigated. You et al.
[125] reported that a strand 
with a triplet of LNAs centred on the mismatched base provided the best 
discrimination, with the largest difference in T
m, between matched and 
mismatched sequence. 
The extent to which LNAs affect stabilisation and mismatch discrimination is 
sequence dependent. Mismatch discrimination was found to depend on the two 
nucleotides flanking the mismatch as well as on the mismatch itself. For 
example, the +C·C mismatch within the sequence 5ʹ+A+C+T3ʹ/3ʹTCA5ʹ (where 
+N denotes an LNA) was found to be the least stable mismatch.
[126] An 
exception to the improvement in mismatch discrimination is that of the +G·T 
mismatch, which was found to decrease discrimination relative to a G·T 
mismatch in DNA.
[125, 126]  
The reasons for improved duplex stability and mismatch discrimination of 
LNAs are still uncertain. Duplex formation between two single strands occurs 
due to favourable enthalpic changes which result from base stacking and 
hydrogen bonding. However, the entropic effect is negative due to the 
reduction in flexibility and degrees of freedom when the strand is fixed in the 
helical conformation. You et al.
[125] proposed that improved base stacking in 
(a)   (b) 5.  Indirect Analysis of RNA Using Self-Reporting Probes 
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oligonucleotides containing LNAs could be responsible for their increased 
affinity towards the complementary sequence. Owczarzy et al.
[126] conclude that 
one LNA base located in the interior of a sequence (≥3 base pairs from a 
terminus) increases stability by minimising the negative entropic effect and the 
addition of consecutive LNAs stabilises the duplex by improving the base 
stacking and enthalpic effects.  
Two sets of probes were designed for this study (Table 5-2); one with 
analyte complementary regions formed entirely of DNA and one with LNAs 
incorporated into these regions (referred to herein as LNA probes). Following 
the results of You et al.,
[125] three LNAs were incorporated into the detection 
probes centred around the site of mutation in the mutant analytes. To ensure 
similar melting temperatures of the capture probe·analyte and detection 
probe·analyte duplexes, three LNAs were also incorporated into the capture 
probe sequence. LNAs were investigated for use in this study to improve the 
hybridisation assay and its ability to discriminate between target sequences 
and sequences containing mutations. This aimed to allow for an investigation 
which focused on the effectiveness of the indirect analysis approach using the 
self-reporting probes, whilst minimising the effects of any imperfections in the 
hybridisation steps. 
ID  Sequence (5ʹ  3ʹ)  MW
(mono)  MW
(av) 
DNA capture 
probe  CGATTAGCATTAATTT-Biotin  5437.1  5439.8 
DNA detection 
probe 1 
TTTTTTcAu
BrAu
BrAu
BrTTTTTACCCCTATCA  8671.1  8678.1 
DNA detection 
probe 2  TTTTTTcTu
BrTu
BrTu
BrTTTTTACCCGTATCA  8684.0  8691.0 
LNA capture 
probe  CGATTA+G+C+ATTAATTT-Biotin  5535.1  5537.9 
LNA detection 
probe 1  TTTTTTcAu
BrAu
BrAu
BrTTTTTACC+C+C+TATCA  8783.1  8790.1 
LNA detection 
probe 2  TTTTTTcTu
BrTu
BrTu
BrTTTTTACC+C+G+TATCA  8782.0  8789.1 
Table 5-2   Sequences of capture probes and detection probes for use in 
hybridisation assay experiments. Upper case = DNA, lower case = RNA, +N = LNA, 
u
Br = 5-bromouridine, red base = site of mutation complement 5. Indirect Analysis of RNA Using Self-Reporting Probes 
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5.1.3  Hybridisation and Immobilisation 
The sandwich hybridisation assay requires hybridisation between the analyte 
and the two probes and for the resulting complex to be immobilised onto a 
solid support. However, two possible methods exist for undertaking the 
hybridisation and immobilisation steps; direct capture and indirect capture. For 
direct capture, the biotinylated capture probe is added to the streptavidin 
coated magnetic beads and allowed to immobilise, followed by addition of the 
analyte and detection probe which are then allowed to hybridise. For indirect 
capture, the capture probe, analyte and detection probe are added together in 
solution and allowed to hybridise followed by addition of the beads and 
subsequent immobilisation of the complex. 
5.1.3.1  Direct Capture 
Initially, a hybridisation assay was undertaken using direct capture with the 
aim of comparing results with the indirect capture method. For this 
experiment, miR-155 was used as the analyte along with the complementary 
LNA probes. However, using direct capture followed by a simple wash step (see 
section 5.1.4) and incubation with RNase A, no nucleic acid species, either 
in-tact or digested, were observed upon HPLC-ESI MS analysis. 
Numerous possible reasons for the failure of this assay were considered. For 
example, nucleic acid species could have been present below the limit of 
detection of the mass spectrometer, however based on the amount of 
oligonucleotides used and previous analyses at similar on-column amounts this 
was thought unlikely. Another potential problem was that all previous 
digestion experiments were undertaken with the analyte in solution, therefore 
it was thought that solid phase captured oligonucleotides may behave 
differently and may require a higher amount of RNase A for efficient cleavage. 
To test this hypothesis additional RNase A was added to the assay which was 
then incubated for a further period of time. HPLC-ESI MS analysis of a second 
sample again showed no evidence of nucleic acid species making this an 
unlikely explanation. Alternatively, RNase A may have been unable to reach the 
RNA due to steric hindrance caused by the high density of oligonucleotides on 
the surface of the beads. 5.  Indirect Analysis of RNA Using Self-Reporting Probes 
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The aforementioned theories were based on the assumption that the analyte 
and detection probe had successfully hybridised to the immobilised capture 
probe. However, due to the high density of capture probes on the beads, steric 
and/or electrostatic hindrance may have prevented access to the analyte and 
the detection probe meaning they could not hybridise. Peterson et al.
[127] 
reported that the hybridisation efficiency of a single stranded DNA 
oligonucleotide to its gold-thiol immobilised complementary single strand was 
inversely proportional to capture probe density. 
Therefore, an experiment was undertaken to determine whether the analyte 
and detection probe were successfully hybridising to the immobilised capture 
probe. For this assay, miR-155 was used as the target analyte along with the 
LNA capture probe and LNA detection probe 1. In addition, a control assay 
which omitted miR-155 was undertaken.  After capture probe immobilisation, 
hybridisation and a simple wash step, the assay was heated to 90 °C, the beads 
quickly isolated and the solution removed. If the analyte and detection probe 
were hybridised to the immobilised capture probe, this heating step would 
denature the duplex, releasing the analyte and detection probe into solution 
for detection by HPLC-ESI MS. For the control assay, the detection probe was 
not expected to remain after the washing steps due to the absence of miR-155. 
As expected, using HPLC-ESI MS analysis no detection probe was observed in 
the control sample (Figure 5-5). A small amount of capture probe was observed 
however, eluting at t
R 8.1 minutes. This showed that heating to 90 °C under the 
conditions used was sufficient to break the biotin-streptavidin interaction. It 
has been reported that this can occur under low salt conditions at elevated 
temperatures.
[128] It is worth noting that the broad peak at t
R 3.5 minutes was 
also present in the blank sample analysed immediately prior to the assay 
sample. For the assay containing all three oligonucleotides, HPLC-ESI MS 
analysis of the solution following the 90 °C heating step showed similar results 
to the control assay. Neither miR-155 nor the detection probe were observed 
(Figure 5-6). This result showed that hybridisation between the analyte and the 
capture probe did not occur using the direct capture method. One potential 
solution would be to control the surface coverage of the capture probe on the 
beads to achieve a lower capture probe density. Alternatively, use of the 
indirect capture method was expected to solve the problem. Hybridisation of 5. Indirect Analysis of RNA Using Self-Reporting Probes 
  131     
the capture probe, analyte and detection probe in solution prior to 
immobilisation would avoid the problems presented by solid phase capture.  
 
Figure 5-5   HPLC-ESI  MS analysis of the direct capture hybridisation test 
control sample, showing (a) UV chromatogram and (b) negative ion ESI mass 
spectrum at t
R 8.1 min. 
 
Figure 5-6   HPLC-ESI  MS analysis of the direct capture hybridisation test 
sample, showing (a) UV chromatogram and (b) negative ion ESI mass spectrum at 
t
R 8.2 min. 
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5.1.3.2  Indirect Capture 
An assay was undertaken using the indirect capture approach, i.e. solution 
phase hybridisation of the capture probe, analyte and detection probe followed 
by immobilisation of the complex onto the beads. miR-155 was again used as 
the analyte along with the LNA probes and a control assay omitting miR-155 
was also performed. The same 90 °C heating method was undertaken to test 
the success of the hybridisation and immobilisation steps after indirect capture 
and a simple wash step. For the control assay, only the capture probe was 
observed upon HPLC-ESI MS analysis (Figure 5-7). For the assay containing 
miR-155 however, HPLC-ESI MS analysis showed the presence of the capture 
probe, miR-155 and the detection probe (Figure 5-8). This result proved that 
the indirect capture method resulted in successful hybridisation and 
immobilisation of the nucleotide complex and therefore this method was used 
for all subsequent experiments. 
 
Figure 5-7   HPLC-ESI  MS analysis of the indirect capture hybridisation test 
control sample, showing (a) UV chromatogram and (b) negative ion ESI mass 
spectrum at t
R 8.2 min. 
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Figure 5-8   HPLC-ESI  MS analysis of the indirect capture hybridisation test 
sample, showing (a) UV chromatogram and negative ion ESI mass spectra at t
R 
(b)
 7.4 min., (c) 8.0 min. and (d) 8.2 min. 
5.1.4  Wash Steps 
To ensure only the target RNA remained present and immobilised at the end 
of the assay, washing steps were required. Following hybridisation and 
immobilisation, the first washing steps involved isolating the oligonucleotides 
bound to the magnetic beads, removal of the solution and then washing with 
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hybridisation buffer solution, followed by a wash solution and then water.
[129] 
The hybridisation buffer consisted of 10 mM Tris and 1 M NaCl in sterile water 
and the wash buffer was 10 mM Tris and 0.1% sodium dodecyl sulfate (SDS) in 
sterile water.  
These simple washing steps would not remove non-target RNAs which may 
have been captured and formed a mismatched duplex with the capture and 
detection probes. Such mismatched duplexes could occur if non-target RNA 
with a sequence similar to that of the target RNA were present in the solution, 
such as could occur in a biological system. In this study, miR-155 single base 
substituted mutants were used to test the effectiveness of the washing steps 
and the resulting specificity of the assay. An additional thermal mismatch 
denaturation step was included to denature and remove any captured 
non-target RNA by increasing the temperature for a short period of time. This 
step was based on the lower thermal stability, i.e. lower T
m, of the non-target 
RNA· probe duplexes, compared to the target analyte·probe duplex, caused by 
the mismatched base pair. Following thermal denaturation, a second series of 
washing steps was performed to remove the non-target RNA and associated 
detection probes.  
5.1.4.1  Melting Temperature Experiments 
As the temperature of an oligonucleotide duplex increases, the hydrogen 
bonds between strands break and the duplex denatures into two single 
strands. The melting temperature (T
m) of an oligonucleotide duplex is defined 
as the temperature at which 50% is in double stranded form and 50% is in 
single stranded form. T
m can be measured by recording the UV absorbance of 
an oligonucleotide solution whilst increasing the temperature, which produces 
a melting curve (Figure 5-9 (a)). The maximum point of the first order 
derivative of the melting curve can be used to easily identify the T
m (Figure 
5-9 (b)). At lower temperatures, complementary oligonucleotides adopt the 
double helical structure which is stabilised by hydrogen bonding and base 
stacking. As the temperature increases, hydrogen bonds break and the 
oligonucleotide denatures into single strands. UV absorbance by 
oligonucleotides is due to the aromatic structure of the bases. When an 
oligonucleotide is in duplex form, bases are stacked and are on the interior of 5. Indirect Analysis of RNA Using Self-Reporting Probes 
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the double helix. As an oligonucleotide denatures into single strands the bases 
become exposed and are therefore able to absorb more UV light.  
 
Figure 5-9   Example (a) melting curve with oligonucleotide illustrations and 
(b) first order derivative of the melting curve  
The optimum temperature required for the thermal mismatch denaturation 
step was dependent on the T
ms of the duplexes involved. Therefore, T
ms of 
duplexes formed between the complementary regions of the capture probe or 
the detection probes with matched or mismatched analytes were measured 
(Table 5-3). DNA probes and LNA probes were both investigated to determine 
whether LNA probes would provide better specificity during the hybridisation 
assay. For future development of this assay into a multiplexed assay, detection 
probes 1 and 2 will both be analysed in order to ensure that the thermal 
mismatch denaturation temperature will be suitable for the multiplexed assay.  
(a)  (b)  T
m 
Temp (°C)   Temp (°C) 
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b
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p
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Oligonucleotides  Complementarity 
LNA capture probe  +  miR-155  Match 
LNA capture probe  +  Scrambled  - 
DNA capture probe  +  miR-155  Match 
DNA capture probe  +  Scrambled  - 
LNA detection probe 1  +  miR-155  Match 
LNA detection probe 1  +  RNA-c  +C·C mismatch 
LNA detection probe 1  +  RNA-a  +C·A mismatch 
LNA detection probe 1  +  RNA-u  +C·U mismatch 
LNA detection probe 1  +  Scrambled  - 
LNA detection probe 2  +  miR-155  +G·G mismatch 
LNA detection probe 2  +  RNA-c  Match 
LNA detection probe 2  +  RNA-a  +G·A mismatch 
LNA detection probe 2  +  RNA-u  +G·U mismatch 
LNA detection probe 2  +  Scrambled  - 
DNA detection probe 1  +  miR-155  Match 
DNA detection probe 1  +  RNA-c  C·C mismatch 
DNA detection probe 1  +  RNA-a  C·A mismatch 
DNA detection probe 1  +  RNA-u  C·U mismatch 
DNA detection probe 1  +  Scrambled  - 
DNA detection probe 2  +  miR-155  G·G mismatch 
DNA detection probe 2  +  RNA-c  Match 
DNA detection probe 2  +  RNA-a  G·A mismatch 
DNA detection probe 2  +  RNA-u  G·U mismatch 
DNA detection probe 2  +  Scrambled  - 
Table 5-3   Combinations of oligonucleotides studied to determine melting 
temperatures 5. Indirect Analysis of RNA Using Self-Reporting Probes 
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Ideally, the mismatch denaturation temperature would be between the T
m of 
the most stable mismatched duplex and the T
m of the least stable matched 
duplex (ΔT
m(assay)). This is illustrated in Figure 5-10, where at the assay 
temperature chosen (dotted black line), all mismatched sequences (red) are 
denatured whilst all matched sequences (green) remain in duplex form, still 
captured on the streptavidin beads. This would result in an assay which is 
specific for the chosen analyte. A larger ΔT
m(assay) value means an assay has a 
higher capability to be specific for a chosen analyte. 
 
Figure 5-10   Illustrated example showing how melting curves were used to 
determine the temperature of the mismatch denaturation step of the 
hybridisation assay 
The shape of the melting curve can also influence the specificity of the assay. 
Both illustrations in Figure 5-11 have the same ΔT
m(assay) value, but the steeper 
slope of the curve in Figure 5-11 (a) would mean that at the mismatch 
denaturation temperature all mismatched duplexes would be denatured whilst 
all matched duplexes would remain bound in duplex form. However, for the 
curves in Figure 5-11 (b) there is no temperature where this would be the case; 
either some mismatched duplex remains bound or some matched duplex 
becomes denatured.  
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Figure 5-11   Illustrated example showing how melting curve shape can 
influence specificity of a hybridisation assay 
Results of melting temperature studies (Table 5-4) showed that LNA probes 
formed more stable duplexes with the RNA analytes than DNA probes did. LNA 
probes formed duplexes with RNA with T
m increases ranging from 16.2 °C to 
27.9 °C, with a mean average of 22.0 °C. 
Oligonucleotides 
DNA probes 
T
m (°C) 
LNA probes 
T
m (°C) 
Capture probe + miR-155  45.3*  61.5* 
Capture probe + Scrambled  39.7
†  35.6 
Detection probe 1 + miR-155  55.7  81.8 
Detection probe 1 + RNA-c  23.4  51.3 
Detection probe 1 + RNA-a  33.9  54.0 
Detection probe 1 + RNA-u  31.5  53.1 
Detection probe 1 + Scrambled  39.0  - 
Detection probe 2 + miR-155  33.8  57.0 
Detection probe 2 + RNA-c  51.2  74.0 
Detection probe 2 + RNA-a  34.1  50.6 
Detection probe 2 + RNA-u  38.2  62.1
† 
Detection probe 2 + Scrambled  39.7  - 
Table 5-4   T
ms of complementary sections of oligonucleotides. Bold = fully 
complementary duplexes. *T
m(matched
lowest), 
†T
m(mismatched
highest) 
Thermal mismatch 
denaturation temperature 
Matched 
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Temp (°C)  
A
b
s
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To determine which probes to use for the hybridisation assay the 
discrimination between matched and mismatched duplexes of analyte and 
detection probe was analysed. T
m differences between the fully complementary 
duplexes and duplexes containing a single base mismatch were calculated 
using Equation 5-1.  
ΔTm(matched – mismatched) = T
m(matched) – T
m(mismatched)
  Equation 5-1 
Results of this analysis (Figure 5-12) showed that for duplexes containing 
C·A, C·U and G·A mismatches, the LNA detection probe provided improved 
mismatch discrimination compared to the DNA probe. However, the G·G 
mismatch showed no significant difference and for the C·C and G·U 
mismatches the inverse was true, i.e. LNA probes showed a decrease in 
mismatch discrimination compared to DNA probes. The poorer +G·U mismatch 
discrimination was not surprising as it was reported that LNA probes caused a 
decrease in the mismatch discrimination of the +G·T mismatch compared to 
DNA probes at a G·T mismatch.
[125, 126] However, the result for the C·C mismatch 
was unexpected and contrary to previous reports. The +C·C mismatch was 
reported as being the least stable mismatch and that using an LNA probe 
improved the level of mismatch discrimination,
[126] which was the basis for 
choosing to use it in this study. 
 
Figure 5-12   Differences in T
m (°C) between matched and mismatched base 
pairs calculated using Equation 5-1 for LNA probe-analyte (blue) and DNA probe-
analyte (red) duplexes. Error bars show ± 1 standard deviations from four 
temperature ramps of one sample 
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It was expected that LNA probes would provide a greater ΔTm(assay) value 
(explained in Figure 5-10). ΔTm(assay) was calculated using Equation 5-2. 
ΔTm(assay) = T
m(matched lowest) – T
m(mismatched highest)
  Equation 5-2 
Using the values indicated in Table 5-4 (* and 
†), ΔTm(assay) for the DNA 
probes was calculated to be 5.6 °C and ΔTm(assay) for the LNA probes was 
−0.6 °C. The negative value for the LNA probes occurred due to the relatively 
high T
m of the +G·U mismatched duplex. This meant that the +G·U mismatched 
detection probe 2·RNA-u duplex had a higher T
m than the matched capture 
probe·miR-155 duplex. This meant it would not be possible to remove the 
mismatched analyte without removing the matched analyte, meaning the assay 
could not be specific for the desired miR-155 analyte. This situation was partly 
due to the decrease in mismatch discrimination using LNA probes for the G·U 
mismatched base pair. It was also partly due to the large difference in T
m of the 
matched capture probe·analyte duplex and the matched detection probe(s)-
analyte(s), where ideally the T
ms would be as close as possible. Excluding the 
result for the +G·U mismatched duplex and using the next highest mismatched 
T
m, ΔTm(assay) using LNA probes would be 4.6 °C.  
From analysis of T
m values alone, DNA probes appeared to provide superior 
mismatch discrimination. However, analysis of melting curve shapes suggested 
that LNA probes would provide superior mismatch discrimination. LNA 
probe·RNA duplexes showed a more defined transition from duplex to single 
stranded form than DNA probe·RNA duplexes, which was not evident from the 
T
m values or results in Figure 5-12. This meant that at the temperature where 
all matched duplexes remained in duplex form a greater amount of 
mismatched analytes were removed, this allowing the potential for higher 
specificity. T
m values suggested that a limitation to this assay would be for the 
RNA-u mutant analyte, which due to its high T
m, would be indistinguishable 
from the target miR-155 analyte.  5. Indirect Analysis of RNA Using Self-Reporting Probes 
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Figure 5-13   Melting curves showing matched (green) and mismatched (red) 
duplexes formed between (a) DNA probes and RNA and (b) LNA probes and RNA. 
Absorbance has been normalised to 1 for ease of comparison 
Based on melting temperature analyses, LNA probes were chosen for use in 
the hybridisation assay. Results suggested they would provide a greater 
potential for higher specificity than DNA probes. Whilst there was one instance 
where this would not be the case, the sharper transition between duplex and 
single stranded form for LNA·RNA duplexes compared to DNA·RNA duplexes 
meant that in all other cases LNA probes were expected to provide superior 
specificity. 
The optimum temperature for the thermal mismatch denaturation step was 
determined to be 56 °C (Figure 5-13 (b), dotted line). At this temperature all 
matched duplexes should remain stable. However, some mismatched duplexes 
may also remain stable at this temperature. Use of a higher temperature to 
remove these mismatched duplexes would have compromised sensitivity and 
the possibility of quantification because matched duplexes would also be 
denatured and washed away.  
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5.2  Indirect Analysis of RNA via Bromine 
Labelled Cleavable Small Molecule Mass 
Tags 
Results from investigations into individual steps of the sandwich 
hybridisation assay discussed above were combined and used to design an 
assay for the indirect detection of miR-155. Briefly, the LNA capture probe, LNA 
detection probe 1 and miR-155 were hybridised in solution before being 
immobilised onto streptavidin coated magnetic beads, i.e. the indirect capture 
method. The beads were then washed using a simple washing procedure 
followed by heating to 56 °C to denature mismatched RNA. A further wash step 
using hybridisation buffer at 56 °C was then performed before the final wash 
steps using wash buffer and water at room temperature and suspension in 
ammonium acetate buffer. Analysis was performed at this stage to confirm that 
no oligonucleotides were present in solution and that any oligonucleotides 
observed in subsequent analyses were immobilised on the beads at this stage. 
The final stage of the assay was incubation with RNase A at 37 °C before 
HPLC-ESI MS analysis (Figure 5-14). HPLC-ESI MS analysis was chosen for 
analyses due to its higher sensitivity and better repeatability compared to 
MALDI-TOF MS as well as for the chromatographic advantages provided and the 
ability to automate sample analysis.  5. Indirect Analysis of RNA Using Self-Reporting Probes 
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Figure 5-14   Schematic of the indirect capture hybridisation assay using a 
self-reporting detection probe for detection of miR-155 with HPLC-ESI MS analysis 
Analysis of the supernatant after hybridisation and capture onto the beads 
showed no evidence of oligonucleotides present for either the experiment 
containing the miR-155 analyte or the control experiment (data not shown). 
This confirmed that any oligonucleotides observed during subsequent analyses 
were immobilised onto the beads at this point.  
Following incubation with RNase A, for the assay containing no analyte 
HPLC-ESI MS analysis showed no evidence of nucleic acid species (data not 
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shown). For the assay containing miR-155, HPLC-ESI MS analysis showed 
evidence of products originating from miR-155 as well as from the detection 
probe (Figure 5-15). Observation of products originating from miR-155 was 
unexpected because it should have remained in duplex form with the capture 
and detection probes and RNase A was supposedly specific for single stranded 
RNA. The presence of these digestion products did not interfere with the 
detection of mass tags because they did not possess a bromine label. 
Significantly, the bromine labelled dinucleotide mass tag Au
Br
p eluted at t
R 6.4 
minutes and was observed as the deprotonated molecule, with ions of equal 
intensity observed at m/z 713.97 and 715.97 (Figure 5-15 (b)). This result 
provided the proof-of-concept that bromine labelled small molecule mass tags 
could be used for the indirect detection of RNA using mass spectrometry.  5. Indirect Analysis of RNA Using Self-Reporting Probes 
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Figure 5-15 continued overleaf 
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Figure 5-15   HPLC-ESI MS analysis following a hybridisation assay for the 
indirect analysis of miR-155 using LNA capture probe, miR-155 and LNA detection 
probe 1. Showing (a) UV chromatogram and negative ion ESI mass spectra at t
R (b) 
6.4 min., (c) 6.6 min., (d) 6.8 min., (e) 7.7 min. and (f) 8.6 min. 
A second hybridisation assay was undertaken for the indirect detection of 
RNA-c using the LNA capture probe and LNA detection probe 2 (See Table 5-1 
and Table 5-2 for sequences). The same method was followed and once again 
the assay was found to be successful. As expected, no oligonucleotides were 
detected by HPLC-ESI MS in the ammonium acetate buffer prior to addition of 
RNase A for either the assay containing RNA-c or the control assay (data not 
shown). For the control assay, HPLC-ESI MS analysis of the solution after 
addition of RNase A showed no evidence of oligonucleotide species (data not 
shown). For the assay containing the RNA-c analyte however, digestion 
products relating to the analyte and detection probe were detected in solution 
following incubation with RNase A (Figure 5-16). Importantly, the mass tag Tu
Br
p, 
designed to be produced by detection probe 2 eluted at t
R 5.9 minutes and was 
observed as [Tu
Br
p − H]–, with equal intensity ions observed at m/z 704.94 and 
706.94, (Figure 5-16 (b)).  
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Figure 5-16 continued overleaf 
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Figure 5-16   HPLC-ESI MS analysis following a hybridisation assay for the 
indirect analysis of RNA-c using LNA capture probe, RNA-c and LNA detection 
probe 2. Showing (a) UV chromatogram and negative ion ESI mass spectra at (b) t
R 
5.9 min., (c) 6.1 min., (d) 6.4 min., (e) 7.7 min. and (f) 8.6 min. 
To test the specificity of the sandwich hybridisation assay, individual 
experiments were undertaken using the miR-155 analytes with single base 
substitution mutations at position 19; RNA-c, RNA-a and RNA-u as well as a 
scrambled sequence (see Table 5-1 for sequences). Out of these five RNA 
oligonucleotides, only miR-155 should give a signal for the mass tag Au
Br
p when 
used in an assay with detection probe 1. When used in an assay with detection 
probe 2, only RNA-c should give a signal for the mass tag Tu
Br
p.  
For comparison, EICCs of ions relating to the mass tags were constructed 
from the HPLC-ESI MS data acquired for each analysis. As shown above (Figure 
5-17), Au
Br
p was detected following the assay with miR-155 and detection probe 
1 and consequently a peak was observed in the EICC (Figure 5-17, pink line). 
For the assay undertaken with RNA-a and detection probe 1 a small peak 
relating to the mass tag was observed (Figure 5-17, green line). This result 
shows that the hybridisation assay would be unable to distinguish between 
miR-155 and RNA-a. For assays with the other three analytes (RNA-c, RNA-u 
and RNA-scrambled) and detection probe 1, no evidence of Au
Br
p was observed 
when a mismatched base pair was present (Figure 5-17, light blue, blue and 
orange lines, respectively). 
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Figure 5-17   EICCs of m/z 713.5-718.6 ([Au
Br
p – H]
-) for the hybridisation assays 
containing capture probe, detection probe 1 and RNA analyte; miR-155 (pink), 
RNA-c (light blue), RNA-a (green), RNA-u (blue) or RNA-scrambled (orange) 
For experiments undertaken using detection probe 2, only the target 
analyte, RNA-c, gave a peak in the EICC constructed of ions relating to the 
mass tag Tu
Br
p (Figure 5-18, light blue line). The other analytes which would 
have had a mismatched base pair, as well as the scrambled sequence, gave no 
peak in the EICC and no evidence of the mass tag was observed. These results 
showed that the assay had a high degree of specificity towards the target 
analyte and that the washing procedures were sufficient to remove mismatched 
analytes in most cases. 
 
Figure 5-18   EICCs of m/z 704.5-709.6 ([Tu
Br
p – H]
-) for the hybridisation assays 
containing capture probe, detection probe 2 and RNA analyte; miR-155 (pink), 
RNA-c (light blue), RNA-a (green), RNA-u (blue) or RNA-scrambled (orange) 
An experiment was undertaken to determine whether the developed 
hybridisation assay method could be used for multiplexed analysis. The two 
RNA analytes (miR-155 and RNA-c) and their detection probes (detection 
probes 1 and 2) were used together in the hybridisation assay. HPLC-ESI MS 
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following the assay showed that both mass tags Au
Br
p and Tu
Br
p were detected, 
with the two EICCs of ions relating to each mass tag both showing a peak 
(Figure 5-19). This result demonstrated the potential to use this approach for 
multiplexed analysis. 
 
Figure 5-19   EICCs of m/z (a) 713.5-718.6 (pink, [Au
Br
p – H]
–) and (b) 704.5-709.6 
(light blue, [Tu
Br
p – H]
–) for the hybridisation assay containing capture probe, 
miR-155, RNA-c, detection probe 1 and detection probe 2 
5.3  Conclusions 
A hybridisation assay was designed and used to successfully detect target 
RNA sequences via RNase A cleavable small molecule nucleotide mass tags. 
miR-155 was detected via the mass tag Au
Br
p and RNA-c was detected via the 
mass tag Tu
Br
p. 
Melting temperature analysis showed that duplex stability was higher for 
duplexes formed between RNA and LNA probes than duplexes formed between 
RNA and DNA probes. T
ms for RNA duplexes with LNA probes were on average 
22.0 °C higher than the equivalent RNA duplexes with DNA probes. Mismatch 
discrimination was found to be enhanced by the use of LNA probes compared 
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to DNA probes in most cases and therefore LNA probes were used for the 
hybridisation assays. 
The direct capture method, i.e. capture probe immobilisation followed by 
analyte and detection probe hybridisation, was found to be unsuccessful. 
Instead however, the indirect capture method of solution phase hybridisation 
of all three oligonucleotides followed by immobilisation was successful and 
was therefore used for the hybridisation assay.  
Melting temperatures of analyte·probe duplexes were used to determine 
that 56 °C was a suitable temperature for a thermal mismatch denaturation 
step. This temperature depends on the T
ms of the duplexes involved, therefore 
for an assay containing different analytes and detection probes melting 
temperature analyses would need to be undertaken using these 
oligonucleotides to determine the optimum thermal mismatch denaturation 
temperature. This step, along with the additional washing steps which used 
hybridisation buffer, wash buffer and water, successfully removed mismatched 
analytes and detection probes in all but one case. 
The multiplexing potential of the hybridisation assay was demonstrated by 
simultaneous analysis of two analytes via two different mass tags.  
 6. Concluding Remarks 
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6. CONCLUDING REMARKS 
6.1  Further Work 
The hybridisation assay designed has been demonstrated to provide 
qualitative results, however further experiments would be required to 
investigate the potential of using the assay for quantification. HPLC-ESI MS 
analysis of the mass tags Au
Be
p and Tu
Be
p at concentrations ranging from 0.1 to 
100 pmol/µL were undertaken and calibration curves constructed using EICC 
peak areas of ions relating to the mass tags. The calibration curves showed 
excellent linearity with R
2 values of 0.9997 and 0.9995 for Au
Br
p and Tu
Be
p, 
respectively (Figure 6-1). However, for the assay to provide quantitative results, 
the signal produced by a mass tag would need to be proportional to the 
amount of the analyte it was indirectly detecting. Hybridisation assays would 
need to be performed with a range of target analyte amounts and the 
correlation between mass tag signal and analyte amount could then be 
determined and a calibration curve constructed based on this correlation.  
 
Figure 6-1   EICC peak area of all isotopic peaks vs. oligonucleotide 
on-column of (a) [Au
Br
p  –  H]
– and (b) [Tu
Br
p  –  H]
– analysed using HPLC-ESI MS. Error 
bars show ±  1  SD from three replicate analyses. Linear trendlines (dashed lines) 
and R
2 values are shown. 
The potential to use this assay for multiplexed analysis was demonstrated 
by the simultaneous indirect analysis of two RNA analytes. This approach has 
the potential for a higher degree of multiplexing due to the variety of mass 
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tags it affords (Table 4-1). Demonstration of this multiplexing ability would be 
desirable to show the advantage of cleavable mass tags over fluorescent tags. 
Finally, applying the hybridisation assay to analysis of oligonucleotides in 
biological samples would be required to determine the potential significance of 
this approach to industrial and academic applications. 
6.2  Conclusions 
RNase A was used to digest bromine labelled RNA and the expected 
digestion products were formed after 5 minutes digestion time under the 
conditions used. No partially digested products or cyclic phosphate 
intermediates were observed (Chapter 3). HPLC-ESI MS was found to be capable 
of detecting mononucleotides whereas these species were not consistently 
observed using MALDI-TOF MS. HPLC-ESI MS was the preferred analysis method 
due to its superior repeatability and the advantages of separation and 
desalting provided by HPLC.  
The ribose-phosphate group was used as a built-in enzyme cleavable linker, 
which when combined with choice of enzyme and custom design of the 
oligonucleotide sequence allowed for the design of the digestion products. 
RNase A was used for digestion and the oligonucleotide sequences were 
custom designed as DNA/RNA chimeras. The use of chimeric sequences was 
required due to non-specific cleavage by RNase A occurring upon digestion of 
RNA. RNase A is commonly reported to be specific for cleavage of the 
phosphate group at the 3ʹ side of cytidine and uridine bases. However, 
cleavage at the 3ʹ side of adenosine and guanosine has also been reported
[113] 
and was observed during this study. Suggested methods of preventing this 
overdigestion were attempted, including the addition of NaCl and a reduction 
in RNase A concentration. Whilst use of these methods was observed to 
decrease the extent of overdigestion over time, they were not able to eliminate 
it completely. Normal digestion and overdigestion were determined to occur 
simultaneously. Overdigestion of nucleotide mass tags would compromise the 
multiplexing potential of the approach. Therefore, cytidine or uridine bases 
were only located at positions where RNase A cleavage was desired. All other 
nucleotides were deoxyribonucleotides which lacked the 2ʹ-OH group required 6. Concluding Remarks 
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for RNase A cleavage. The design of DNA/RNA chimeras gave greater control 
over digestion and the products formed than altering digestion conditions. Use 
of DNA/RNA chimeras was shown to successfully avoid the problem of 
overdigestion
[115] (Chapter 4). 
Incorporation of the custom designed DNA/RNA sequences into the reporter 
regions of detection probes afforded self-reporting probes which were 
successfully used in a hybridisation assay. After the hybridisation and washing 
steps of the assay, RNase A digestion of the probe generated the small 
molecule mass tags which were analysed using HPLC-ESI MS for the indirect 
detection of RNA. Use of the ribose-phosphate group as a built-in enzyme 
cleavable linker avoids the often time-consuming and expensive process of 
designing or synthesising a cleavable linker. Instead, this approach exploits 
the properties of the RNA molecule, which can be easily synthesised using well 
established, automated phosphoramidite chemistry. The multiplexing potential 
of the assay was demonstrated by the simultaneous analysis of two 
oligonucleotides
[116] (Chapter 5). 
The high specificity of the hybridisation assay would allow for differentiation 
of oligonucleotides of the same base composition and thus the same mass, but 
different sequence. Two such oligonucleotides could be simultaneously 
analysed via two different mass tags.  
LODs of the 21mer and 24mer analysed directly using HPLC-ESI MS were 
found to be 0.2 pmol ± 26% and 0.2 pmol ± 11%, respectively (Chapter 2). The 
LODs of the mass tags Tu
Br
p and Au
Br
p were found to be 0.5 pmol ± 16% and 
0.2 pmol ± 12%, respectively. The LODs of the mass tags were not found to be 
lower than the LODs of the oligonucleotides. However, the use of mass tags 
gives the possibility of obtaining lower LODs by designing detection probes 
with custom sequences to include multiple identical mass tags. This can lead 
to an increase in signal intensity, as demonstrated by a comparison of EICC 
peak areas of ONT-1-ii and ONT-1-iii (section 3.2.3). The peak area of the EICC 
of ions relating to the mass tag was increased over twofold for ONT-1-iii, which 
was designed to produce three identical mass tag molecules, compared to 
ONT-1-ii, which was designed to produce one mass tag molecule. Designing 
the reporter regions of detection probes to produce even more mass tag 6.  Concluding Remarks 
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molecules would provide further increases in signal intensity and lower LODs 
of the oligonucleotides being indirectly detected.  
This indirect approach offers the benefit of improved multiplexing potential 
compared to assays employing fluorescence detection. The simultaneous use 
of a total of fourten bromine labelled di- and trinucleotides would be possible. 
Additional multiplexing capabilities could be provided by use of different 
isotope labels, such as chlorine, or additional modification of the bases to alter 
the mass.  
 7.  Experimental 
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7. EXPERIMENTAL 
7.1  General Experimental Information 
7.1.1  Oligonucleotide Synthesis and Purification 
All oligonucleotides used in this study were synthesised in-house by ATDBio 
Ltd and Dr Nittaya Gale using an Applied Biosystems 394 automated DNA/RNA 
synthesiser. Standard DNA and RNA protected phosphoramidite monomers and 
solid support resins were purchased from Link Technologies Ltd (Lanarkshire, 
UK). The phosphoramidite monomers used for DNA/RNA/LNA chimera 
synthesis were dmf-dG-CE, Bz-dA-CE, Bz-dC-CE, dT-CE, 5-Br-rU-CE and Ac-rC 
(where the exocyclic amino protecting groups are denoted by dmf 
(dimethylformamidine), Bz (benzoyl) and Ac (acetyl) and CE is the β-cyanoethyl 
protecting group of the phosphate group). These phosphoramidite monomers 
were purchased from Link Technologies (Lanarkshire, UK) Ltd and Applied 
Biosystems Ltd (Paisley, UK). The LNA amidites used were LNA™-A(Bz), 
LNA™-mC(Bz), LNA™-G(dmf) and LNA™-T, purchased from Exiqon (Vedbæk, 
Denmark). All oligonucleotides were synthesised using the standard 1.0 μmol 
DNA phosphoramidite cycle, except where stated, with the following steps; 
acid catalysed detritylation, coupling, capping and iodine oxidation. 
Immediately prior to use, β-cyanoethyl phosphoramidite RNA and DNA 
monomers were dissolved in anhydrous acetonitrile, to a 0.1 M concentration. 
The LNA monomers were also dissolved in acetonitrile except LNA™-mC(Bz) 
which was dissolved in anhydrous tetrahydrofuran:acetonitrile (4:6, v/v) and 
left over 3 Å activated molecular sieves for 4 hours before use. Coupling time 
for the standard DNA monomers was 40 seconds and for the RNA and LNA 
monomers was 480 seconds. For the first monomer after the biotin TEG resin, 
coupling time was extend to 120 seconds using 5-benzylthio-1H-tetrazole as 
the coupling reagent. Oxidation time for the RNAs and LNAs was extended 
from 15 seconds to 40 seconds. Cleavage from the solid support and 
simultaneous exocyclic amino group deprotection was completed by exposing 
the solution to a mixture of aqueous ammonia and ethanol (3:1, v/v) for 12 7.   Experimental 
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hours at room temperature. For RNA, removal of the 2ʹ TBDMS protecting 
group was then performed. Following freeze drying, the deprotection was 
performed using dimethyl sulfoxide (DMSO)/triethylamine trihydrofluoride 
(TEA.3HF) (1.25:1.00, v/v) at 65 °C for 2.5 hours. Sodium acetate (3 M, 25 μL) 
was added followed by precipitation with n-butanol (1.5 mL). The reaction was 
held at 80 °C for 30 minutes before centrifugation at 12 g for 10 minutes. The 
supernatant was removed and the solid washed with ethanol (2 × 750 μL) 
before purification. 
Oligonucleotides were purified by reversed-phase HPLC using a Gilson 
system with a Phenomenex C8 column (10 μm, 10 mm × 250 mm). A binary 
gradient elution was used, with mobile phase A being 0.1 M triethylammonium 
acetate (TEAA) in water, pH 7.0 and mobile phase B being 0.1 M TEAA in 
water/acetonitrile (1:1, v/v), pH 7.0. A 20 minute run time was used with a flow 
rate of 4 mL/min and the following gradient: time in minutes (% buffer B); 0 (0); 
3 (0); 3.5 (5); 15 (45); 16 (100); 17 (100); 17.5 (0); 20 (0). Oligonucleotide 
elution was monitored by UV absorption. Following purification, 
oligonucleotides were desalted using NAP-25 and NAP-10 Sephadex columns 
(GE Healthcare), aliquotted into Eppendorf tubes and stored at −20 °C.  
7.1.2  MALDI-TOF MS 
Samples were prepared for MALDI-TOF MS analysis by spotting 1 μL Dowex 
H
+ ion exchange beads onto a MALDI plate for desalting,
[63] followed by 1 μL of 
sample solution and 1 μL of matrix and mixing within the pipette tip. A 
mixture of 3-hydroxypicolinic acid (3-HPA)/picolinic acid (PA) (10:1, w/w) in 
acetonitrile/water (1:1, v/v) was used as the matrix. The spot was left to dry 
under a stream of warm air. Positive ion data were acquired using a Micromass 
TofSpec 2E MALDI-TOF mass spectrometer in reflectron mode with an 
acceleration voltage of 20 kV and a pulse voltage of 3 kV. A nitrogen laser was 
used operating at a wavelength of 337 nm with a pulse duration of 5 ns. Each 
spectrum acquired was a summation of 5 laser shots and a total of 33 spectra 
were acquired by sampling in a spiral pattern around the sample spot. Data 
were analysed using MassLynx™ software v4.1. 7.  Experimental 
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7.1.3  HPLC-ESI MS 
Samples were prepared for HPLC-ESI MS analysis by diluting in water. For 
RNase A digestion samples, 1 μL of assay solution was diluted in 19 μL of 
sterile water in a plastic vial. For hybridisation assay samples, 5 µL of assay 
solution was diluted in 15 µL of sterile water in a plastic vial.  
HPLC separation was performed using a Dionex UltiMate 3000 liquid 
chromatography system with a quaternary solvent delivery system, UV/visible 
detector, heated column compartment and chilled autosampler (Dionex, Hemel 
Hempstead, UK). An Acquity UPLC BEH C18 column (1.7 μm, 1 mm × 100 mm, 
Waters, Milford, MA, USA) was used for separation. The column temperature 
was 40 °C and UV absorbance was measured at 290 nm. A binary gradient 
solvent system was used with mobile phase A consisting of 10 mM TEAA and 
100 mM hexafluoroisopropanol (HFIP) in water and mobile phase B consisting 
of 20 mM TEAA in acetonitrile. For analysis of intact oligonucleotides, mobile 
phase B was at 5% for 1 minute, then increased to 40% over 14 minutes and 
then returned to 5% until 18 minutes. For analysis of digested samples, mobile 
phase B was at 1% for 1 minute, then increased to 20% over 7 minutes, then 
increased to 40% over 2 minutes and then returned to 1% until 13 minutes. The 
flow rate was 100 μL/min and a 2 μL injection volume was used. Negative ion 
ESI data were acquired using a micrOTOF (Bruker, Bremen, Germany) mass 
spectrometer over the m/z range 250 − 3500. Data were analysed using Data 
Analysis™ software v4.0. 
7.1.4  Experiments using RNA 
Work was undertaken in a sterile environment regularly with a solution of 
water/ethanol (70:30, v/v) and irradiated under UV light. Water used 
throughout was obtained from an Elga system at 15 MΩ and for studies 
involving RNA nucleotides the water was autoclaved and irradiated under UV 
light prior to use to achieve sterile water.  7.   Experimental 
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7.2  Experimental Details for Chapter 2 
Freeze dried aliquots of oligonucleotides used for this study were dissolved 
in water and their concentration determined by optical density (OD) 
measurements. OD measurements were made using a Varian Cary 50 Bio 
UV-visible spectrophotometer with detection at 260 nm. Samples were 
prepared in Hellma SUPRASIL synthetic quartz cuvettes with a 10 mm path 
length. Oligonucleotides were then diluted to the desired concentrations using 
water and analysed using MALDI-TOF MS and HPLC-ESI MS. 
7.3  Experimental Details for Chapter 3 and 
Chapter 4 
7.3.1  Buffer Preparation 
220 mM ammonium acetate buffer was prepared by dissolving ammonium 
acetate (16.96 mg/mL, ≥99.0%, for molecular biology (Fluka)) in sterile water 
followed by filtering and degassing.  
7.3.2  RNase A Digestion of RNA and DNA/RNA 
chimeras 
Freeze dried aliquots of RNA or DNA/RNA chimeras were dissolved in 
220 mM ammonium acetate buffer and then split into an assay sample and a 
control sample. Prior to addition of RNase A, samples were taken and prepared 
for analysis by HPLC-ESI MS (1 μL) and MALDI-TOF MS (1 μL). RNase A was 
dissolved in 220 mM ammonium acetate buffer and was then added to the 
assay sample, whereas no RNase A was added to the control sample. The total 
volume of each assay was approximately 45 μL. The final concentration of RNA 
in the assay solution was 2 μg/μL and the amount of RNase A added 
corresponded to 0.1 Kunitz units per μg RNA. The assay sample and the 
control sample were incubated at 37 °C for 5 minutes and then samples were 7.  Experimental 
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taken and prepared for analysis by HPLC-ESI MS (1 μL) and MALDI-TOF MS 
(1 μL). 
7.4  Experimental Details for Chapter 5 
7.4.1  Buffer Preparation 
Hybridisation buffer was prepared by dissolving Tris (Trizma® Base, 
Biotechnology Performance Certified (Sigma)) to a concentration of 10 mM 
(1.21 mg/mL) and NaCl (Biotechnology Performance Certified (Sigma)) to a 
concentration of 1 M (58.51 mg/mL) in sterile water and adjusting to pH 7.2 
using HCl (BioReagent (Sigma)). The buffer was then filtered and degassed. 
This hybridisation buffer was used for melting temperature analyses (7.4.2) 
and the hybridisation assay using indirect capture (7.4.4). For the hybridisation 
assay using direct capture, 0.1% (w/v) bovine serum albumin (BSA) (1 mg/mL) 
was added as indicated (7.4.4). 
Wash buffer was prepared by dissolving Tris (Trizma® Base, Biotechnology 
Performance Certified (Sigma)) to a concentration of 10 mM (1.21 mg/mL) in 
sterile water and adding 0.1% (w/v) sodium dodecylsulfate (SDS) (1.00 mg/mL). 
The buffer was then filtered and degassed. 
7.4.2  Melting Temperature Experiments 
Melting temperature analyses were performed using a Varian Cary 400 Scan 
UV-visible spectrophotometer with monitoring at 260 nm. Oligonucleotide 
probes were present at 2.0 µM and oligonucleotide analytes were present at 
1.0 µM in a final volume of 1 mL hybridisation buffer.  
From a starting temperature of 20 °C, an initial ramp to 85 °C at a rate of 
10 °C/min was performed for denaturation. The temperature was then lowered 
to 20 °C at 1 °C/minute for annealing, held at 20 °C for 2 min and was then 
increased to 85 °C at a rate of 1 °C/min. This cycle was repeated before a final 
fast annealing ramp from 85 °C to 20 °C at 1 °C/min (Figure 7-1). Data acquired 7.   Experimental 
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from temperature ramps 2, 3, 4 and 5 were used for calculations and were 
analysed using Origin v8.5.1. 
 
Figure 7-1   Temperature ramp used for melting temperature studies 
7.4.3  Washing Procedure for the Streptavidin Coated 
Magnetic Beads 
Prior to use, the bottle of streptavidin coated magnetic beads (Dynabeads® 
MyOne Streptavidin C1, 10 mg/mL (Invitrogen, Oslo, Norway)) was vortexed for 
30 seconds to resuspend the beads in solution. The required amount of beads 
was then transferred to an Eppendorf tube, the beads isolated using a 
magnetic sample rack (Dynal Magnetic Particle Concentrator MPC®-S 
(Invitrogen, Oslo, Norway)), the supernatant removed and the beads washed 
with binding buffer (3 × ≤1 mL, with the volume of binding buffer being 500 µL 
per 300 µg beads). 
7.4.4  Capture and Immobilisation using Direct 
Capture 
Two assays were undertaken during this initial investigation with the 
following oligonucleotides (see Table 5-1 and Table 5-2 for sequences): 
Assay 1: LNA capture probe, miR-155 and LNA detection probe 1 
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For each assay, pre-washed streptavidin coated magnetic beads (3 µL, 
30 µg) were suspended in hybridisation buffer (20 µL). To each assay was 
added LNA capture probe (150 pmol) in hybridisation buffer (150 µL) and the 
experiments were incubated at room temperature for 30 minutes. The beads 
were then isolated and washed with hybridisation buffer (2 × 200 µL) and 
hybridisation buffer with 0.1% BSA (2 × 200 µL).  
To assay 1 was added miR-155 (150 pmol) in hybridisation buffer with 0.1% 
BSA (50 µL) and LNA detection probe 1 (200 pmol) in hybridisation buffer with 
0.1% BSA (50 µL). To assay 2 was added LNA detection probe 1 (200 pmol) in 
hybridisation buffer with 0.1% (w/v) BSA (100 µL). The assays were heated to 
90 °C for 15 minutes and then left to cool to room temperature over 1 hour for 
hybridisation to take place.  
Beads were washed with hybridisation buffer with 0.1% BSA (2 × 200 µL), 
hybridisation buffer (2 × 200 µL), wash buffer (2 × 200 µL) and water 
(2 × 200 µL) before resuspension in hybridisation buffer (250 µL). The assays 
were then heated to 56 °C for 10 minutes and the beads washed with 
hybridisation buffer (2 × 200 µL at 56 °C), wash buffer (2 × 200 µL at 56 °C) 
and water (2 × 200 µL at 56 °C) before resuspension in ammonium acetate 
buffer (20 µL). Beads were isolated and a sample (5 µL) taken and prepared for 
analysis by HPLC-ESI MS.  
Assay 1 was heated to 37 °C and to it was added RNase A (0.13 Kunitz units, 
corresponding to 0.1 Kunitz units per µg LNA detection probe 1) in ammonium 
acetate buffer (5 µL). The assay was incubated at 37 °C for 5 minutes for 
digestion to occur. Beads were isolated and a sample (5 µL) taken and analysed 
by HPLC-ESI MS. This process was then repeated for assay 2.  
Due to failure to observe nucleic acid species upon analysis of assay 1, a 
further amount of RNase A (1.0 Kunitz units per µg LNA detection probe) in 
ammonium acetate buffer (50 µL) was added and the assay incubated at 37 °C 
for a further 5 minutes. A second sample (5 μL) was then taken and analysed 
by HPLC-ESI MS, although nucleic acid species were still not observed. 7.   Experimental 
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7.4.4.1  Hybridisation Test 
Two assays were undertaken during this test to determine whether 
hybridisation of miR-155 and LNA capture probe 1 was occurring using the 
indirect capture method: 
Assay 1: LNA capture probe (150 pmol), miR-155 (150 pmol) and LNA 
detection probe 1 (200 pmol) 
Assay 2: LNA capture probe (150 pmol) and LNA detection probe 1 
(200 pmol) 
The hybridisation assay was performed as described above (section 7.4.4) 
up to the point where the beads were washed after the hybridisation step 
(heating to 90 °C and cooling to room temperature over 1 hour). After this 
washing step, the beads were resuspended in ammonium acetate buffer 
(20 µL) and a sample (5 µL) from each assay was taken for HPLC-ESI MS 
analysis. The remaining solution was heated to 90 °C for 15 minutes. The 
beads were then quickly isolated and the supernatant was removed and 
transferred to another Eppendorf tube and allowed to cool to room 
temperature. Finally, a sample (5 µL) from each assay was analysed by HPLC-ESI 
MS.  
7.4.5  Capture and Immobilisation using Direct 
Capture; Hybridisation Test 
Two experiments were undertaken during this investigation with the 
following oligonucleotides (see Table 5-1 and Table 5-2 for sequences): 
Assay 1: LNA capture probe (300 pmol), miR-155 (300 pmol) and LNA 
detection probe 1 (400 pmol) in hybridisation buffer (500 µL) 
Assay 2: LNA capture probe (300 pmol) and LNA detection probe 1 
(400 pmol) in hybridisation buffer (500 µL).  
The assays were heated to 90 °C for 15 minutes and then left to cool to 
room temperature over 1 hour for hybridisation to take place. BSA was added 
(0.1% w/v) to each assay and each solution was transferred to an Eppendorf 
tube containing pre-washed streptavidin coated magnetic beads. The solutions 7.  Experimental 
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were vortexed and then incubated at room temperature for 30 minutes. Beads 
were isolated, washed with hybridisation buffer (2 × 400 µL), wash buffer 
(2 × 400 µL) and water (2 × 400 µL) and resuspended in ammonium acetate 
buffer (40 µL). Each assay was then divided. For one half (20 µL) the beads 
were isolated and a sample (5 µL) taken and analysed using HPLC-ESI MS. The 
remainder of this sample was then heated to 90 °C for 15 minutes, after which 
time the beads were quickly isolated, the supernatant removed and transferred 
to another Eppendorf tube and allowed to cool to room temperature. A sample 
(5 µL) was then analysed using HPLC-ESI MS.  
7.4.6  Hybridisation Assay 
Each hybridisation assay experiment was performed using LNA capture 
probe, an RNA analyte and an LNA detection probe. The RNA analyte used was 
either miR-155, RNA-c, RNA-a, RNA-u or RNA-scrambled and the LNA detection 
probe used was either LNA detection probe 1 or 2. Combinations of analyte 
and detection probe used and results of their analyses are discussed in section 
5.2.  
Each hybridisation assay contained LNA capture probe (150 pmol), RNA 
analyte (150 pmol) and LNA detection probe (200 pmol) in hybridisation buffer 
(250 µL). The assays were heated to 90 °C for 15 minutes and then allowed to 
cool to room temperature over 1 hour for hybridisation to occur.  Once cool, 
BSA (0.1% w/v) was added, the solution transferred to an Eppendorf tube 
containing pre-washed streptavidin coated magnetic beads (300 µg) and 
incubated at room temperature for 30 minutes. Beads were isolated, washed 
with hybridisation buffer (2 × 500 µL), wash buffer (2 × 500 µL) and water 
(2 × 500 µL) and resuspended in hybridisation buffer (250 µL). The solution 
was heated to 56 °C for 10 minutes, washed with hybridisation buffer at 56 °C 
(2 × 500 µL), wash buffer (2 × 500 µL) and water (2 × 500 µL) and resuspended 
in ammonium acetate buffer (20 µL). The solution was then heated to 37 °C, 
RNase A (0.2 Kunitz units per µg LNA detection probe) in ammonium acetate 
buffer (10 µL) added and incubated at 37 °C for 10 minutes. Beads were 
isolated and a sample (5 µL) taken and analysed using HPLC-ESI MS.  7.   Experimental 
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7.4.6.1  Multiplexed Hybridisation Assay 
For the hybridisation assay designed for the simultaneous analysis of 
miR-155 and RNA-c an assay was undertaken containing LNA capture probe 
(300 pmol), miR-155 (150 pmol), RNA-c (150 pmol), LNA detection probe 1 
(200 pmol) and LNA detection probe 2 (200 pmol) in hybridisation buffer 
(500 μL). The assay was heated to 90 °C for 15 minutes and then allowed to 
cool to room temperature over 1 hour.  Once cool, BSA (0.1% w/v) was added, 
the solution transferred to an Eppendorf tube containing pre-washed 
streptavidin coated magnetic beads (600 µg) and incubated at room 
temperature for 30 minutes. Beads were isolated, washed with hybridisation 
buffer (2 × 1 mL), wash buffer (2 × 1 mL) and water (2 × 1mL) and resuspended 
in hybridisation buffer (500 µL). ). The solution was heated to 56 °C for 10 
minutes, washed with hybridisation buffer at 56 °C (2 × 500 µL), wash buffer 
(2 × 500 µL) and water (2 × 500 µL) and resuspended in ammonium acetate 
buffer (40 µL). The assay was divided with one half set aside for possible future 
use. The other half was heated to 37 °C, RNase A (10 μL, 0.2 Kunitz units per 
μg LNA detection probe) in ammonium acetate buffer (10 μL) added and the 
solution incubated at 37 °C for 10 minutes. Beads were isolated and a sample 
(5 μL) taken and prepared for analysis by HPLC-ESI MS.  
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APPENDICES 
APPENDIX 1 – HPLC-ESI MS ANALYSIS OF INTACT OLIGONUCLEOTIDES 
USED IN CHAPTERS 3 AND 4 
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Res2099_t=0_2_RE2_01_5421.d: -MS, 7.1-7.2min, Deconvoluted (MaxEnt)
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Res2621_t=0_2_RA2_01_8400.d: -MS, 8.7-8.8min #(517-523), Background Subtracted, Background Subtracted
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Res2622_t=0_2_RA2_01_8546.d: -MS, 8.5-8.7min, Background Subtracted, Deconvoluted (MaxEnt)
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6163.42
Res2623_t=0_1_RA2_01_8692.d: -MS, 8.9-9.0min, Background Subtracted, Deconvoluted (MaxEnt)
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Res2623_t=0_1_RA2_01_8692.d: -MS, 8.9-9.0min #(530-536), Background Subtracted
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APPENDIX 2 – MELTING CURVES AND DERIVATIVES OF 
OLIGONUCLEOTIDES USED IN CHAPTER 5 
Melting curves (left) and first order derivatives of melting curves (right) for 
the oligonucleotides used in the hybridisation assay experiments discussed in 
Chapter 5 (see section 7.4.2 for experimental details). The maximum point of 
the first order derivative of the melting curve was labelled using Origin v8.5. 
The following legend applies to all melting curves and derivatives shown 
below: 
  
   
Temperature ramp 2 
Temperature ramp 3 
Temperature ramp 4 
Temperature ramp 5 
Average of temperature ramps 2, 3, 4 and 5 (10 points adjacent 
average smoothed) Appendix 2 
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s
Temp (oC)
 Res2771+Res2836  85.00-20.00°C Ramp 2
 Res2771+Res2836  20.00-85.00°C Ramp 3
 Res2771+Res2836  85.00-20.00°C Ramp 4
 Res2771+Res2836  20.00-85.00°C Ramp 5
 Average of B, C10, C20, C30
 10 pts AAv smooth of "Averaged Y" 
  DNA capture probe + miR-155 (fully complementary) 
 
 
DNA capture probe + Scrambled (non-complementary) 
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Temp (oC)
 Res2771+Res2779  85.00-20.00°C Ramp 2
 Res2771+Res2779  20.00-85.00°C Ramp 3
 Res2771+Res2779  85.00-20.00°C Ramp 4
 Res2771+Res2779  20.00-85.00°C Ramp 5
 Average of "Res2771+Res2779  85.00-20.00°C Ramp 2", "Res2771+Res2779  20.00-85.00°C Ramp 3", "Res2771+Res2779  85.00-20.00°C Ramp 4", "Res2771+Res2779  20.00-85.00°C Ramp 5"
 10 pts AAv smooth of "Averaged Y"
 
 
 
 
LNA capture probe + miR-155 (fully complementary) 
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 Res2762+Res2836  85.00-20.00°C Ramp 2
 Res2762+Res2836  20.00-85.00°C Ramp 3
 Res2762+Res2836  85.00-20.00°C Ramp 4
 Res2762+Res2836  20.00-85.00°C Ramp 5
 Average of B, C10, C20, C30
 10 pts AAv smooth of "Averaged Y"
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 Res2762+Res2779  85.00-20.00°C Ramp 2
 Res2762+Res2779  20.00-85.00°C Ramp 3
 Res2762+Res2779  85.00-20.00°C Ramp 4
 Res2762+Res2779  20.00-85.00°C Ramp 5
 Average of "Res2762+Res2779  85.00-20.00°C Ramp 2", "Res2762+Res2779  20.00-85.00°C Ramp 3", "Res2762+Res2779  85.00-20.00°C Ramp 4", "Res2762+Res2779  20.00-85.00°C Ramp 5"
 10 pts AAv smooth of "Averaged Y" LNA capture probe + Scrambled (non-complementary) Appendix 2 
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 Res2772 + Res2386  85.00-20.00°C Ramp 2
 Res2772 + Res2386  20.00-85.00°C Ramp 3
 Res2772 + Res2386  85.00-20.00°C Ramp 4
 Res2772 + Res2386  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 1 + miR-155 (fully complementary) 
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 Res2772 + Res2765  85.00-20.00°C Ramp 2
 Res2772 + Res2765  20.00-85.00°C Ramp 3
 Res2772 + Res2765  85.00-20.00°C Ramp 4
 Res2772 + Res2765  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 1 + RNA-c (C∙c mismatch) 
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0.88
A
b
s
Temp (°C)
 Res2772 + Res2766  85.00-20.00°C Ramp 2
 Res2772 + Res2766  20.00-85.00°C Ramp 3
 Res2772 + Res2766  85.00-20.00°C Ramp 4
 Res2772 + Res2766  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 1 + RNA-a (C∙a mismatch) 
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 Res2772 + Res2767  85.00-20.00°C Ramp 2
 Res2772 + Res2767  20.00-85.00°C Ramp 3
 Res2772 + Res2767  85.00-20.00°C Ramp 4
 Res2772 + Res2767  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 1 + RNA-u (C∙u mismatch) Appendix 2 
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Temp (°C)
 Res2763+Res2836  85.00-20.00°C Ramp 2
 Res2763+Res2836  20.00-85.00°C Ramp 3
 Res2763+Res2836  85.00-20.00°C Ramp 4
 Res2763+Res2836  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + miR-155 (fully complementary) 
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Temp (°C)
 Res2763+Res2765  85.00-20.00°C Ramp 2
 Res2763+Res2765  20.00-85.00°C Ramp 3
 Res2763+Res2765  85.00-20.00°C Ramp 4
 Res2763+Res2765  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + RNA-c (+C∙c mismatch) 
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0.66
0.68
0.70
0.72
0.74
0.76
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s
Temp (°C)
 Res2763+Res2766  85.00-20.00°C Ramp 2
 Res2763+Res2766  20.00-85.00°C Ramp 3
 Res2763+Res2766  85.00-20.00°C Ramp 4
 Res2763+Res2766  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + RNA-a (+C∙a mismatch) 
 
 
10 20 30 40 50 60 70 80 90
0.70
0.72
0.74
0.76
0.78
0.80
A
b
s
Temp (°C)
 Res2763+Res2767  85.00-20.00°C Ramp 2
 Res2763+Res2767  20.00-85.00°C Ramp 3
 Res2763+Res2767  85.00-20.00°C Ramp 4
 Res2763+Res2767  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + RNA-u (+C∙u mismatch) 
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0.490
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Temp (°C)
 Res2763+Res2836 + formamide  85.00-20.00°C Ramp 2
 Res2763+Res2836 + formamide  85.00-20.00°C Ramp 4
 Res2763+Res2836 + formamide  20.00-85.00°C Ramp 5
 Res2763+Res2836 + formamide  20.00-85.00°C Ramp 3
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + miR-155 + formamide (fully complementary) 
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 Res2763+Res2765 + formamide  85.00-20.00°C Ramp 2
 Res2763+Res2765 + formamide  20.00-85.00°C Ramp 3
 Res2763+Res2765 + formamide  85.00-20.00°C Ramp 4
 Res2763+Res2765 + formamide  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detection probe 1 + RNA-c + formamide (+C∙c mismatch) Appendix 2 
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Temp (°C)
 Res2773 + Res2386  85.00-20.00°C Ramp 2
 Res2773 + Res2386  20.00-85.00°C Ramp 3
 Res2773 + Res2386  85.00-20.00°C Ramp 4
 Res2773 + Res2386  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 2 + miR-155 (G∙g mismatch) 
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 Res2773 + Res2765  85.00-20.00°C Ramp 2
 Res2773 + Res2765  20.00-85.00°C Ramp 3
 Res2773 + Res2765  85.00-20.00°C Ramp 4
 Res2773 + Res2765  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 2 + RNA-c (fully complementary) 
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0.68
0.69
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0.71
0.72
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Temp (°C)
 Res2773 + Res2766  85.00-20.00°C Ramp 2
 Res2773 + Res2766  20.00-85.00°C Ramp 3
 Res2773 + Res2766  85.00-20.00°C Ramp 4
 Res2773 + Res2766  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 2 + RNA-a (G∙a mismatch) 
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 Res2773 + Res2767  85.00-20.00°C Ramp 2
 Res2773 + Res2767  20.00-85.00°C Ramp 3
 Res2773 + Res2767  85.00-20.00°C Ramp 4
 Res2773 + Res2767  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 DNA detection probe 2 + RNA-u (G∙u mismatch) Appendix 2 
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 Res2764+Res2836  85.00-20.00°C Ramp 2
 Res2764+Res2836  20.00-85.00°C Ramp 3
 Res2764+Res2836  85.00-20.00°C Ramp 4
 Res2764+Res2836  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detec tion probe 2 + miR -155 ( +G∙g mismatch) 
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 Res2764+Res2765  85.00-20.00°C Ramp 2
 Res2764+Res2765  20.00-85.00°C Ramp 3
 Res2764+Res2765  85.00-20.00°C Ramp 4
 Res2764+Res2765  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detec tion probe 2 + RNA -c ( fully  complementary)  
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 Res2764+Res2766  85.00-20.00°C Ramp 2
 Res2764+Res2766  20.00-85.00°C Ramp 3
 Res2764+Res2766  85.00-20.00°C Ramp 4
 Res2764+Res2766  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detec tion probe 2 + RNA -a (+G∙a mismatch) 
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 Res2764+Res2767  85.00-20.00°C Ramp 2
 Res2764+Res2767  20.00-85.00°C Ramp 3
 Res2764+Res2767  85.00-20.00°C Ramp 4
 Res2764+Res2767  20.00-85.00°C Ramp 5
 Averaged Y
 Smoothed Y1 LNA detec tion probe 2 + RNA -u ( +G∙u mismatch) Appendix 3 
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APPENDIX 3 – SELF REPORTING RNA PROBES AS AN ALTERNATIVE TO 
CLEAVABLE SMALL MOLECULE MASS TAGS, ANALYST 2012, 137, 24, 
5817 
Reproduced by permission of The Royal Society of Chemistry 
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APPENDIX 4 – SELF-REPORTING HYBRIDISATION ASSAY FOR RNA 
ANALYSIS, ANALYST 2014, ACCEPTED, DOI 10.1039/C3AN01825C 
Reproduced by permission of The Royal Society of Chemistry 
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